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Reported Tuberculosis in the United States, 
2011 presents summary data for tuberculosis 
(TB) cases verified and counted in 2011.  Re-
port of Verified Case of Tuberculosis (RVCT) 
forms are submitted to the Division of Tubercu-
losis Elimination (DTBE), Centers for Disease 
Control and Prevention (CDC), by 60 reporting 
areas (the 50 states, the District of Columbia, 
New York City, Puerto Rico, and seven other 
jurisdictions in the Pacific and Caribbean). First 
released in 1993, the RVCT was expanded in 
2009 to collect additional information for each 
reported TB case in order to better monitor 
trends in TB and TB control.  
Reported Tuberculosis in the United States, 
2011 is similar to previous publications (see 
page xi, #19) and contains an Executive Com-
mentary, Technical Notes, and six major sec-
tions. The Executive Commentary includes 
highlights of the 2011 data, and the Technical 
Notes section provides information about how 
the data were collected and reported; these sec-
tions are included to help the reader interpret 
the data. The 2011 report also includes a spe-
cial supplement section on the U.S. Affiliated 
Pacific Islands (USAPI).
Morbidity Trend Tables, United States present 
trends in the overall TB case counts and case 
rates by selected demographic and clinical 
characteristics. Morbidity Tables, United States, 
2011 present overall case counts and case rates 
for the United States by selected demographic 
characteristics. Morbidity Tables, Reporting 
Areas, United States, 2011 present TB case 
counts and case rates by state and other juris-
dictions with tables of selected demographic 
and clinical characteristics.  Morbidity Tables, 
Reporting Areas, United States, 2011 and 2009 
present data for the most recent year for which 
data are available on selected variables such as 
completion of therapy by reporting area. Mor-
bidity Tables, Cities and Metropolitan Statisti-
cal Areas, 2011 provide TB case counts and 
case rates by metropolitan statistical areas (MSAs: 
see Technical Notes, page 9, for further details) 
with tables of selected demographic and clinical 
characteristics. United States Affiliated Pacific 
Islands, 2011 presents an overview of USAPI 
TB programs and provides USAPI TB surveil-
lance data highlights. Surveillance Slide Set, 2011 
presents figures from the annual surveillance 
slide set, which emphasize key recent trends in 
TB epidemiology in the United States. The slides 
with accompanying text can also be viewed and 
downloaded from the DTBE website accessible at 
http://www.cdc.gov/tb/.  
The current Tuberculosis Case Definition for 
Public Health Surveillance and Recommendations 
for Reporting and Counting Tuberculosis Cases 
are provided in Appendices A and B, respectively 
(pages 139 and 140).  National Surveillance for 
Severe Adverse Events Associated with Treatment 
for Latent Tuberculosis Infection - Reporting In-




Previous Statistical Reports in this Series:
  1.   Special Tuberculosis Projects, 1961–1965. Atlanta:  CDC; 1966.
  2.   Special Tuberculosis Projects, December 1965. Atlanta:  CDC; 1966.
  3.   Special Tuberculosis Projects, June 1966. Atlanta:  CDC; 1967.
  4.   Special Tuberculosis Projects, December 1966. Atlanta:  CDC; 1967.
  5.   Summary Report. Atlanta:  CDC; 1967.
  6.   Special Tuberculosis Projects, June 1967. Atlanta:  CDC; 1968.
  7.   Tuberculosis Program Reports, December 1967. Atlanta:  CDC; 1968.
  8.   Tuberculin testing during 1966–1967 school year. In:  Tuberculosis Program Reports. Atlanta:   
 CDC; 1968.
  9.   Tuberculosis Program Reports: Six Month Period Ending June 1968. Atlanta:  CDC; 1969.
10.   Program Performance Analyses, June–December 1968. In: Tuberculosis Program Reports.             
 Atlanta: CDC; 1970.
11.   Tuberculin testing data, 1967–1968 school year. In: Tuberculosis Program Reports.                        
 Atlanta:  CDC; 1970.
12.   The project years, 1961–1969, In: Tuberculosis Program Reports. Atlanta:  CDC; 1970.
13.   Tuberculosis programs (for years 1970–1973). In: Tuberculosis Program Reports. Atlanta:              
 CDC; 1971–1974.
14.   Reported Tuberculosis Data (for years 1962–1973). Atlanta:  CDC; 1963–1974.
15.  Tuberculosis Statistics: States and Cities (for years 1974–1985). Atlanta:  CDC; 1971–1986.
16.   Tuberculosis in the United States (for years 1974–1986). Atlanta:  CDC; 1976–1987.
17.   Tuberculosis program management in the United States, 1984. In:  Tuberculosis Program   
 Reports. Atlanta: CDC; 1986.
18.   Tuberculosis Statistics in the United States (for years 1987–1992). Atlanta:  CDC: 1989–1993.
19.   Reported Tuberculosis in the United States (for years 1993–2010). Atlanta:  CDC: 1994–2011. 
Reports from 2006 through 2011 are available on the Internet at
http://www.cdc.gov/tb/statistics/
xii





























































Previous Statistical Reports in this Series ............................................................................................ xi
State TB Statistics on the Internet ....................................................................................................... xii
Executive Commentary ..........................................................................................................................3
Technical Notes ......................................................................................................................................9
Morbidity Trend Tables, United States
Table 1.  Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per 
100,000 Population, and Percent Change: United States, 1953–2011 ...........................................15
Table 2.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic 
Ethnicity and non-Hispanic Race: United States, 1993–2011 .......................................................16
Table 3.  Tuberculosis Cases and Percentages by Hispanic Ethnicity and non-Hispanic Race, and 
Origin of Birth: United States, 1993–2011 ....................................................................................17
Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age 
Group: United States, 1993–2011 ..................................................................................................18
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of 
Birth: United States, 1993–2011 ....................................................................................................18
Table 6.  Tuberculosis Cases and Percentages Among Foreign-born Persons by the Top 30 
Countries of Birth: United States, 2007–2011 ...............................................................................19
Table 7.  Tuberculosis Cases and Percentages Among Foreign-born Persons by the Top 30 
Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2011 .....20
Table 8.  Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease: 
United States, 1993–2011 ..............................................................................................................21
Table 9.  Tuberculosis Cases and Percentages by Resistance to INH, Origin of Birth, and 
Previous History of TB: United States, 1993–2011 .......................................................................22
Table 10.  Tuberculosis Cases and Percentages, by Multidrug Resistance, Origin of Birth, and 
Previous History of TB: United States, 1993–2011 .......................................................................23
Table 11.  Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly Observed 
Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2011 .........................24
xiv
Table 12.  Tuberculosis Cases and Percentages in Persons with HIV Test Results and with HIV 
Coinfection, by Age Group: United States, 1993–2011 .................................................................24
Table 13.  Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Stopped: United 
States, 1993–2009 ..........................................................................................................................25
Morbidity Tables, United States, 2011
Table 14.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age 
Group: United States, 2011 ............................................................................................................29
Table 15.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2011 ............................................................30
Table 16.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic 
Race, Sex, and Age Group: United States, 2011 ............................................................................31
Table 17.  Tuberculosis Cases in Foreign-born Persons by Hispanic Ethnicity and Non-Hispanic 
Race, Sex, and Age Group: United States, 2011 ............................................................................32
Table 18.  Tuberculosis Cases Among Foreign-born Persons by Country of Birth: United States, 
2011 ................................................................................................................................................34
Morbidity Tables, Reporting Areas, 2011
Table 19.  Tuberculosis Cases and Case Rates per 100,000 Population: Reporting Areas, 
2011 and 2010 ................................................................................................................................39
Table 20.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by 
Number of Cases: United States and the District of Columbia, 2011 and 2010 ............................40
Table 21.  Tuberculosis Cases and Percentages by Age Group: Reporting Areas, 2011 ...............42
Table 22.  Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race, 
U.S.-born and Foreign-born Persons: Reporting Areas, 2011 .......................................................44
Table 23.  Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons: 
United States, 2011 ........................................................................................................................46
Table 24.  Tuberculosis Cases and Percentages in Foreign-born Persons by Top 7 Countries of 
Birth: United States, 2011 ..............................................................................................................48
Table 25.  Tuberculosis Cases and Percentages in Foreign-born Persons by Number of Years in 
the United States: United States, 2011 ...........................................................................................50
Table 26.  Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease: 
Reporting Areas, 2011 ....................................................................................................................51
xv
Table 27.  Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: 
Reporting Areas, 2011 ....................................................................................................................52
 Morbidity Tables, Reporting Areas, 2011 and 2009
Table 28.  Tuberculosis Cases and Percentages by Residence in Correctional Facilities, Age >15:   
Reporting Areas, 2011 ....................................................................................................................57
Table 29.  Tuberculosis Cases and Percentages by Homeless Status,  Age >15: 
Reporting Areas, 2011 ....................................................................................................................58
Table 30.  Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,  
Age >15:  Reporting Areas, 2011 ...................................................................................................59
Table 31.  Tuberculosis Cases and Percentages by Injecting Drug Use,  Age >15: 
Reporting Areas, 2011 ....................................................................................................................60
Table 32.  Tuberculosis Cases and Percentages by Noninjecting Drug Use,  Age >15: 
Reporting Areas, 2011 ...................................................................................................................61
Table 33.  Tuberculosis Cases and Percentages by Excess Alcohol Use,  Age >15: 
Reporting Areas, 2011 ....................................................................................................................62
Table 34.  Tuberculosis Cases and Percentages by Primary Occupation,  Age >15: 
Reporting Areas, 2011  ...................................................................................................................63
Table 35.  Tuberculosis Cases and Percentages by Initial Drug Regimen: 
Reporting Areas, 2011  ...................................................................................................................64
Table 36.  Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results, 
by Resistance to INH or Multidrug Resistance: Reporting Areas, 2011 .......................................65
Table 37.  Tuberculosis Cases and Percentages by HIV Status: Reporting Areas, 2011 ...............66
Table 38.  Tuberculosis Cases and Percentages by Type of Health Care Provider: 
Reporting Areas, 2009 ...................................................................................................................67
Table 39.  Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): 
Reporting Areas, 2009 ...................................................................................................................68
Table 40.  Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy (COT): 
Reporting Areas, 2009 ...................................................................................................................69
Table 41.  Tuberculosis Cases and Percentages by Reason Therapy Stopped: 
Reporting Areas, 2009...................................................................................................................70
Table 42.  Completion of Tuberculosis Therapy (COT) Cases and Percentages by Hispanic 
Ethnicity and Non-Hispanic Race: Reporting Areas, 2009 ...........................................................72
xvi
Table 43.  Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom 
Therapy Was Indicated for One Year or Less: Reporting Areas, 2005–2009 ................................74
Morbidity Tables, Cities and Metropolitan Statistical Areas, 2011
Table 44. Tuberculosis Cases in Selected Cities: 2011 and 2010 ..................................................77
Table 45. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical 
Areas with >500,000 Population, 2011 and 2010 ..........................................................................78
Table 46. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000 
Population, 2011 ............................................................................................................................80
Table 47. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statis-
tical Areas with >500,000 Population, 2011 ..................................................................................82
Table 48. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Persons: 
Metropolitan Statistical Areas with >500,000 Population, 2011 ...................................................84
Table 49. Tuberculosis Cases and Percentages by Homeless Status, Age >15: 
Metropolitan Statistical Areas with >500,000 Population, 2011 ...................................................86








Appendix A: Tuberculosis Case Definition for Public Health Surveillance ................................139
Appendix B: Recommendations for Counting Reported Tuberculosis Cases .............................140
Appendix C: National Surveillance for Severe Adverse Events Associated with Treatment for 








Highlights of 2011 Report
Since 1953, in cooperation with state and local health departments, the United States national tubercu-
losis program has collected information on each newly reported case of tuberculosis (TB) disease in the 
United States.  Currently, each individual TB case report (Report of Verified Case of Tuberculosis, or 
RVCT) is submitted electronically. Following are the highlights of the 2011 report.
1. Updated case counts for each year from 1993 through 2010.
2. Case counts: 10,528 TB cases were reported to CDC from the 50 states and the District of Columbia 
(DC) for 2011, representing a 5.8% decrease from 2010 (Table 1).
Eighteen states reported increased case counts from 2010 (Table 20).• 
California, Texas, New York, and Florida accounted for 50% of the national case total (Table 19). • 
For the first time, Asians exceeded all other racial or ethnic groups with the largest percentage of total • 
cases (30%) (Table 2).
Hispanics, who since 2004 had the largest percentage of total cases, now comprise the second largest • 
racial or ethnic group (29%) (Table 2).
Blacks or African Americans born in the United States represented 39% of TB cases in U.S.-born • 
persons (Table 16) and accounted for approximately 15% of the national case total.
Asians born outside the United States represented 46% of TB cases in foreign-born persons (Table • 
17) and accounted for 29% of the national case total.
3. Case rates:  In 2011, the TB case rate declined from 3.6 to 3.4 per 100,000 persons, representing a 
6.4% decrease from 2010. 
Twelve states and DC reported rates above the national average (Table 19).• 
The TB case rate was 1.5 per 100,000 for U.S.-born persons and 17.2 for foreign-born persons • 
 (Table 5). 
Asians continued to have the highest case rate (20.9 per 100,000 persons) among all racial or ethnic • 
groups (Table 2).
4. Burden among the foreign-born:  In 2011, the percentage of cases occurring in foreign-born persons 
increased to 62% of the national case total. This percentage has risen steadily since 1993.
Foreign-born Hispanics and Asians together represented 80% of TB cases in foreign-born persons, • 
and accounted for 50% of the national case total (Table 17).
In 34 states, ≥ 50% of TB cases occurred among foreign-born persons (Table 23).• 
In 17 states, ≥ 70% of TB cases occurred among foreign-born persons (Table 23).• 
In 10 states, ≥ 75% of TB cases occurred among foreign-born persons (Table 23).• 
The top five countries of origin of foreign-born persons with TB were Mexico, the Philippines, Viet-• 
nam, India, and China (Table 6).
5. Drug resistance: 1.3% of reported cases had primary multidrug resistance, which is defined as no 
previous history of TB disease and resistance to at least isoniazid and rifampin (Table 10). 
6. HIV status: In 2011, 82% of persons with TB reported HIV test results.
Among persons of all ages, the percentage with HIV test results increased from 67% in 2010 to 82% • 
in 2011; among persons 25–44 years of age, reporting of HIV test results increased from 75% to 
90% (Table 12).
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The percentage of persons with TB who re-• 
ported HIV-positive results has remained the 
same (6%) since 2008 for persons of all ages. 
Among persons 25–44 years of age, 10% 
of persons with TB reported HIV-positive 
results; this percentage has remained between 
9%-10% since 2008(Table 12). The percent-
ages have declined since 1993, when 15% of 
persons with TB reported HIV-positive results 
among persons of all ages, and 29% for per-
sons between 25−44 years of age.
Tuberculosis in the United States
In 2011, the reported number of TB cases (10,528) 
and case rate (3.4 cases per 100,000) both de-
creased; these represented declines of 5.8% and 
6.4%, respectively, compared to 2010.  Since the 
1992 TB resurgence peak in the United States, the 
number of TB cases reported annually has de-
creased by 61% (Table 1).
TB case rates vary by well-known factors such 
as age, race and ethnicity, and country of origin. 
The proportion of total cases occurring in foreign-
born persons has been increasing since 1993.  In 
2011, 62% of TB cases occurred in foreign-born 
persons.  Foreign-born persons have accounted for 
the majority of TB cases in the United States every 
year since 2001.  Moreover, the case rate among 
foreign-born persons in 2011 was approximately 
11 times higher than among U.S.-born persons 
(Table 5).
Tuberculosis deaths decreased by 10%, from 590 
deaths in 2008 to 529 deaths in 2009.   The number 
of TB deaths reported annually has decreased by 
69% since 1992 (Table 1).
Age
Since 1993, TB case rates have declined annually 
for almost all age groups.  In 2011, TB case rates 
continued the trend with declines in all age groups.  
The highest burden of disease continues to be 
among older adults.  In 2011, adults aged 65 years 
and older had a case rate of 5.4 cases per 100,000, 
while children aged ≤ 14 years had the lowest rate 
at 0.9 cases per 100,000 (Table 4). 
Race and Ethnicity
In 2003, the race and ethnicity category “non-
Hispanic, Asian or Pacific Islander” was split into 
“non-Hispanic Asian” and “non-Hispanic Native 
Hawaiian or Other Pacific Islander.”  In 2011, 
Asians had the highest TB case rate at 20.9 cases 
per 100,000, which was a slight decrease from 21.5 
in 2010.  Native Hawaiians or Other Pacific Island-
ers had the second-highest TB case rate at 15.9 
cases per 100,000, which is a decrease compared 
to 19.0 cases per 100,000 reported in 2010.  Ow-
ing to low case numbers among Native Hawaiians 
or other Pacific Islanders, case rates fluctuate and 
must be interpreted with caution (Table 2).
Since 1993, TB case rates have declined between 
60% and 78% in the following racial and ethnic 
groups:  among Hispanic or Latinos, from 19.9 to 
5.8 cases per 100,000; among non-Hispanic blacks 
or African Americans, from 28.5 to 6.3 cases per 
100,000; among American Indian or Alaska Na-
tives, from 14.0 to 5.6 cases per 100, 000; and 
among non-Hispanic whites, from 3.6 to 0.8 cases 
per 100,000.  In 2011, the TB case rate for Asians 
remained approximately three times higher than 
that for Hispanics or blacks or African Americans 
(Table 2).
Origin of Birth
Since 1993, the TB case rate among U.S.-born 
persons has declined annually.  In 2011, the TB 
case rate for U.S.-born persons was 1.5 cases 
per 100,000, representing a 80% decrease from 
7.4 cases per 100,000 in 1993. The TB case rate 
among foreign-born persons also declined dur-
ing the same interval, though the decline was 
less substantial.  In 2011, the TB case rate among 
foreign-born persons was 17.2 cases per 100,000, 
representing a 49% decrease from 34.0 cases per 
100,000 in 1993 (Table 5). 
The proportion of TB cases among persons born in 
the United States has also declined annually since 
1993.  In 2011, 38% of TB cases were among U.S-
born persons compared to 69% in 1993 (Table 5).  
In 34 states, ≥ 50% of TB cases occurred among 
foreign-born persons.  In 17 states (California, 
Colorado, Connecticut, Delaware, Hawaii, Iowa, 
Maryland, Massachusetts, Minnesota, Nevada, 
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New Jersey, New York, North Dakota, Rhode 
Island, Utah, Washington, Wyoming), ≥ 70% of TB 
cases occurred among foreign-born persons (Table 
23).
Country of Origin and World Region
From 2007 through 2011, the top five countries 
of origin of foreign-born persons with TB were 
Mexico, the Philippines, India, Vietnam and China 
(Table 6).  The distribution of TB cases by world 
region of origin reflects immigration patterns 
among persons settling in the United States.1  Of 
the 6,510 TB cases reported among foreign-born 
persons in 2011, 38% occurred among persons 
born in the Americas region, and 31% occurred 
among persons born in the Western Pacific region 
(Table 18).  From 1993 through 2011, the propor-
tion of cases increased among persons born in the 
Eastern Mediterranean region (3% in 1993 to 4% 
in 2011), the Southeast Asia region (6% in 1993 to 
14% in 2011), and the Africa region (2% in 1993 
and 8% in 2011) (Table 18).
Multidrug-Resistant Tuberculosis
From 1993, when the RVCT was expanded to in-
clude drug-susceptibility results, the proportion of 
patients with primary multidrug-resistant (MDR) 
TB, which is defined as no previous history of 
TB disease and resistance to at least isoniazid and 
rifampin, decreased from 2.5% to 1.0% by 1998.  
However, there has been a slight increase in the 
percentage of primary MDR TB cases, from 0.9% 
of the total number of reported TB cases in 2008 
(88 cases), to 1.1% percent in 2009 (86 cases), 
to 1.2% in 2010 (89 cases), to 1.3% in 2011 (98 
cases). Since 1997, the percentage of U.S.-born pa-
tients with primary MDR TB has remained below 
1.0%.  However, of the total number of reported 
primary MDR TB cases, the proportion occurring 
in foreign-born persons increased from 25.3% (103 
of 407) in 1993 to 82.7% (81 of 98) in 2011 (Table 
10).
1 United States Department of Homeland Security. 2010 
Yearbook of Immigration Statistics. In: U.S. Department of 
Homeland Security, Office of Immigration Statistics; 2011.
Extensively Drug-Resistant Tuberculosis
CDC has included an updated case count of exten-
sively drug-resistant (XDR) TB cases from 1993 to 
2011 in the slide set that accompanies this report.  
XDR TB is defined as resistance to isoniazid and 
rifampin, plus resistance to any fluoroquinolone 
and at least one of three injectable second-line 
anti-TB drugs (i.e., amikacin, kanamycin, or 
capreomycin).2,3  Six cases were reported as XDR 
TB in 2011, compared with 1 case in 2010, 0 cases 
in 2009, and 5 in 2008. Of the 12 XDR TB cases 
reported since 2008, 11 were among foreign-born 
persons.
Tuberculosis Therapy
The proportion of TB patients prescribed an initial 
treatment regimen including at least isoniazid, 
rifampin, and pyrazinamide increased from 72% in 
1993 to 88% in 2011.  The proportion of patients 
who completed therapy within 1 year increased 
from 64% in 1993 to 88% in 2009 (the latest year 
for which complete outcome data are available).  
The proportion of persons receiving directly ob-
served therapy for at least a portion of the treat-
ment duration also increased from 36% in 1993 to 
90% in 2009, the latest year for which complete 
outcome data are available (Table 11).
HIV Status
Between 2010 and 2011, the proportion of persons 
with TB who reported HIV test results increased 
by 20% for all ages and 22% for persons aged 
25–44.  This increase is attributed to new reporting 
by states that were not previously reporting HIV 
test results.  The American Thoracic Society and 
the Infectious Diseases Society of America recom-
mend that all TB patients be counseled and tested 
for HIV.4 
2 Centers for Disease Control and Prevention. Revised 
Definition of Extensively Drug-Resistant Tuberculosis. 
MMWR Morb Mortal Wkly Rep 2006;55:1176.
3 Extensively drug-resistant tuberculosis (XDR-TB): rec-
ommendations for prevention and control. Wkly Epide-
miol Rec 2006;81:430-2.
4 CDC. Treatment of tuberculosis. American Thoracic 




Both the absolute number of TB cases and the TB 
case rate in the United States continued to decrease 
in 2011. With 10,528 total cases, representing a 
case rate of 3.4 cases per 100,000 persons, 2011 
had the lowest number of reported TB cases since 
reporting began in 1953.  Furthermore, the number 
of TB cases reported in 2011 and the correspond-
ing case rate decreased by approximately 6% from 
the previous year.  However, despite successful 
declines in TB cases and case rates over the past 
60 years, it is unlikely that current TB control and 
prevention efforts will result in TB elimination (<1 
case per 1,000,000 population)5 in this century.6 
 
Racial and ethnic minorities and foreign-born per-
sons continue to be disproportionately affected by 
TB.  In 2011, 84% of all TB cases occurred among 
persons who were Asian, black or African Ameri-
can, Hispanic, American Indian or Alaskan Na-
tive, or Native Hawaiian.  The TB case rate among 
Asians is 25 times higher than the TB case rate 
among non-Hispanic whites.  Asians accounted for 
30% of all TB cases reported in 2011, the highest 
percentage of any racial or ethnic group, and 96% 
of Asian TB patients were foreign-born.  
Since 2002, more than half of all TB cases reported 
in the U.S. have occurred among foreign-born per-
sons.  The gap between the proportion of TB cases 
among foreign-born and U.S.-born persons con-
tinued to widen in 2011, with 62% of all TB cases 
occurring among foreign-born persons.  TB control 
strategies that have been successful in reducing 
transmission among U.S.-born TB cases have had 
less success in controlling TB among foreign-born 
persons.7 Focusing on LTBI testing and treatment 
of foreign-born persons would likely be more 
successful in decreasing TB among this group.7 
Additionally, a new LTBI regimen that reduces 
5 Ending Neglect: The Elimination of Tuberculosis in the 
United States. Washington, DC: National Academy Press; 
2000.
6 Hill AN, Becerra JE, Castro KG. Modelling tuberculosis 
trends in the USA. Epidemiol Infect 2012;140(10):1862-
72.
7 Cain KP, Benoit SR, Winston CA, MacKenzie WR. 
Tuberculosis among foreign-born persons in the United 
States. JAMA. 2008;300(4):405-12.
treatment time may lead to better LTBI treatment 
completion among foreign-born persons.8
 
Continuing the decline in TB cases in the United 
States will require sustained focus on domestic TB 
control activities and further support of global TB 
control initiatives.9 Improving TB control among 
racial/ethnic minorities and foreign-born persons is 
imperative as the United States strives to prevent 
TB transmission and meet TB elimination goals.10 
8 Jereb JA, Goldberg SV, Powell K, Villarino E, LoBue 
P.  Recommendations for use of an Isoniazid-Rifapentine 
regimen with direct observation to treat latent Mycobacte-
rium tuberculosis Infection. MMWR Morb Mortal Wkly 
Rep.  2011;60(48):1650-3.
9 Centers for Disease Control and Prevention. Trends in 
tuberculosis – United States 2011. MMWR Morb Mortal 
Wkly Rep 2012;61(11):181-5.
10 Centers for Disease Control and Prevention. CDC’s 
response to ending neglect: the elimination of tuberculosis 
in the United States 2002. http://www.cdc.gov/tb/publica-





1Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Mi-
cronesia, Guam, the Republic of the Marshall Islands, the Republic of Palau, and U.S. Virgin Islands.
2CDC. Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment, 2007.  Atlanta: CDC, Division of 
Global Migration and Quarantine, revised September 2007; http://www.cdc.gov/ncidod/dq/pdf/ti_tb_8_9_2007.pdf. 
Technical Notes
National Surveillance for Tuberculosis
Reporting areas (i.e., the 50 states, the District of Colum-
bia, New York City, Puerto Rico, and other U.S. jurisdic-
tions in the Pacific and Caribbean1) report tuberculosis 
(TB) cases to CDC using a standard case report form, 
Report of Verified Case of Tuberculosis (RVCT), through 
2011. TB cases are verified according to the Tuberculosis 
Case Definition for Public Health Surveillance in Appendix 
A. TB cases are reported and counted according to the Rec-
ommendations for Reporting and Counting Tuberculosis 
Cases in Appendix B. 
The 2011 Report contains several new features:
Race/ethnicity information on TB cases is displayed • 
by origin of birth (U.S.-born or foreign-born) (Table 
3). 
Drug-resistance patterns are displayed in separate • 
tables with drug-resistance trend data by previous TB 
status and origin of birth (Tables 9 and 10).
California now reports HIV test results to CDC, re-• 
sulting in a significant improvement in the complete-
ness of HIV status reporting in 2011.
TB case data are shown by homeless status among • 
those 15 years of age or older by MSA (Table 49).
TB Case Definition
In 2009, the case definition was modified. TB cases are 
verified according to the following specified laboratory and 
clinical criteria.
Laboratory criteria for diagnosis
A case may be verified by the laboratory case definition 
with at least one of the following criteria: 1) isolation of 
M. tuberculosis complex from a clinical specimen, OR 2) 
demonstration of M. tuberculosis complex from a clinical 
specimen by nucleic acid amplification test (NAAT), OR 3) 
demonstration of acid-fast bacilli (AFB) in a clinical speci-
men when a culture has not been or cannot be obtained or 
is falsely negative or contaminated.
Clinical case criteria
A case may be verified by the clinical case definition in 
the presence of ALL of the following clinical criteria: 1) a 
positive tuberculin skin test (TST) result or positive inter-
feron gamma release assay (IGRA) result for M. tuberculo-
sis, AND 2) other signs and symptoms compatible with TB  
(e.g., abnormal chest radiograph, abnormal chest comput-
erized tomography scan or other chest imaging study, or 
clinical evidence of current disease, AND 3) treatment with 
two or more anti-TB drugs, AND 4) a completed diagnostic 
evaluation. 
Provider Diagnosis
Provider diagnosis is not a component of the case defini-
tion for TB as described in Appendix A. However, when 
cases of TB are diagnosed but do not meet either the clini-
cal or laboratory case definition, reporting areas have the 
option of verifying TB cases based on provider diagnosis 
as described in Appendix B. Through 2008, the RVCT did 
not collect information on IGRA results. If an IGRA was 
performed in lieu of the TST, then the RVCT would have 
indicated that the TST was not performed. Thus, culture- 
and smear-negative cases without a TST that are diagnosed 
by a positive IGRA result prior to 2008 were considered 
to have been confirmed by provider diagnosis. However, 
starting in 2009, positive results for an IGRA are included 
as part of the clinical case definition for TB confirmation. 
Anergic patients with a clinical presentation consistent 
with TB but without laboratory evidence of M. tuberculo-
sis complex would also be an example of provider diagno-
sis and one which has not changed over time.
TB Case Verification Criteria Calculation
The software for TB surveillance developed by CDC in-
cludes a calculated variable for TB case verification called 
“Vercrit,” which was modified in 2009.  The new variables, 
Nucleic Acid Amplification Test Result, Interferon 
Gamma Release Assay (IGRA) for Mycobacterium 
tuberculosis at Diagnosis, and Initial Chest CT Scan or 
Other Chest Imaging Study were added in the Vercrit 
calculation.
“Vercrit” is calculated by using the following criteria in 
hierarchical order:
Positive culture1. 
Positive nucleic acid amplification test2. 
Positive acid-fast bacilli test3. 
Clinical case confirmation4. 
Provider diagnosis5. 
Changes in Reporting and Counting TB Cases
In 2009, the Recommendations for Reporting and Count-
ing Tuberculosis Cases in Appendix B were modified. 
TB cases that are verified but not countable for morbidity 
statistics can now be reported to CDC as a measure of pro-
grammatic and case management burden. However, data 
on noncountable TB cases are incomplete and not included 
in this report. 
The recommendations for counting TB cases among immi-
grants, refugees,, and foreign visitors were revised based 
on the recommendations in the 2007 Technical Instructions 
for Tuberculosis Screening and Treatment for Panel Phy-
sicians.2 Regardless of of Panel Physician classification or 
citizenship status, immigrants and refugees examined after 
arriving in the United States and diagnosed with clinically 
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active TB requiring anti-TB medications should be report-
ed and counted by the locality of their current residence at 
the time of diagnosis. Foreign visitors diagnosed with TB, 
receiving anti-TB therapy, and planning to remain in the 
United States for 90 days or more should be reported and 
counted by the locality of current residence.
New and Expanded RVCT Variables
Data on demographic, clinical, laboratory, initial treatment, 
and treatment outcomes are collected through the RVCT’s 
three data collection reports:
Report of Verified Case of Tuberculosis: for all 1. 
patients with a verified case of TB.
Initial Drug Susceptibility Report (Follow-Up 2. 
Report 1): for all patients who had a culture that 
was positive for M. tuberculosis complex. 
Case Completion Report (Follow-Up Report 2): 3. 
for all patients who were alive when TB was 
diagnosed. 
In 2009, the RVCT was modified and expanded to include 
11 additional variables. Modifications to the RVCT ac-
commodate the changing epidemiology of TB in terms of 
risk factors, new drug treatments, and enhanced laboratory 
capacity for diagnostic tests.  These new variables will be 
made available in a future annual report.
The instructions for completing the RVCT forms and the 
definitions for all data items are available at: CDC. Report 
of Verified Case of Tuberculosis (RVCT) Instruction Man-
ual.  Atlanta, GA: U.S. Department of Health and Human 
Services, CDC, 2009.  http://www.cdc.gov/tb/programs/
rvct/InstructionManual.pdf. 
Tabulation and Presentation of TB Data  
This report presents summary data for TB cases reported 
to CDC in 2011. TB cases are tabulated by year in which 
the reporting area verified that the patient had TB and 
included the patient in its official annual TB case count. 
Since 2004, the published report has reflected updated 
information on the numbers of cases of confirmed TB for 
each year from 1993 onward. Totals for the United States 
include data from the 50 states, the District of Columbia 
(DC), and New York City.  
Trend data are presented in Tables 1 through 13, except 
Table 7, which now only presents number of years in the 
United States for 2011. Age group tabulations are based 
on the patient’s age in the month and year the patient was 
reported to the health department as a suspected TB case.  
State or metropolitan area data tabulations are based on the 
patient’s residence at diagnosis of TB.
Rates
Rates are expressed as the number of cases reported each 
calendar year per 100,000 population. Population de-
nominators used in calculating TB rates were based on 
official census and midyear postcensal estimates from the 
U.S. Census Bureau.  In Tables 1, 19, and 20, the U.S. 
total populations for 2000–2009 were taken from An-
nual Estimates of the Resident Population for the United 
States, Regions, States, and Puerto Rico (April 1, 2000 
to July 1, 2009); populations for 2010–2011 were taken 
from   Annual Estimates of the Population for the United 
States, Regions, States, and Puerto Rico (April 1, 2010 
to July 1, 2011). In 2003, two modifications were made 
to the RVCT form: 1) entries for multiple race (two or 
more races reported for a person) were allowed, and 2) the 
previous category of “Asian/Pacific Islander” was di-
vided into “Asian” and “Native Hawaiian or Other Pacific 
Islander.” To calculate rates in Table 2, denominators for 
2000–2011 were obtained from the Annual Estimates of 
the Resident Population by Sex, Race, and Hispanic Origin 
for the United States (April 1, 2000 to July 1, 2009) and 
Annual Estimates of the Resident Population by Sex, 
Race, and Hispanic Origin for the United States (April 1, 
2010 to July 1, 2011). The population source for nativity 
is the Current Population Survey and is used to calculate 
case rates for U.S. and foreign-born TB.  This population 
source includes populations for the 50 states and D.C., 
those born abroad of U.S. parents, and those born in U.S. 
outlying areas (the U.S.-affiliated areas) as the U.S-born 
population.  
To calculate rates for Table 4, denominators were obtained 
from the Annual Estimates of the Resident Population by 
Sex and Five-Year Age Groups for the United States (April 
1, 2000 to July 1, 2009) and Annual Estimates of the 
Resident Population by Sex and Five-Year Age Group for 
the United States (April 1, 2010 to July 1, 2011).  Denomi-
nators for computing 2011 rates in Table 15 were obtained 
from Annual Estimates of the Population by Sex, Race, 
and Hispanic or Latino Origin for the United States (April 
1, 2000 to July 1, 2011). In 2004, the method for calculat-
ing the annual percentage change in the TB case rate was 
modified. Unrounded figures are applied to calculate the 
percentage change in the case rate.
In Table 5, the populations for U.S.-born and foreign-born 
persons for 1993 and 1994 were obtained from Quarterly 
Estimates of the United States Foreign-born and Native 
Resident Populations: April 1, 1990–July 1, 1999.  De-
nominators for computing the 1995–2011 rates were based 
on extrapolations from the U.S. Census Current Population 
Survey (March Supplement). 
Mortality Data
Official TB mortality statistics for the United States are 
compiled by the National Center for Health Statistics 
(NCHS), CDC. The annual mortality rate is calculated as 
the number of deaths due to TB in that year, divided by the 
estimated population for the year, multiplied by 100,000 
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(Table 1). The number of deaths for 2009 was obtained 
from the NCHS, National Vital Statistics Report, Vol. 
60, No. 3, December 29, 2011. The finalized numbers of 
deaths for 2010 and 2011 were not available at the time of 
this publication.
Race and Ethnicity
Beginning with the 2011 report, Table 3 now includes  
information on TB cases and percentages by race/ethnicity 
and origin of birth (U.S.-born or foreign-born). 
Drug Resistance
Beginning with the 2011 report, drug-resistance patterns 
are displayed in separate tables with drug-resistance trend 
data by previous TB status and origin of birth. Isoniazid 
(INH) resistance and multidrug resistance (MDR) are 
shown in Tables 9 and 10, respectively.
Completion of Tuberculosis Therapy
Tables 11, 40, 42, and 43 present rates of completion of 
TB therapy (COT).  Data collected by RVCT Follow Up 
Report-2 on date and reason therapy stopped (e.g., patient 
completed therapy) were used to calculate rates of COT.  
Cases were stratified by the indicated length of therapy, 
based on American Thoracic Society/CDC/Infectious 
Diseases Society of America treatment guidelines3 in effect 
during the period covered, and the patient’s initial drug-
susceptibility test results, age, and site of disease.  
In Table 40, the first column shows the total number of 
cases reported during 2009.  The remaining columns are 
grouped under three headings: therapy of 1 year or less 
indicated therapy, greater than 1 year indicated, and over-
all. Patients eligible to complete therapy within 1 year had 
to have been alive at diagnosis, and initiated therapy with 
at least one drug. Eligible patients did not have rifampin 
resistance, did not die during therapy, did not move out of 
country during treatment, and did not have meningeal TB, 
regardless of age.  In addition, TB patients under the age 
of 15 were not eligible to complete therapy within 1 year if 
they had disseminated disease (defined as miliary tubercu-
losis and/or a positive tuberculosis blood culture). Patients 
with culture-negative disease, those with an unknown cul-
ture status, and those with culture-positive disease but un-
known initial drug-susceptibility test results were included 
under the category of 1 year or less of therapy indicated.    
In Table 40, each group under an indicated length of 
therapy has an initial column showing the number of cases 
in persons who were alive at diagnosis and prescribed an 
initial regimen of one or more drugs, and who did not die 
during therapy. This number was used as the denominator 
in COT rate calculations.
COT rates, shown as percentages, were only calculated 
for areas reporting reason therapy stopped for at least 90% 
of cases shown in the overall column. For the group with 
an indicated length of therapy of 1 year or less, rates are 
shown for both COT in 1 year or less (COT ≤1 year) and 
for COT, regardless of duration (i.e., duration of therapy 
≤1 year, >1 year, or unknown).  For COT ≤1 year, the 
numerator included only those patients completing therapy 
in ≤366 days (based on the dates therapy started and 
stopped).  Patients with missing dates were classified as 
“treatment not completed” for this calculation.
Rates of COT, regardless of duration, were calculated 
by dividing the number of patients reported as having 
completed therapy by the number of total eligible pa-
tients.  Patients with an outcome other than completed 
therapy (i.e., moved, lost, refused treatment, or other) were 
classified as “treatment not completed.”  Patients with an 
unknown outcome were also classified as “treatment not 
completed.”  For the remaining two groups of indicated 
therapy length (greater than 1 year and overall), only rates 
of COT, regardless of duration, are presented.  Table 12 
provides rates for COT ≤1 year and for COT, regardless of 
duration, only for the group with an indicated therapy of 
1 year or less.  Table 42 presents rates of COT by ethnic-
ity and non-Hispanic race and by state for those in whom 
therapy less than 1 year was indicated.
Because streptomycin is no longer being used as part of 
the standard treatment for TB disease, streptomycin has 
been removed from the calculated variable for initial drug 
regimen. Consequently, a separate column for the treat-
ment regimen of isoniazid, rifampin, pyrazinamide (IRZ), 
ethambutol, streptomycin (E/S) is no longer reported in 
Tables 11 and 35.
Site of TB Disease
Miliary disease is classified as both an extrapulmonary and 
a pulmonary form of TB (Tables 8, 26, and 27).  In pub-
lications prior to 1997, miliary disease was classified as 
extrapulmonary TB unless pulmonary disease was reported 
as the major site of TB disease.  Beginning in 2009, mil-
iary disease could not be classified as a site of TB disease 
because it is a clinical or radiologic finding and should be 
recorded under Initial Chest Radiograph, Initial Chest 
CT Scan, or Other Chest Imaging Study.
Reporting of HIV Status 
Information on HIV status for persons with TB is shown 
in Tables 12 and 37; Table 12 additionally shows trend 
data for persons aged 25–44 years. The completeness 
of reporting on HIV status among persons with TB has 
significantly improved to 90% of TB cases tested among 
persons aged 25–44 years in 2011; however, this variable 
is still underreported among jurisdictions. Data on the 
HIV-infection status of persons with reported TB cases 
should be interpreted with caution.  These data are not 
representative of all TB patients with HIV infection.  HIV 
3CDC.  Treatment of Tuberculosis, American Thoracic Society, CDC, and the Infectious Diseases Society of America.  MMWR 
2003;52(No.RR-11):1-77.  
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testing is performed after a patient receives counseling 
and gives informed consent.  TB patients who are tested 
anonymously may choose not to share the results of HIV 
testing with their health care provider.  TB patients man-
aged in the private sector may receive confidential HIV 
testing, but results may not be reported to the TB program 
in the health department.  In addition, many factors may 
influence HIV testing of TB patients, including the extent 
to which testing is targeted or routinely offered to specific 
groups (e.g., 25- to 44-year-old males, injecting drug us-
ers, homeless persons), and the availability of and access 
to HIV testing services.  These data may overrepresent or 
underrepresent the proportion of TB patients known to be 
HIV infected in a reporting area.
 
Primary Occupation for the Past Year
Table 34 now reflects the new 2009 RVCT variable, Pri-
mary Occupation Within the Past Year, which replaces 
the Occupation Within Past 24 months of TB Diagnosis 
in previous reports. Following the 2009 RVCT revision, 
“Multiple Occupation” was removed and the “Retired” and 
“Not Seeking Employment” categories were added.
Reason Therapy Stopped
Tables 13 and 41 report a new 2009 RVCT data entry op-
tion; these tables now include a patient’s adverse reaction 
to anti-TB drug therapy as an option for the reason therapy 
stopped. The 2009 RVCT revision removed the option 
of “Moved” as a valid response to the variable Reason 
Therapy Stopped; however, in 2009 data, the “Moved” 
option was still utilized by the following reporting areas: 
Alaska, California, Georgia, Iowa, and New York City. 
It is anticipated that future reports will not include the 
“Moved” option from 2009 forward.
Metropolitan Statistical Areas
Tables 45 through 49 present data by metropolitan statisti-
cal areas (MSAs) with an estimated 2011 population of 
500,000 or more. MSAs are defined by the federal Office 
of Management and Budget, and the definitions effective 
as of December 2009 were used for this publication (http://
www.whitehouse.gov/sites/default/files/omb/assets/bul-
letins/b10-02.pdf). Beginning with the 2011 report, Table 
49 will show TB cases by homeless status among those 15 
years of age or older by MSA.
On June 6, 2003, the OMB announced new MSA defini-
tions based on Census 2000 data, and the information has 
been updated annually. Some MSAs added or dropped 
counties and some MSAs merged. The MSA definitions 
apply to all areas except the six New England states; for 
these states, the New England County Metropolitan Areas 
(NECMAs) are used. MSAs are named for a central city 
in the MSA or NECMA, may include several cities and 
counties, and may cross state boundaries. For example, 
the TB cases and case rates presented for the District of 
Columbia in Table 19 include only persons residing within 
the geographic boundaries of the District. However, the TB 
cases and case rates for the Washington, D.C., MSA (Table 
45) include persons residing within the several counties 
in the metropolitan area, including counties in Maryland, 
Virginia, and West Virginia.   
A city/MSA with incomplete or unavailable data was not 
included in the tables, and some cities’ or MSAs’ total 







1953 84,304 52.6 -- -- 19,707 12.4 -- --
1954 79,775 48.9 -5.4 -7.0 16,527 10.2 -16.1 -17.7
1955 77,368 46.6 -3.0 -4.7 15,016 9.1 -9.1 -10.8
1956 69,895 41.4 -9.7 -11.1 14,137 8.4 -5.9 -7.7
1957 67,149 39.0 -3.9 -5.8 13,390 7.8 -5.3 -7.1
1958 63,534 36.3 -5.4 -6.9 12,417 7.1 -7.3 -9.0
1959 57,535 32.4 -9.4 -10.7 11,474 6.5 -7.6 -8.5
1960 55,494 30.7 -3.5 -5.2 10,866 6.0 -5.3 -7.7
1961 53,726 29.2 -3.2 -4.9 9,938 5.4 -8.5 -10.0
1962 53,315 28.6 -0.8 -2.1 9,506 5.1 -4.3 -5.6
1963 54,042 28.6 1.4 0.0 9,311 4.9 -2.1 -3.9
1964 50,874 26.5 -5.9 -7.3 8,303 4.3 -10.8 -12.2
1965 49,016 25.2 -3.7 -4.9 7,934 4.1 -4.4 -4.7
1966 47,767 24.3 -2.5 -3.6 7,625 3.9 -3.9 -4.9
1967 45,647 23.0 -4.4 -5.3 6,901 3.5 -9.5 -10.3
1968 42,623 21.2 -6.6 -7.8 6,292 3.1 -8.8 -11.4
1969 39,120 19.3 -8.2 -9.0 5,567 2.8 -11.5 -9.7
1970 37,137 18.1 -5.1 -6.2 5,217 2.6 -6.3 -7.1
1971 35,217 17.0 -5.2 -6.1 4,501 2.2 -13.7 -15.4
1972 32,882 15.7 -6.6 -7.6 4,376 2.1 -2.8 -4.5
1973 30,998 14.6 -5.7 -7.0 3,875 1.8 -11.4 -14.5
 19742 30,122 14.1 -2.8 -3.4 3,513 1.7 -9.3 -5.6
1975 33,989 15.7 -- -- 3,333 1.6 -5.1 -5.9
1976 32,105 14.7 -5.5 -6.4 3,130 1.5 -6.1 -6.3
1977 30,145 13.7 -6.1 -6.8 2,968 1.4 -5.2 -6.7
1978 28,521 12.8 -5.4 -6.6 2,914 1.3 -1.8 -7.1
 19793 27,669 12.3 -3.0 -3.9 2,007 0.9 -31.1 -30.8
1980 27,749 12.2 0.3 -0.7 1,978 0.9 -1.4 0.0
1981 27,373 11.9 -1.4 -2.3 1,937 0.8 -2.1 -11.1
1982 25,520 11.0 -6.8 -7.7 1,807 0.8 -6.7 0.0
1983 23,846 10.2 -6.6 -7.4 1,779 0.8 -1.5 0.0
1984 22,255 9.4 -6.7 -7.5 1,729 0.7 -2.8 -12.5
1985 22,201 9.3 -0.2 -1.1 1,752 0.7 1.3 0.0
1986 22,768 9.5 2.6 1.6 1,782 0.7 1.7 0.0
1987 22,517 9.3 -1.1 -2.0 1,755 0.7 -1.5 0.0
1988 22,436 9.2 -0.4 -1.3 1,921 0.8 9.5 14.3
1989 23,495 9.5 4.7 3.7 1,970 0.8 2.6 0.0
1990 25,701 10.3 9.4 8.2 1,810 0.7 -8.1 -12.5
1991 26,283 10.4 2.3 0.9 1,713 0.7 -5.4 0.0
1992 26,673 10.4 1.5 0.1 1,705 0.7 -0.5 0.0
1993 25,103 9.7 -5.9 -7.1 1,631 0.6 -4.3 -14.3
1994 24,205 9.2 -3.6 -4.8 1,478 0.6 -9.4 0.0
1995 22,727 8.5 -6.1 -7.2 1,336 0.5 -9.6 -16.7
1996 21,210 7.9 -6.7 -7.8 1,202 0.5 -10.0 0.0
1997 19,751 7.2 -6.9 -8.0 1,166 0.4 -3.0 -20.0
1998 18,287 6.6 -7.4 -8.5 1,112 0.4 -4.6 0.0
1999 17,500 6.3 -4.3 -5.4 930 0.3 -16.4 -25.0
2000 16,309 5.8 -6.8 -7.8 776 0.3 -16.6 0.0
2001 15,944 5.6 -2.2 -3.2 764 0.3 -1.6 0.0
2002 15,055 5.2 -5.6 -6.5 784 0.3 2.6 0.0
2003 14,835 5.1 -1.5 -2.3 711 0.2 -10.2 -33.3
2004 14,499 4.9 -2.3 -3.2 662 0.2 -6.9 0.0
2005 14,068 4.8 -3.0 -3.9 648 0.2 -2.1 0.0
2006 13,727 4.6 -2.4 -3.4 644 0.2 -0.6 0.0
2007 13,278 4.4 -3.3 -4.2 554 0.2 -14.0 0.0
2008 12,895 4.2 -2.9 -3.8 590 0.2 6.5 0.0
2009 11,528 3.8 -10.6 -11.4 529 0.2 -10.3 0.0
2010 11,171 3.6 -3.1 -3.8 … … … …
2011 10,528 3.4 -5.8 -6.4 … … … …
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates 
per 100,000 Population, and Percent Change:  United States, 1953–2011
Tuberculosis Cases Tuberculosis Deaths
Percent ChangePercent Change
Number Rate Number RateNumber Number1Rate Rate1Year
1 Official tuberculosis mortality statistics were compiled by the National Center for Health Statistics, CDC, National Vital Statistics Reports. 
2 Case data after 1974 are not comparable to prior years due to changes in the surveillance case definition that became effective in 1975. 
3 The large decrease in death rate in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleurisy with effusion (without mention of cause) are 
no longer included in tuberculosis deaths.
Percent change in tuberculosis death rates is calculated with rounded figures. See Technical Notes (page 9). 
Note: 1993 to 2011 tuberculosis case counts and rates updated as of June 25, 2012, using Bridged-Race 1990–1999 Intercensal Population Estimates for 1990–1999 (ftp://
ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridgedintercena1.doc) (accessed July 20, 2012) and Annual Estimates of the Population for the 
United States and States, and for Puerto Rico (July 1, 2000– July 1, 2010)  (www.census.gov/popest/states/tables/NST-PEST2010-01.xls) (accessed July 20, 2012) and Annual 
Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2011 (http://www.census.gov/popest/data/national/totals/2011/index.


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1993 25103 17435 (69) 7.4 7402 (29) 34.0 266 (1)
1994 24205 16191 (67) 6.9 7750 (32) 34.4 264 (1)
1995 22727 14676 (65) 6.2 7998 (35) 34.9 53 (0)
1996 21210 13398 (63) 5.6 7739 (36) 31.5 73 (0)
1997 19751 11935 (60) 5.0 7742 (39) 30.0 74 (0)
1998 18287 10634 (58) 4.4 7599 (42) 28.9 54 (0)
1999 17500 9806 (56) 4.0 7602 (43) 29.2 92 (1)
2000 16309 8648 (53) 3.5 7619 (47) 27.3 42 (0)
2001 15944 7872 (49) 3.2 8009 (50) 26.9 63 (0)
2002 15055 7282 (48) 2.9 7718 (51) 25.4 55 (0)
2003 14835 6861 (46) 2.7 7929 (53) 23.5 45 (0)
2004 14499 6632 (46) 2.6 7845 (54) 23.2 22 (0)
2005 14068 6308 (45) 2.5 7730 (55) 22.4 30 (0)
2006 13727 5888 (43) 2.3 7815 (57) 22.0 24 (0)
2007 13278 5478 (41) 2.1 7731 (58) 20.7 69 (1)
2008 12895 5282 (41) 2.0 7603 (59) 20.4 10 (0)
2009 11528 4570 (40) 1.7 6941 (60) 18.9 17 (0)
2010 11171 4383 (39) 1.6 6748 (60) 18.2 40 (0)
2011 10528 3981 (38) 1.5 6510 (62) 17.2 37 (0)
 Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age 




0–14 15–24 25–44 45–64 >65 Unk.1
No. No. No. No. No. No. (%)(%)(%)(%)(%)(%) Rate Rate Rate Rate Rate
1Includes unknown and missing.
Note:  Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates for 
1990–1999 (ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridgedintercena1.doc) (accessed August 
30, 2011)  Denominators for computing 2000–2011 case rates were obtained from the Annual Estimates of the Resident Population by 
Sex and Five-Year Age Groups for the United States: April 1, 2000 to July 1, 2009 (http://www.census.gov/popest/data/historical/2000s/
vintage_2009/index.html), and Annual Estimates of the Resident Population by Sex and Five-Year Age Group for the United States: April 1, 
2010 to July 1, 2011 (http://www.census.gov/popest/data/national/asrh/2011/index.html) (accessed July 20, 2012). 
Data for all years updated through June 25, 2012.
See Technical Notes.
Zero % (0) denotes <0.5%.
See Surveillance Slides #5 and #6.
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin 




U.S.-born Persons Foreign-born Persons1 Unknown or Missing
No. (%)No. (%) RateNo. (%) Rate
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
Note:  Denominators for computing rates for years 1993–1994 were obtained from Quarterly Estimates of the United States Foreign-
born and Native Resident Populations: April 1, 1990–July 1, 1999, located at http://www.census.gov/population/estimates/nation/nativity/
fbtab001.txt (accessed July 20, 2012). Denominators for computing the 1995–2011 rates are based on the U.S. Census Bureau, Current 
Population Survey (March Supplement).  
Data for all years updated through June 25, 2012.
 See Technical Notes.
Zero % (0) denotes <0.5%.
See Surveillance Slides #11, #12, #15, and #16.
1993 25103 1660 (7) 2.9 1821 (7) 5.0 9589 (38) 11.5 6196 (25) 12.4 5820 (23) 17.7 17 (0)
1994 24205 1659 (7) 2.9 1832 (8) 5.0 9043 (37) 10.7 6125 (25) 11.9 5540 (23) 16.6 6 (0)
1995 22727 1536 (7) 2.6 1697 (7) 4.6 8200 (36) 9.7 5960 (26) 11.3 5329 (23) 15.8 5 (0)
1996 21210 1356 (6) 2.3 1637 (8) 4.4 7564 (36) 8.9 5572 (26) 10.2 5076 (24) 14.9 5 (0)
1997 19751 1251 (6) 2.1 1674 (8) 4.5 6884 (35) 8.0 5278 (27) 9.4 4663 (24) 13.6 1 (0)
1998 18287 1077 (6) 1.8 1543 (8) 4.1 6335 (35) 7.4 4954 (27) 8.5 4378 (24) 12.6 0 (0)
1999 17500 1038 (6) 1.7 1518 (9) 3.9 6062 (35) 7.1 4860 (28) 8.1 4020 (23) 11.6 2 (0)
2000 16309 965 (6) 1.6 1618 (10) 4.1 5576 (34) 6.6 4635 (28) 7.4 3515 (22) 10.0 0 (0)
2001 15944 929 (6) 1.5 1597 (10) 4.0 5609 (35) 6.6 4515 (28) 7.0 3293 (21) 9.3 1 (0)
2002 15055 944 (6) 1.6 1498 (10) 3.7 5288 (35) 6.3 4182 (28) 6.3 3142 (21) 8.8 1 (0)
2003 14835 911 (6) 1.5 1573 (11) 3.8 5074 (34) 6.1 4283 (29) 6.3 2994 (20) 8.3 0 (0)
2004 14499 953 (7) 1.6 1603 (11) 3.8 4939 (34) 5.9 4192 (29) 5.9 2811 (19) 7.8 1 (0)
2005 14068 854 (6) 1.4 1541 (11) 3.7 4740 (34) 5.7 4124 (29) 5.7 2809 (20) 7.7 0 (0)
2006 13727 803 (6) 1.3 1532 (11) 3.6 4689 (34) 5.6 4039 (29) 5.4 2663 (19) 7.2 1 (0)
2007 13278 775 (6) 1.3 1580 (12) 3.7 4313 (32) 5.2 4036 (30) 5.3 2574 (19) 6.8 0 (0)
2008 12895 785 (6) 1.3 1444 (11) 3.4 4241 (33) 5.1 3929 (30) 5.0 2496 (19) 6.4 0 (0)
2009 11528 647 (6) 1.0 1278 (11) 3.0 3889 (34) 4.7 3424 (30) 4.3 2283 (20) 5.8 7 (0)
2010 11171 637 (6) 1.0 1199 (11) 2.7 3672 (33) 4.5 3433 (31) 4.2 2228 (20) 5.5 2 (0)
2011 10528 577 (5) 0.9 1033 (10) 2.4 3369 (32) 4.1 3297 (31) 4.0 2247 (21) 5.4 5 (0)
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 Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by the Top 30 
Countries2 of Birth: United States, 2007–2011
Country of Origin
2011 2010 2009 2008 2007
Year
No. No. No. No. No.(%) (%) (%) (%) (%)
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
2The top 30 countries were selected based on their ranked 5-year average number of TB cases.
3 Includes Not Specified for Country of Origin. 
Note: Zero (0) denotes <0.5%.
Data for all years updated through June 25, 2012.
Total Cases 6510 (100) 6748 (100) 6941 (100) 7603 (100) 7731 (100)
Mexico 1432 (22) 1537 (23) 1595 (23) 1762 (23) 1,841 (24)
Philippines 757 (12) 750 (11) 805 (12) 860 (11) 951 (12)
India 502 (8) 583 (9) 541 (8) 598 (8) 625 (8)
Viet Nam 546 (8) 536 (8) 532 (8) 583 (8) 570 (7)
China 376 (6) 368 (5) 345 (5) 405 (5) 386 (5)
Guatemala 166 (3) 195 (3) 214 (3) 252 (3) 243 (3)
Haiti 187 (3) 196 (3) 207 (3) 237 (3) 173 (2)
Ethiopia 154 (2) 161 (2) 172 (2) 183 (2) 178 (2)
Honduras 127 (2) 143 (2) 152 (2) 195 (3) 181 (2)
Korea, Republic of 131 (2) 119 (2) 156 (2) 150 (2) 155 (2)
Somalia 116 (2) 126 (2) 113 (2) 151 (2) 176 (2)
El Salvador 103 (2) 116 (2) 119 (2) 147 (2) 158 (2)
Peru 93 (1) 111 (2) 94 (1) 144 (2) 139 (2)
Ecuador 79 (1) 84 (1) 99 (1) 114 (2) 116 (2)
Cambodia 91 (1) 68 (1) 99 (1) 77 (1) 95 (1)
Myanmar 90 (1) 118 (2) 104 (2) 108 (1) 65 (1)
Pakistan 86 (1) 74 (1) 84 (1) 87 (1) 79 (1)
Dominican Republic 74 (1) 84 (1) 71 (1) 88 (1) 89 (1)
Kenya 74 (1) 62 (1) 73 (1) 82 (1) 69 (1)
Nepal 77 (1) 61 (1) 74 (1) 70 (1) 53 (1)
Laos 59 (1) 68 (1) 60 (1) 68 (1) 79 (1)
Bangladesh 66 (1) 58 (1) 46 (1) 55 (1) 56 (1)
Thailand 37 (1) 46 (1) 57 (1) 62 (1) 47 (1)
Nigeria 52 (1) 43 (1) 46 (1) 50 (1) 44 (1)
Colombia 32 (0) 42 (1) 40 (1) 43 (1) 56 (1)
Indonesia 32 (0) 58 (1) 34 (0) 30 (0) 52 (1)
Cuba 41 (1) 33 (0) 36 (1) 42 (1) 41 (1)
Liberia 26 (0) 36 (1) 34 (0) 33 (0) 46 (1)
Taiwan 38 (1) 26 (0) 26 (0) 31 (0) 38 (0)
Russia 23 (0) 20 (0) 31 (0) 35 (0) 40 (1)
All Others3 843 (13) 826 (12) 882 (13) 861 (11) 890 (12)
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 Table 7. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by the Top 30 
Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2011
Country of Origin2
Total Cases < 1 Year 1 - 4 Years ≥ 5 Years Unknown
No.Years in U.S.3
No. No. No. No. No.(%) (%) (%) (%)
1 Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
2 Ranked by total case count.
3 Among foreign-born persons, the number of years since arrival in the United States before diagnosis with tuberculosis.
4 Includes Not Specified for Country of Origin. 
See Surveillance Slide #18
Mexico 1432 128 (9) 164 (11) 946 (66) 194 (14)
Philippines 757 112 (15) 101 (13) 462 (61) 82 (11)
Vietnam 546 57 (10) 68 (12) 336 (62) 85 (16)
India 502 85 (17) 122 (24) 255 (51) 40 (8)
China 376 54 (14) 59 (16) 242 (64) 21 (6)
Haiti 187 29 (16) 39 (21) 107 (57) 12 (6)
Guatemala 166 17 (10) 56 (34) 80 (48) 13 (8)
Ethiopia 154 30 (19) 64 (42) 57 (37) 3 (2)
Korea, Republic of 131 8 (6) 7 (5) 98 (75) 18 (14)
Honduras 127 23 (18) 21 (17) 75 (59) 8 (6)
Somalia 116 22 (19) 33 (28) 57 (49) 4 (3)
El Salvador 103 7 (7) 18 (17) 73 (71) 5 (5)
Peru 93 12 (13) 12 (13) 65 (70) 4 (4)
Cambodia 91 1 (1) 10 (11) 71 (78) 9 (10)
Myanmar 90 39 (43) 32 (36) 13 (14) 6 (7)
Pakistan 86 14 (16) 12 (14) 57 (66) 3 (3)
Ecuador 79 5 (6) 17 (22) 46 (58) 11 (14)
Nepal 77 22 (29) 37 (48) 17 (22) 1 (1)
Dominican Republic 74 22 (30) 10 (14) 42 (57) 0 (0)
Kenya 74 15 (20) 22 (30) 36 (49) 1 (1)
Bangladesh 66 16 (24) 16 (24) 26 (39) 8 (12)
Laos 59 0 (0) 3 (5) 48 (81) 8 (14)
Nigeria 52 18 (35) 16 (31) 16 (31) 2 (4)
Cuba 41 4 (10) 6 (15) 28 (68) 3 (7)
Bhutan 39 30 (77) 8 (21) 0 (0) 1 (3)
Taiwan 38 1 (3) 2 (5) 33 (87) 2 (5)
Korea, DPR 37 3 (8) 5 (14) 27 (73) 2 (5)
Thailand 37 6 (16) 6 (16) 24 (65) 1 (3)
Colombia 32 5 (16) 3 (9) 23 (72) 1 (3)
Indonesia 32 6 (19) 4 (13) 18 (56) 4 (13)
All Others4 816 134 (16) 131 (16) 460 (56) 91 (11)







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1993 (12.9) (31.2) (40.3) (21.7) (14.4) (64.1) (87.5)
1994 (7.0) (23.3) (55.7) (28.1) (20.5) (69.0) (87.9)
1995 (5.2) (20.3) (62.7) (37.3) (21.5) (74.0) (89.8)
1996 (4.2) (17.5) (67.3) (42.5) (22.4) (76.5) (90.6)
1997 (3.2) (15.1) (71.9) (47.0) (23.8) (78.3) (91.4)
1998 (2.6) (12.9) (74.3) (47.7) (26.6) (80.7) (92.5)
1999 (2.2) (11.2) (76.9) (49.4) (27.6) (80.9) (92.4)
2000 (2.0) (10.4) (78.5) (52.5) (25.8) (81.6) (92.7)
2001 (1.7) (9.6) (79.8) (53.6) (27.5) (81.8) (92.8)
2002 (1.8) (8.9) (80.3) (55.4) (27.8) (82.4) (92.7)
2003 (1.4) (8.1) (81.3) (56.5) (28.5) (83.0) (92.9)
2004 (1.5) (6.4) (82.4) (58.9) (27.7) (83.7) (92.7)
2005 (1.3) (5.5) (83.7) (57.9) (29.6) (83.2) (92.6)
2006 (1.2) (4.8) (83.3) (57.5) (30.4) (84.1) (93.3)
2007 (1.1) (4.6) (83.6) (56.3) (32.9) (84.8) (94.0)
2008 (1.0) (3.5) (84.3) (56.3) (33.5) (85.2) (93.3)
2009 (1.0) (3.1) (84.2) (59.5) (30.3) (87.7) (95.3)
2010 (0.9) (2.9) (84.9) ... ... ... ...
20115 (0.7) (2.7) (85.6) ... ... ... ...
 Table 12.  Tuberculosis Cases and Percentages in Persons with HIV Test Results1 and with 
HIV Coinfection by Age Group: United States, 1993–2011
Year





No. No. No. No.(%) (%) (%) (%)
1Includes persons with positive, negative, or indeterminate HIV test results and persons from California with co-diagnosis of TB and AIDS. 
Rhode Island did not report HIV test results for years 1993–1997. HIV test results for Vermont are not included for years 2007–2010. HIV 
test results for California are not included for years 2004 - 2010.
2 California began reporting HIV test results to CDC in 2011
Note:  Data for all years updated through June 25, 2012.
See Surveillance Slides #24 and #25. 
 Table 11.  Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly  




Therapy <1 Year Indicated4
IRZ DOT Only
Both DOT and Self-
Administered COT <1 Year COTI R
 1 Includes persons alive at diagnosis.
2 I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol.  Excludes cases with no information on initial drug regimen; In 2011, 2.17% re-
ceived no initial drug therapy, 0.12% were started on one drug, and 10.02% had an initial multidrug regimen other than IR, IRZ, or IRZE.
3 Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4 Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy.  Excludes 
persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or 
positive blood culture. 
5 Begining in 2011, those who moved out of country during treatment are excluded from the denominator of those eligible for COT.
Note: Data for all years updated through June 25, 2012.
See Technical Notes for description of COT calculation.
See Surveillance Slides #28 and #29..
IRZE
1993 4382 (46) 2790 (29) 7457 (30) 3682 (15)
1994 4442 (49) 2669 (30) 7887 (33) 3601 (15)
1995 4276 (52) 2171 (26) 8178 (36) 3037 (13)
1996 4366 (58) 1856 (25) 8832 (42) 2615 (12)
1997 4141 (60) 1471 (21) 8771 (44) 2091 (11)
1998 3862 (61) 1240 (20) 8292 (45) 1831 (10)
1999 3810 (63) 1174 (19) 8419 (48) 1725 (10)
2000 3525 (63) 955 (17) 8117 (50) 1464 (9)
2001 3576 (64) 911 (16) 8095 (51) 1408 (9)
2002 3512 (66) 845 (16) 8022 (53) 1390 (9)
2003 3424 (67) 807 (16) 8117 (55) 1320 (9)
2004 3442 (70) 683 (14) 8509 (59) 1195 (8)
2005 3277 (69) 611 (13) 8231 (59) 1042 (7)
2006 3285 (70) 558 (12) 8302 (60) 962 (7)
2007 3160 (73) 488 (11) 8353 (63) 882 (7)
2008 3109 (73) 411 (10) 8244 (64) 820 (6)
2009 2857 (73) 402 (10) 7398 (64) 716 (6)
2010 2751 (75) 324 (9) 7445 (67) 627 (6)
20112 3042 (90) 342 (10) 8683 (82) 672 (6)
25







Moved2 Lost Refused Died3 Unknown4
1 Includes all cases in persons reported as alive at diagnosis and taking one or more TB drugs.
2 In 2009 the moved variable was utilized by the following reporting areas: Alaska, California, Georgia, Iowa, and New York City.
3 Died = died of any cause (not only TB).
4 Includes cases in persons reporting reason therapy stopped = Other, Missing, or Unknown. 
Note: Data for all years are updated through June 25, 2012.
Data complete through 2009 only.  See Technical Notes for details.
No. (%) No. No. No. No. No.(%) (%) (%) (%) (%)No.
1993 23741 18044 (76.0) 0 (0.0) 1120 (4.7) 1086 (4.6) 223 (0.9) 3053 (12.9) 215 (0.9)
1994 23051 17763 (77.1) 0 (0.0) 1194 (5.2) 740 (3.2) 183 (0.8) 2743 (11.9) 428 (1.9)
1995 21706 17306 (79.7) 0 (0.0) 969 (4.5) 570 (2.6) 156 (0.7) 2396 (11.0) 309 (1.4)
1996 20298 16528 (81.4) 0 (0.0) 783 (3.9) 525 (2.6) 156 (0.8) 1998 (9.8) 308 (1.5)
1997 18930 15673 (82.8) 0 (0.0) 667 (3.5) 444 (2.3) 119 (0.6) 1755 (9.3) 272 (1.4)
1998 17584 14766 (84.0) 0 (0.0) 534 (3.0) 411 (2.3) 104 (0.6) 1580 (9.0) 189 (1.1)
1999 16862 14234 (84.4) 0 (0.0) 456 (2.7) 359 (2.1) 104 (0.6) 1437 (8.5) 272 (1.6)
2000 15785 13408 (84.9) 0 (0.0) 408 (2.6) 397 (2.5) 112 (0.7) 1294 (8.2) 166 (1.1)
2001 15408 13241 (85.9) 0 (0.0) 378 (2.5) 402 (2.6) 99 (0.6) 1121 (7.3) 167 (1.1)
2002 14564 12482 (85.7) 0 (0.0) 336 (2.3) 412 (2.8) 87 (0.6) 1080 (7.4) 167 (1.1)
2003 14379 12418 (86.4) 0 (0.0) 313 (2.2) 389 (2.7) 84 (0.6) 994 (6.9) 181 (1.3)
2004 14081 12119 (86.1) 0 (0.0) 337 (2.4) 370 (2.6) 82 (0.6) 975 (6.9) 198 (1.4)
2005 13681 11735 (85.8) 0 (0.0) 323 (2.4) 338 (2.5) 90 (0.7) 985 (7.2) 210 (1.5)
2006 13316 11540 (86.7) 0 (0.0) 292 (2.2) 358 (2.7) 79 (0.6) 939 (7.1) 108 (0.8)
2007 12903 11343 (87.9) 0 (0.0) 241 (1.9) 327 (2.5) 73 (0.6) 819 (6.3) 100 (0.8)
2008 12551 10876 (86.7) 6 (0.0) 257 (2.0) 328 (2.6) 78 (0.6) 843 (6.7) 163 (1.3)











Table 14.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age 
Group: United States, 2011
1Persons of Hispanic or Latino ethnicity may be of any race or multiple race.             
2Indicates two or more races reported for a person.         
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does 
not include persons of Hispanic ethnicity.
See Technical Notes.                 
See Surveillance Slide #10.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65 Unknown
Total Cases 10,528 350 227 1033 3369 3297 2247 5
Male 6413 197 114 572 1932 2267 1330 1
Female 4112 153 113 461 1437 1029 917 2
Unknown 3 0 0 0 0 1 0 2
Hispanic or Latino1 3008 165 90 387 1100 799 465 2
Male 1969 98 47 246 730 571 276 1
Female 1039 67 43 141 370 228 189 1
Unknown 0 0 0 0 0 0 0 0
American Indian or Alaska Native 129 7 4 8 26 53 31 0
Male 76 4 2 5 12 37 16 0
Female 53 3 2 3 14 16 15 0
Unknown 0 0 0 0 0 0 0 0
Asian 3148 52 37 311 1057 894 796 1
Male 1706 33 21 151 500 535 466 0
Female 1441 19 16 160 557 358 330 1
Unknown 1 0 0 0 0 1 0 0
Black or African American 2408 82 75 232 821 852 346 0
Male 1440 37 31 121 479 582 190 0
Female 968 45 44 111 342 270 156 0
Unknown 0 0 0 0 0 0 0 0
Native	Hawaiian	or	Other	Pacific	Islander 81 4 7 16 22 22 10 0
Male 45 2 6 11 11 13 2 0
Female 36 2 1 5 11 9 8 0
Unknown 0 0 0 0 0 0 0 0
White 1664 35 11 66 324 651 577 0
Male 1123 19 5 34 188 511 366 0
Female 541 16 6 32 136 140 211 0
Unknown 0 0 0 0 0 0 0 0
Multiple Race2 37 3 2 5 7 12 8 0
Male 26 2 2 2 4 10 6 0
Female 11 1 0 3 3 2 2 0
Unknown 0 0 0 0 0 0 0 0
Unknown 53 2 1 8 12 14 14 2
Male 28 2 0 2 8 8 8 0
Female 23 0 1 6 4 6 6 0
Unknown 2 0 0 0 0 0 0 2
30
Total Rate 3.4 1.7 0.6 2.4 4.1 4.0 5.4
Male 4.2 1.9 0.5 2.5 4.7 5.6 7.4
Female 2.6 1.6 0.6 2.2 3.5 2.4 3.9
Hispanic or Latino1 5.8 3.2 0.9 4.3 6.8 8.7 15.7
Male 7.4 3.7 1.0 5.2 8.7 12.6 21.8
Female 4.1 2.6 0.9 3.3 4.8 4.9 11.1
American Indian or Alaska Native 5.6 4.0 1.1 2.1 4.3 9.3 16.1
Male 6.7 4.5 1.1 2.5 4.0 13.5 18.6
Female 4.6 3.5 1.1 1.6 4.5 5.4 14.1
Asian 20.9 5.8 2.0 15.1 21.0 23.9 53.3
Male 23.8 7.2 2.3 14.4 21.0 31.2 72.1
Female 18.2 4.3 1.8 15.9 20.9 17.7 38.9
Black or African American 6.3 2.9 1.3 3.6 7.9 9.0 9.9
Male 7.9 2.6 1.1 3.7 9.6 13.2 13.7
Female 4.8 3.3 1.6 3.5 6.2 5.3 7.3
Native	Hawaiian	or	Other	Pacific	Islander 15.9 10.2 9.1 17.9 13.7 20.0 30.0
Male 17.5 10.0 15.1 24.0 13.5 24.0 13.1
Female 14.3 10.4 2.7 11.5 14.0 16.2 44.2
White 0.8 0.3 0.0 0.3 0.7 1.1 1.8
Male 1.2 0.4 0.0 0.3 0.8 1.8 2.5
Female 0.5 0.3 0.1 0.3 0.6 0.5 1.1
Multiple Race2 0.6 0.3 0.1 0.5 0.6 1.5 3.0
Male 0.9 0.4 0.3 0.4 0.7 2.6 5.2
Female 0.4 0.2 0.0 0.5 0.5 0.5 1.3
Table 15.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2011
1 Persons of Hispanic or Latino origin may be of any race or multiple race.             
2 Indicates two or more races reported for a person.         
Note: Denominators for computing 2000–2011 case rates were obtained from the Annual Estimates of the Population by Sex, Race, and 
Hispanic or Latino Origin for the United States: April 1, 2000, to July 1, 2011 (http://www.census.gov/popest/data/national/asrh/2011/files/
NC-EST2011-ALLDATA-R-File04.csv) (accessed July 20, 2012). 
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific 
Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not 
include persons of Hispanic ethnicity.
See Technical Notes.                 
See Surveillance Slide #7.                 
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45 –64 >65
31
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65 Unknown
Table 16.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic 
Race, Sex, and Age Group: United States, 2011
1 Persons of Hispanic or Latino origin may be of any race or multiple race.             
2 Indicates two or more races reported for a person.         
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes.
See Surveillance Slide #13.
Total Cases 3981 315 141 326 855 1,467 877 0
Male 2611 174 77 176 525 1,096 563 0
Female 1370 141 64 150 330 371 314 0
Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino1 764 158 65 131 171 150 89 0
Male 477 95 36 71 109 105 61 0
Female 287 63 29 60 62 45 28 0
Unknown 0 0 0 0 0 0 0 0
American Indian or Alaska Native 127 7 4 8 25 53 30 0
Male 75 4 2 5 11 37 16 0
Female 52 3 2 3 14 16 14 0
Unknown 0 0 0 0 0 0 0 0
Asian 133 41 9 24 36 9 14 0
Male 74 22 6 14 18 5 9 0
Female 59 19 3 10 18 4 5 0
Unknown 0 0 0 0 0 0 0 0
Black or African American 1533 69 45 104 378 668 269 0
Male 991 31 22 57 239 482 160 0
Female 542 38 23 47 139 186 109 0
Unknown 0 0 0 0 0 0 0 0
Native	Hawaiian	or	Other	Pacific	Islander 59 4 7 12 15 14 7 0
Male 31 2 6 8 7 7 1 0
Female 28 2 1 4 8 7 6 0
Unknown 0 0 0 0 0 0 0 0
White 1325 32 8 45 222 561 457 0
Male 935 17 3 21 134 452 308 0
Female 390 15 5 24 88 109 149 0
Unknown 0 0 0 0 0 0 0 0
Multiple Race2 22 3 2 2 4 6 5 0
Male 15 2 2 0 3 5 3 0
Female 7 1 0 2 1 1 2 0
Unknown 0 0 0 0 0 0 0 0
Unknown 18 1 1 0 4 6 6 0
Male 13 1 0 0 4 3 5 0
Female 5 0 1 0 0 3 1 0
Unknown 0 0 0 0 0 0 0 0
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Table 17.  Tuberculosis Cases in Foreign-born Persons1 by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2011
1 Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.                 
2 Persons of Hispanic or Latino ethnicity may be of any race or multiple race.            
3 Indicates two or more races reported for a person.         
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes.
See Surveillance Slide #13.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not 
Stated
Total Cases 6510 35 86 703 2509 1815 1357 5
Male 3780 23 37 394 1405 1160 760 1
Female 2727 12 49 309 1104 654 597 2
Unknown 3 0 0 0 0 1 0 2
Hispanic or Latino2 2222 7 25 253 924 643 368 2
Male 1479 3 11 173 619 462 210 1
Female 743 4 14 80 305 181 158 1
Unknown 0 0 0 0 0 0 0 0
American Indian or Alaska Native 2 0 0 0 1 0 1 0
Male 1 0 0 0 1 0 0 0
Female 1 0 0 0 0 0 1 0
Unknown 0 0 0 0 0 0 0 0
Asian 3010 11 28 286 1021 883 780 1
Male 1629 11 15 137 482 529 455 0
Female 1380 0 13 149 539 353 325 1
Unknown 1 0 0 0 0 1 0 0
Black or African American 871 13 30 128 443 180 77 0
Male 445 6 9 64 240 96 30 0
Female 426 7 21 64 203 84 47 0
Unknown 0 0 0 0 0 0 0 0
Native	Hawaiian	or	Other	Pacific	Islander 22 0 0 4 7 8 3 0
Male 14 0 0 3 4 6 1 0
Female 8 0 0 1 3 2 2 0
Unknown 0 0 0 0 0 0 0 0
White 334 3 3 21 102 88 117 0
Male 187 2 2 13 54 58 58 0
Female 147 1 1 8 48 30 59 0
Unknown 0 0 0 0 0 0 0 0
Multiple Race3 15 0 0 3 3 6 3 0
Male 11 0 0 2 1 5 3 0
Female 4 0 0 1 2 1 0 0
Unknown 0 0 0 0 0 0 0 0
Unknown 34 1 0 8 8 7 8 2
Male 14 1 0 2 4 4 3 0
Female 18 0 0 6 4 3 5 0
Unknown 2 0 0 0 0 0 0 2
33
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Algeria 4 Ethiopia 154 Niger 3
Angola 4 Gabon 0 Nigeria 52
Benin 0 Gambia 10 Rwanda 4
Botswana 3 Ghana 7 Sao Tome and Principe 0
Burkina Faso 1 Guinea 6 Senegal 10
Burundi 2 Guinea-Bissau 0 Seychelles 0
Cameroon 21 Kenya 74 Sierra Leone 16
Cape Verde 3 Lesotho 0 South Africa 5
Central African Republic 3 Liberia 26 Swaziland 0
Chad 1 Madagascar 1 Tanzania, UR 5
Comoros 0 Malawi 1 Togo 3
Congo, Republic of 18 Mali 3 Uganda 7
Côte d’Ivoire 4 Mauritania 5 Zambia 6
DR Congo 0 Mauritius 0 Zimbabwe 7
Equatorial Guinea 1 Mozambique 2   
Eritrea 27 Namibia 1
Anguilla 0 Costa Rica 3 Netherland Antilles 0
Antigua and Barbuda 0 Cuba 41 Nicaragua 16
Argentina 5 Dominica 0 Panama 7
Bahamas 1 Dominican Republic 74 Paraguay 1
Barbados 1 Ecuador 79 Peru 93
Belize 7 El Salvador 103 St. Kitts and Nevis 1
Bermuda 1 Grenada 2 St. Lucia 0
Bolivia 18 Guatemala 166 St. Vincent & Grenadines 0
Brazil 17 Guyana 16 Suriname 0
British Virgin Islands 0 Haiti 187 Trinidad and Tobago 14
Canada 1 Honduras 127 Turks and Caicos Islands 0
Cayman Islands 0 Jamaica 22 Uruguay 1
Chile 2 Mexico 1432 Venezuela 13
Colombia 32 Montserrat 0
  
 
Afghanistan 17 Lebanon 1 Sudan 12
Bahrain 0 Libyan Arab Jamahiriya 0 Syrian Arab Republic 0
Djibouti 0 Morocco 7 Tunisia 0
Egypt 2 Oman 0 United Arab Emirates 1
Iran, Islamic Republic of 15 Pakistan 86 West Bank and Gaza 0
Iraq 11 Qatar 1 Yemen 5
Jordan 1 Saudi Arabia 3
Kuwait 2 Somalia 116
Eastern Mediterranean Region
Total Cases = 280
Table 18. Tuberculosis Cases Among Foreign-born Persons1 by Country of Birth2: 
United States, 2011
African Region
Total Cases = 500 
Americas Region
Total Cases = 2,483
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Albania 8 Greece 3 Poland 19
Andorra 0 Hungary 4 Portugal 4
Armenia 4 Iceland 0 Romania 13
Austria 0 Ireland 2 Russian Federation 23
Azerbaijan 3 Israel 2 San Marino 0
Belarus 2 Italy 9 Serbia 1
Belgium 0 Kazakhstan 4 Slovakia 1
Bosnia and Herzegovina 9 Kyrgyzstan 1 Slovenia 1
Bulgaria 3 Latvia 1 Spain 2
Croatia 3 Lithuania 1 Sweden 0
Cyprus 1 Luxembourg 0 Switzerland 2
Czech Republic 1 Macedonia, TFYR 2 Tajikistan 0
Denmark 1 Malta 0 Turkey 9
Estonia 1 Moldova, Republic of 2 Turkmenistan 2
Finland 1 Monaco 0 Ukraine 31
France 4 Montenegro 1 United Kingdom 10
Georgia 2 Netherlands 0 Uzbekistan 8
Germany 20 Norway 0
Bangladesh 66 Korea, DPR 37 Sri Lanka 2
Bhutan 39 Maldives 0 Thailand 37
India 502 Myanmar 90 Timor-Leste 0
Indonesia 32 Nepal 77
Australia 1 Kiribati 0 Philippines 757
Brunei Darussalam 0 Korea, Rep. 131 Samoa 5
Cambodia 91 Lao, PDR 59 Singapore 1
China 376 Malaysia 17 Solomon Islands 0
China, Hong Kong SAR 24 Mongolia 11 Tokelau 0
China, Macao SAR 0 Nauru 0 Tonga 7
Cook Islands 0 New Caledonia 0 Tuvalu 0
Fiji 3 New Zealand 0 Vanuatu 0
French Polynesia 0 Niue 0 Vietnam 546
Japan 19 Papua New Guinea 0 Wallis and Futuna 0
1 Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands
2 Country as reported by patient.
3 Includes country codes currently reported via the National Tuberculosis Surveillance System that are not represented by WHO member 
states.
Note:  Regional composition of countries based on WHO Report Global Tuberculosis Control 2011, World Health Organization  
(WHO/HTM/TB/2011.16) (http://www.who.int/tb/publications/global_report/2011/en/).
Table 18.  (Cont’d) Tuberculosis Cases Among Foreign-born Persons1 by Country of Birth2: 
United States, 2011
European Region
Total Cases = 221
Other3
Total Cases = 44
Unknown
Total Cases = 52
Southeast Asia Region
Total Cases = 882
Western	Pacific	Region
Total Cases = 2,048
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United States 10,528 11,171 3.4 3.6 -- -- 311,591,917
Alabama 161 146 3.4 3.1 13 19 4,802,740
Alaska 67 57 9.3 8.0 1 2 722,718
Arizona 255 282 3.9 4.4 8 9 6,482,505
Arkansas 85 78 2.9 2.7 18 22 2,937,979
California 2,323 2,324 6.2 6.2 3 3 37,691,912
Colorado 70 71 1.4 1.4 36 39 5,116,796
Connecticut 83 85 2.3 2.4 27 26 3,580,709
Delaware 21 20 2.3 2.2 28 29 907,135
District of Columbia1 56 43 9.1 7.1 -- -- 617,996
Florida 754 834 4.0 4.4 7 7 19,057,542
Georgia 347 411 3.5 4.2 11 10 9,815,210
Hawaii 123 115 8.9 8.4 2 1 1,374,810
Idaho 12 15 0.8 1.0 47 44 1,584,985
Illinois 359 372 2.8 2.9 19 21 12,869,257
Indiana 100 90 1.5 1.4 35 40 6,516,922
Iowa 40 48 1.3 1.6 37 37 3,062,309
Kansas 36 46 1.3 1.6 40 36 2,871,238
Kentucky 71 90 1.6 2.1 34 30 4,369,356
Louisiana 167 200 3.7 4.4 10 8 4,574,836
Maine 9 8 0.7 0.6 50 50 1,328,188
Maryland 233 220 4.0 3.8 6 13 5,828,289
Massachusetts 196 222 3.0 3.4 16 15 6,587,536
Michigan 170 183 1.7 1.9 32 32 9,876,187
Minnesota 137 135 2.6 2.5 22 23 5,344,861
Mississippi 91 116 3.1 3.9 14 12 2,978,512
Missouri 98 107 1.6 1.8 33 34 6,010,688
Montana 8 6 0.8 0.6 46 49 998,199
Nebraska 23 27 1.2 1.5 41 38 1,842,641
Nevada 95 114 3.5 4.2 12 11 2,723,322
New Hampshire 11 10 0.8 0.8 45 47 1,318,194
New Jersey 331 405 3.8 4.6 9 6 8,821,155
New Mexico 49 50 2.4 2.4 26 25 2,082,224
New York 910 954 4.7 4.9 5 5 19,465,197
North Carolina 244 296 2.5 3.1 23 18 9,656,401
North Dakota 7 9 1.0 1.3 44 41 683,932
Ohio 145 190 1.3 1.6 39 35 11,544,951
Oklahoma 94 86 2.5 2.3 24 27 3,791,508
Oregon 74 87 1.9 2.3 30 28 3,871,859
Pennsylvania 260 238 2.0 1.9 29 31 12,742,886
Rhode Island 27 26 2.6 2.5 21 24 1,051,302
South Carolina 140 153 3.0 3.3 15 17 4,679,230
South Dakota 15 15 1.8 1.8 31 33 824,082
Tennessee 156 193 2.4 3.0 25 20 6,403,353
Texas 1,325 1,385 5.2 5.5 4 4 25,674,681
Utah 34 20 1.2 0.7 43 48 2,817,222
Vermont 8 5 1.3 0.8 38 46 626,431
Virginia 221 268 2.7 3.3 20 16 8,096,604
Washington 200 239 2.9 3.5 17 14 6,830,038
West Virginia 13 15 0.7 0.8 49 45 1,855,364
Wisconsin 70 55 1.2 1.0 42 43 5,711,767
Wyoming 4 7 0.7 1.2 48 42 568,158
American Samoa1,2 3 3 5.4 5.4 -- -- 55,198
Fed. States of Micronesia1,2 140 172 131.0 160.5 -- -- 106,836
Guam1,2 78 102 48.9 64.0 -- -- 159,600
Marshall Islands1,2 149 211 221.8 320.4 -- -- 67,182
N. Mariana Islands1,2 27 32 51.8 59.8 -- -- 52,167
Puerto Rico1,2 50 80 1.3 2.1 -- -- 3,706,690
Republic of Palau1,2 8 17 38.2 81.4 -- -- 20,956
U.S. Virgin Islands1,2 ... ... ... ... -- -- 105,784
Table 19. Tuberculosis Cases and Case Rates per 100,000 Population: 
Reporting Areas, 2011 and 2010
1 Not ranked with the states. See Table 20 for District of Columbia ranking among states.
2 Not included in U.S. totals. 
Note: Denominators for computing 2010 and 2011 rates for states, the District of Columbia, and Puerto Rico were obtained from Annual 
Estimates of the Population for the United States, Regions, States, and Puerto Rico (April 1, 2010– July 1, 2011) (http://www.census.gov/
popest/data/national/totals/2011/index.html) (accessed July 20, 2012); for all other areas, from IDB Summary Demographic Data (http://
www.census.gov/population/international/data/idb/informationGateway.php) (accessed July 20, 2012).
Ellipses indicate data not available.
See Technical Notes.
See Surveillance Slide #4.
Reporting Area
Cases Case Rates Rank According to Rate Population Estimates
July 1, 20112011 2010 2011 2010 2011 2010
40
 >= 500 cases in 2011
California 2,323 6.2 2,324 6.2 0.0 0.0 3
Texas 1,325 5.2 1,385 5.5 -4.3 -5.5 4
New York1 910 4.7 954 4.9 -4.6 -4.1 5
Florida 754 4.0 834 4.4 -9.6 -9.1 7
 100 - 499 cases in 2011
Illinois 359 2.8 372 2.9 -3.5 -3.4 19
Georgia 347 3.5 411 4.2 -15.6 -16.7 11
New Jersey 331 3.8 405 4.6 -18.3 -17.4 9
Pennsylvania 260 2.0 238 1.9 9.2 5.3 29
Arizona 255 3.9 282 4.4 -9.6 -11.4 8
North Carolina 244 2.5 296 3.1 -17.6 -19.4 23
Maryland 233 4.0 220 3.8 5.9 5.3 6
Virginia 221 2.7 268 3.3 -17.5 -18.2 20
Washington 200 2.9 239 3.5 -16.3 -17.1 17
Massachusetts 196 3.0 222 3.4 -11.7 -11.8 16
Michigan 170 1.7 183 1.9 -7.1 -10.5 32
Louisiana 167 3.7 200 4.4 -16.5 -15.9 10
Alabama 161 3.4 146 3.1 10.3 9.7 13
Tennessee 156 2.4 193 3.0 -19.2 -20.0 25
Ohio 145 1.3 190 1.6 -23.7 -18.8 39
South Carolina 140 3.0 153 3.3 -8.5 -9.1 15
Minnesota 137 2.6 135 2.5 1.5 4.0 22
Hawaii 123 8.9 115 8.4 7.0 6.0 2
Indiana 100 1.5 90 1.4 11.1 7.1 35
 < 100 cases in 2011
Missouri 98 1.6 107 1.8 -8.4 -11.1 33
Nevada 95 3.5 114 4.2 -16.7 -16.7 12
Oklahoma 94 2.5 86 2.3 9.3 8.7 24
Mississippi 91 3.1 116 3.9 -21.6 -20.5 14
Arkansas 85 2.9 78 2.7 9.0 7.4 18
Connecticut 83 2.3 85 2.4 -2.4 -4.2 27
Oregon 74 1.9 87 2.3 -14.9 -17.4 30
Kentucky 71 1.6 90 2.1 -21.1 -23.8 34
Colorado 70 1.4 71 1.4 -1.4 0.0 36
Wisconsin 70 1.2 55 1.0 27.3 20.0 42
Alaska 67 9.3 57 8.0 17.5 16.3 1
District of Columbia 56 9.1 43 7.1 30.2 28.2 --
New Mexico 49 2.4 50 2.4 -2.0 0.0 26
Iowa 40 1.3 48 1.6 -16.7 -18.8 37
Kansas 36 1.3 46 1.6 -21.7 -18.8 40
Utah 34 1.2 20 0.7 70.0 71.4 43
Rhode Island 27 2.6 26 2.5 3.8 4.0 21
Nebraska 23 1.2 27 1.5 -14.8 -20.0 41
Delaware 21 2.3 20 2.2 5.0 4.5 28
South Dakota 15 1.8 15 1.8 0.0 0.0 31
West Virginia 13 0.7 15 0.8 -13.3 -12.5 49
Idaho 12 0.8 15 1.0 -20.0 -20.0 47
New Hampshire 11 0.8 10 0.8 10.0 0.0 45
Maine 9 0.7 8 0.6 12.5 16.7 50
Montana 8 0.8 6 0.6 33.3 33.3 46
Vermont 8 1.3 5 0.8 60.0 62.5 38
North Dakota 7 1.0 9 1.3 -22.2 -23.1 44
Wyoming 4 0.7 7 1.2 -42.9 -41.7 48
Total 10,528 3.4 11,171 3.6 -5.8 -5.6
Table 20.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped 
by Number of Cases: United States and the District of Columbia, 2011 and 2010
Reporting Area
2011 2010 2010–2011 % Change




1 Includes New York City.
Note: Denominators for computing 2010 and 2011 rates for states, the District of Columbia, and Puerto Rico were obtained from Annual 
Estimates of the Population for the United States, Regions, States, and Puerto Rico (April 1, 2010 to July 1, 2011) (www.census.gov/
popest/data/national/totals/2011/index.html) (accessed July 20, 2012).
See Table 20 for ranking of states without the District of Columbia.
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United States 10,528 3,981 (37.8) 6,510 (61.8) 37 (0.4)
Alabama 161 113 (70.2) 48 (29.8) 0 (0.0)
Alaska 67 52 (77.6) 15 (22.4) 0 (0.0)
Arizona 255 85 (33.3) 170 (66.7) 0 (0.0)
Arkansas 85 66 (77.6) 19 (22.4) 0 (0.0)
California 2,323 513 (22.1) 1,782 (76.7) 28 (1.2)
Colorado 70 21 (30.0) 49 (70.0) 0 (0.0)
Connecticut 83 18 (21.7) 65 (78.3) 0 (0.0)
Delaware 21 5 (23.8) 16 (76.2) 0 (0.0)
District of Columbia 56 26 (46.4) 30 (53.6) 0 (0.0)
Florida 754 362 (48.0) 392 (52.0) 0 (0.0)
Georgia 347 188 (54.2) 159 (45.8) 0 (0.0)
Hawaii 123 32 (26.0) 91 (74.0) 0 (0.0)
Idaho 12 6 (50.0) 6 (50.0) 0 (0.0)
Illinois 359 133 (37.0) 226 (63.0) 0 (0.0)
Indiana 100 57 (57.0) 43 (43.0) 0 (0.0)
Iowa 40 11 (27.5) 29 (72.5) 0 (0.0)
Kansas 36 16 (44.4) 20 (55.6) 0 (0.0)
Kentucky 71 48 (67.6) 23 (32.4) 0 (0.0)
Louisiana 167 128 (76.6) 39 (23.4) 0 (0.0)
Maine 9 3 (33.3) 5 (55.6) 1 (11.1)
Maryland 233 66 (28.3) 167 (71.7) 0 (0.0)
Massachusetts 196 32 (16.3) 164 (83.7) 0 (0.0)
Michigan 170 82 (48.2) 83 (48.8) 5 (2.9)
Minnesota 137 21 (15.3) 116 (84.7) 0 (0.0)
Mississippi 91 73 (80.2) 18 (19.8) 0 (0.0)
Missouri 98 60 (61.2) 38 (38.8) 0 (0.0)
Montana 8 7 (87.5) 1 (12.5) 0 (0.0)
Nebraska 23 9 (39.1) 13 (56.5) 1 (4.3)
Nevada 95 26 (27.4) 69 (72.6) 0 (0.0)
New Hampshire 11 5 (45.5) 6 (54.5) 0 (0.0)
New Jersey 331 85 (25.7) 246 (74.3) 0 (0.0)
New Mexico 49 24 (49.0) 25 (51.0) 0 (0.0)
New York 910 203 (22.3) 706 (77.6) 1 (0.1)
North Carolina 244 137 (56.1) 107 (43.9) 0 (0.0)
North Dakota 7 0 (0.0) 7 (100.0) 0 (0.0)
Ohio 145 63 (43.4) 82 (56.6) 0 (0.0)
Oklahoma 94 70 (74.5) 24 (25.5) 0 (0.0)
Oregon 74 24 (32.4) 50 (67.6) 0 (0.0)
Pennsylvania 260 104 (40.0) 156 (60.0) 0 (0.0)
Rhode Island 27 6 (22.2) 21 (77.8) 0 (0.0)
South Carolina 140 107 (76.4) 33 (23.6) 0 (0.0)
South Dakota 15 9 (60.0) 6 (40.0) 0 (0.0)
Tennessee 156 101 (64.7) 55 (35.3) 0 (0.0)
Texas 1,325 625 (47.2) 700 (52.8) 0 (0.0)
Utah 34 10 (29.4) 24 (70.6) 0 (0.0)
Vermont 8 3 (37.5) 5 (62.5) 0 (0.0)
Virginia 221 69 (31.2) 152 (68.8) 0 (0.0)
Washington 200 45 (22.5) 155 (77.5) 0 (0.0)
West Virginia 13 8 (61.5) 5 (38.5) 0 (0.0)
Wisconsin 70 23 (32.9) 46 (65.7) 1 (1.4)
Wyoming 4 1 (25.0) 3 (75.0) 0 (0.0)
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
Note: See Surveillance Slide #14.




Cases No. No. No.(%) (%) (%)
U.S.-born Persons Foreign-born Persons1 Unknown Origin
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United States 6,510 925 (14.2) 1,104 (17.0) 1,032 (15.9) 1,302 (20.0) 1,503 (23.1) 644 (9.9)
Alabama 48 3 (6.3) 17 (35.4) 15 (31.3) 7 (14.6) 6 (12.5) 0 (0.0)
Alaska 15 2 (13.3) 2 (13.3) 1 (6.7) 3 (20.0) 3 (20.0) 4 (26.7)
Arizona 170 38 (22.4) 21 (12.4) 21 (12.4) 30 (17.6) 34 (20.0) 26 (15.3)
Arkansas 19 5 (26.3) 6 (31.6) 3 (15.8) 2 (10.5) 3 (15.8) 0 (0.0)
California 1,782 174 (9.8) 181 (10.2) 190 (10.7) 315 (17.7) 585 (32.8) 337 (18.9)
Colorado 49 13 (26.5) 10 (20.4) 5 (10.2) 5 (10.2) 11 (22.4) 5 (10.2)
Connecticut 65 6 (9.2) 21 (32.3) 13 (20.0) 16 (24.6) 9 (13.8) 0 (0.0)
Delaware 16 4 (25.0) 7 (43.8) 3 (18.8) 2 (12.5) 0 (0.0) 0 (0.0)
District of Columbia 30 4 (13.3) 13 (43.3) 8 (26.7) 2 (6.7) 3 (10.0) 0 (0.0)
Florida 392 60 (15.3) 64 (16.3) 59 (15.1) 102 (26.0) 84 (21.4) 23 (5.9)
Georgia 159 26 (16.4) 33 (20.8) 41 (25.8) 29 (18.2) 27 (17.0) 3 (1.9)
Hawaii 91 21 (23.1) 9 (9.9) 10 (11.0) 17 (18.7) 22 (24.2) 12 (13.2)
Idaho 6 2 (33.3) 0 (0.0) 1 (16.7) 3 (50.0) 0 (0.0) 0 (0.0)
Illinois 226 31 (13.7) 33 (14.6) 37 (16.4) 57 (25.2) 62 (27.4) 6 (2.7)
Indiana 43 11 (25.6) 9 (20.9) 7 (16.3) 1 (2.3) 0 (0.0) 15 (34.9)
Iowa 29 1 (3.4) 3 (10.3) 1 (3.4) 1 (3.4) 0 (0.0) 23 (79.3)
Kansas 20 2 (10.0) 5 (25.0) 2 (10.0) 1 (5.0) 9 (45.0) 1 (5.0)
Kentucky 23 8 (34.8) 9 (39.1) 2 (8.7) 3 (13.0) 1 (4.3) 0 (0.0)
Louisiana 39 3 (7.7) 8 (20.5) 12 (30.8) 7 (17.9) 8 (20.5) 1 (2.6)
Maine 5 0 (0.0) 1 (20.0) 2 (40.0) 1 (20.0) 1 (20.0) 0 (0.0)
Maryland 167 24 (14.4) 35 (21.0) 43 (25.7) 38 (22.8) 27 (16.2) 0 (0.0)
Massachusetts 164 35 (21.3) 36 (22.0) 22 (13.4) 34 (20.7) 36 (22.0) 1 (0.6)
Michigan 83 10 (12.0) 10 (12.0) 12 (14.5) 18 (21.7) 13 (15.7) 20 (24.1)
Minnesota 116 21 (18.1) 24 (20.7) 27 (23.3) 28 (24.1) 16 (13.8) 0 (0.0)
Mississippi 18 3 (16.7) 6 (33.3) 3 (16.7) 2 (11.1) 4 (22.2) 0 (0.0)
Missouri 38 2 (5.3) 3 (7.9) 0 (0.0) 0 (0.0) 0 (0.0) 33 (86.8)
Montana 1 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0)
Nebraska 13 2 (15.4) 7 (53.8) 2 (15.4) 2 (15.4) 0 (0.0) 0 (0.0)
Nevada 69 10 (14.5) 7 (10.1) 11 (15.9) 11 (15.9) 29 (42.0) 1 (1.4)
New Hampshire 6 1 (16.7) 2 (33.3) 1 (16.7) 0 (0.0) 1 (16.7) 1 (16.7)
New Jersey 246 28 (11.4) 46 (18.7) 40 (16.3) 45 (18.3) 44 (17.9) 43 (17.5)
New Mexico 25 5 (20.0) 5 (20.0) 1 (4.0) 3 (12.0) 11 (44.0) 0 (0.0)
New York 706 100 (14.2) 153 (21.7) 123 (17.4) 170 (24.1) 131 (18.6) 29 (4.1)
North Carolina 107 22 (20.6) 19 (17.8) 21 (19.6) 15 (14.0) 11 (10.3) 19 (17.8)
North Dakota 7 3 (42.9) 1 (14.3) 2 (28.6) 0 (0.0) 0 (0.0) 1 (14.3)
Ohio 82 15 (18.3) 12 (14.6) 14 (17.1) 24 (29.3) 13 (15.9) 4 (4.9)
Oklahoma 24 4 (16.7) 2 (8.3) 5 (20.8) 0 (0.0) 2 (8.3) 11 (45.8)
Oregon 50 7 (14.0) 8 (16.0) 7 (14.0) 9 (18.0) 4 (8.0) 15 (30.0)
Pennsylvania 156 25 (16.0) 29 (18.6) 33 (21.2) 39 (25.0) 28 (17.9) 2 (1.3)
Rhode Island 21 3 (14.3) 7 (33.3) 3 (14.3) 5 (23.8) 3 (14.3) 0 (0.0)
South Carolina 33 4 (12.1) 10 (30.3) 7 (21.2) 5 (15.2) 6 (18.2) 1 (3.0)
South Dakota 6 2 (33.3) 3 (50.0) 1 (16.7) 0 (0.0) 0 (0.0) 0 (0.0)
Tennessee 55 11 (20.0) 12 (21.8) 11 (20.0) 10 (18.2) 11 (20.0) 0 (0.0)
Texas 700 108 (15.4) 134 (19.1) 138 (19.7) 149 (21.3) 171 (24.4) 0 (0.0)
Utah 24 6 (25.0) 4 (16.7) 4 (16.7) 6 (25.0) 4 (16.7) 0 (0.0)
Vermont 5 3 (60.0) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0) 0 (0.0)
Virginia 152 21 (13.8) 29 (19.1) 35 (23.0) 41 (27.0) 26 (17.1) 0 (0.0)
Washington 155 25 (16.1) 33 (21.3) 24 (15.5) 36 (23.2) 33 (21.3) 4 (2.6)
West Virginia 5 1 (20.0) 2 (40.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (40.0)
Wisconsin 46 10 (21.7) 9 (19.6) 8 (17.4) 8 (17.4) 10 (21.7) 1 (2.2)
Wyoming 3 0 (0.0) 3 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Number of Years 




1 Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
                 
<1 Year 1–4 5–9 10–19 >20 Unknown or Missing
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
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United States 10,528 7,024 (66.7) 2,188 (20.8) 1,309 (12.4) 428
Alabama 161 126 (78.3) 24 (14.9) 11 (6.8) 5
Alaska 67 57 (85.1) 7 (10.4) 3 (4.5) 2
Arizona 255 204 (80.0) 34 (13.3) 17 (6.7) 9
Arkansas 85 59 (69.4) 14 (16.5) 12 (14.1) 4
California 2,323 1,564 (67.3) 465 (20.0) 294 (12.7) 87
Colorado 70 44 (62.9) 19 (27.1) 7 (10.0) 2
Connecticut 83 47 (56.6) 20 (24.1) 16 (19.3) 1
Delaware 21 14 (66.7) 6 (28.6) 1 (4.8) 1
District of Columbia 56 38 (67.9) 14 (25.0) 4 (7.1) 3
Florida 754 518 (68.7) 159 (21.1) 77 (10.2) 41
Georgia 347 234 (67.4) 68 (19.6) 43 (12.4) 18
Hawaii 123 93 (75.6) 18 (14.6) 12 (9.8) 7
Idaho 12 10 (83.3) 1 (8.3) 1 (8.3) 0
Illinois 359 225 (62.7) 84 (23.4) 50 (13.9) 22
Indiana 100 72 (72.0) 15 (15.0) 13 (13.0) 6
Iowa 40 22 (55.0) 11 (27.5) 6 (15.0) 4
Kansas 36 31 (86.1) 5 (13.9) 0 (0.0) 0
Kentucky 71 52 (73.2) 12 (16.9) 7 (9.9) 3
Louisiana 167 134 (80.2) 22 (13.2) 11 (6.6) 6
Maine 9 5 (55.6) 3 (33.3) 1 (11.1) 1
Maryland 233 149 (63.9) 59 (25.3) 25 (10.7) 8
Massachusetts 196 118 (60.2) 53 (27.0) 24 (12.2) 7
Michigan 170 106 (62.4) 58 (34.1) 6 (3.5) 6
Minnesota 137 60 (43.8) 58 (42.3) 19 (13.9) 8
Mississippi 91 66 (72.5) 15 (16.5) 10 (11.0) 3
Missouri 98 68 (69.4) 20 (20.4) 8 (8.2) 0
Montana 8 2 (25.0) 5 (62.5) 1 (12.5) 0
Nebraska 23 15 (65.2) 7 (30.4) 1 (4.3) 0
Nevada 95 74 (77.9) 18 (18.9) 3 (3.2) 2
New Hampshire 11 8 (72.7) 1 (9.1) 2 (18.2) 2
New Jersey 331 199 (60.1) 80 (24.2) 52 (15.7) 13
New Mexico 49 32 (65.3) 13 (26.5) 4 (8.2) 3
New York 910 570 (62.6) 207 (22.7) 133 (14.6) 36
North Carolina 244 164 (67.2) 43 (17.6) 37 (15.2) 13
North Dakota 7 3 (42.9) 3 (42.9) 0 (0.0) 0
Ohio 145 90 (62.1) 33 (22.8) 22 (15.2) 7
Oklahoma 94 54 (57.4) 26 (27.7) 14 (14.9) 7
Oregon 74 40 (54.1) 25 (33.8) 9 (12.2) 2
Pennsylvania 260 167 (64.2) 62 (23.8) 31 (11.9) 9
Rhode Island 27 15 (55.6) 11 (40.7) 1 (3.7) 0
South Carolina 140 79 (56.4) 32 (22.9) 29 (20.7) 13
South Dakota 15 10 (66.7) 4 (26.7) 1 (6.7) 1
Tennessee 156 104 (66.7) 30 (19.2) 22 (14.1) 9
Texas 1,325 952 (71.8) 169 (12.8) 204 (15.4) 47
Utah 34 13 (38.2) 16 (47.1) 5 (14.7) 0
Vermont 8 6 (75.0) 2 (25.0) 0 (0.0) 0
Virginia 221 147 (66.5) 48 (21.7) 26 (11.8) 5
Washington 200 97 (48.5) 73 (36.5) 30 (15.0) 5
West Virginia 13 12 (92.3) 1 (7.7) 0 (0.0) 0
Wisconsin 70 51 (72.9) 15 (21.4) 4 (5.7) 0
Wyoming 4 4 (100.0) 0 (0.0) 0 (0.0) 0
American Samoa4 3 0 (0.0) 0 (0.0) 3 (100.0) 3
Fed. States of Micronesia4 140 106 (75.7) 20 (14.3) 14 (10.0) 8
Guam4 78 60 (76.9) 8 (10.3) 10 (12.8) 4
Marshall Islands4 149 75 (50.3) 50 (33.6) 24 (16.1) 3
N. Mariana Islands4 27 23 (85.2) 0 (0.0) 4 (14.8) 3
Puerto Rico4 50 42 (84.0) 8 (16.0) 0 (0.0) 0
Republic of Palau4 8 8 (100.0) 0 (0.0) 0 (0.0) 0
U.S. Virgin Islands4 ... ... ... ... ... ... ... ...









No. No. No. No.(%) (%) (%)
1 Includes cases with pulmonary listed as the only site of disease.
2 Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmonary, listed 
as site of disease.
3 Includes cases with evidence of miliary disease.
4 Not included in U.S. totals.
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Morbidity Tables
Reporting Areas, 2011 and 2009
56
57
United States 9,946 9,884 (99.4) 424 (4.3)
Alabama 150 150 (100.0) 11 (7.3)
Alaska 61 60 (98.4) 1 (1.7)
Arizona 242 242 (100.0) 64 (26.4)
Arkansas 81 81 (100.0) 3 (3.7)
California 2,193 2,167 (98.8) 75 (3.5)
Colorado 62 62 (100.0) 2 (3.2)
Connecticut 80 76 (95.0) 0 (0.0)
Delaware 21 21 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 1 (1.8)
Florida 711 711 (100.0) 21 (3.0)
Georgia 321 320 (99.7) 31 (9.7)
Hawaii 122 122 (100.0) 2 (1.6)
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 341 (99.7) 4 (1.2)
Indiana 93 91 (97.8) 4 (4.4)
Iowa 39 39 (100.0) 0 (0.0)
Kansas 35 35 (100.0) 1 (2.9)
Kentucky 70 70 (100.0) 5 (7.1)
Louisiana 159 159 (100.0) 8 (5.0)
Maine 9 9 (100.0) 0 (0.0)
Maryland 218 218 (100.0) 2 (0.9)
Massachusetts 188 188 (100.0) 4 (2.1)
Michigan 163 160 (98.2) 1 (0.6)
Minnesota 127 127 (100.0) 2 (1.6)
Mississippi 89 89 (100.0) 1 (1.1)
Missouri 91 86 (94.5) 3 (3.5)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 21 21 (100.0) 0 (0.0)
Nevada 85 85 (100.0) 1 (1.2)
New Hampshire 11 11 (100.0) 0 (0.0)
New Jersey 317 317 (100.0) 1 (0.3)
New Mexico 48 48 (100.0) 3 (6.3)
New York State3 206 206 (100.0) 5 (2.4)
New York City 675 661 (97.9) 9 (1.4)
North Carolina 228 228 (100.0) 6 (2.6)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 135 (97.8) 1 (0.7)
Oklahoma 82 81 (98.8) 4 (4.9)
Oregon 73 73 (100.0) 2 (2.7)
Pennsylvania 249 249 (100.0) 9 (3.6)
Rhode Island 25 25 (100.0) 0 (0.0)
South Carolina 133 133 (100.0) 2 (1.5)
South Dakota 14 14 (100.0) 0 (0.0)
Tennessee 148 148 (100.0) 7 (4.7)
Texas 1,227 1,227 (100.0) 116 (9.5)
Utah 32 32 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 213 213 (100.0) 9 (4.2)
Washington 188 188 (100.0) 2 (1.1)
West Virginia 12 12 (100.0) 0 (0.0)
Wisconsin 63 62 (98.4) 1 (1.6)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa4 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia4 99 99 (100.0) 1 (1.0)
Guam4 67 67 (100.0) 1 (1.5)
Marshall Islands4 108 108 (100.0) 0 (0.0)
N. Mariana Islands4 26 26 (100.0) 0 (0.0)
Puerto Rico4 49 49 (100.0) 2 (4.1)
Republic of Palau4 8 8 (100.0) 0 (0.0)
U.S. Virgin Islands4 ... ... ... ... ...
Table 28. Tuberculosis Cases and Percentages by Residence in Correctional Facilities,1 




Cases with Information on Residence
 in Correctional Facilities
Cases Reported As Residents
 of Correctional Facilities2
No. No.(%) (%)
1 Resident of correctional facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Percent of those with known status.
3 Excludes New York City.
4 Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Surveillance Slide #26
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United States 9,946 9,814 (98.7) 565 (5.8)
Alabama 150 150 (100.0) 9 (6.0)
Alaska 61 60 (98.4) 14 (23.3)
Arizona 242 209 (86.4) 15 (7.2)
Arkansas 81 81 (100.0) 8 (9.9)
California 2,193 2,167 (98.8) 124 (5.7)
Colorado 62 62 (100.0) 4 (6.5)
Connecticut 80 76 (95.0) 0 (0.0)
Delaware 21 21 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 2 (3.6)
Florida 711 704 (99.0) 64 (9.1)
Georgia 321 319 (99.4) 32 (10.0)
Hawaii 122 107 (87.7) 9 (8.4)
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 339 (99.1) 33 (9.7)
Indiana 93 93 (100.0) 9 (9.7)
Iowa 39 39 (100.0) 2 (5.1)
Kansas 35 35 (100.0) 1 (2.9)
Kentucky 70 70 (100.0) 6 (8.6)
Louisiana 159 159 (100.0) 12 (7.5)
Maine 9 9 (100.0) 1 (11.1)
Maryland 218 217 (99.5) 13 (6.0)
Massachusetts 188 187 (99.5) 8 (4.3)
Michigan 163 160 (98.2) 17 (10.6)
Minnesota 127 127 (100.0) 2 (1.6)
Mississippi 89 89 (100.0) 11 (12.4)
Missouri 91 86 (94.5) 4 (4.7)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 21 21 (100.0) 2 (9.5)
Nevada 85 85 (100.0) 4 (4.7)
New Hampshire 11 11 (100.0) 1 (9.1)
New Jersey 317 316 (99.7) 7 (2.2)
New Mexico 48 48 (100.0) 4 (8.3)
New York State3 206 202 (98.1) 3 (1.5)
New York City 675 661 (97.9) 16 (2.4)
North Carolina 228 227 (99.6) 15 (6.6)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 133 (96.4) 3 (2.3)
Oklahoma 82 79 (96.3) 6 (7.6)
Oregon 73 73 (100.0) 7 (9.6)
Pennsylvania 249 248 (99.6) 5 (2.0)
Rhode Island 25 25 (100.0) 2 (8.0)
South Carolina 133 132 (99.2) 8 (6.1)
South Dakota 14 14 (100.0) 0 (0.0)
Tennessee 148 148 (100.0) 11 (7.4)
Texas 1,227 1,227 (100.0) 59 (4.8)
Utah 32 32 (100.0) 2 (6.3)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 213 213 (100.0) 1 (0.5)
Washington 188 188 (100.0) 9 (4.8)
West Virginia 12 12 (100.0) 0 (0.0)
Wisconsin 63 62 (98.4) 0 (0.0)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa4 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia4 99 99 (100.0) 7 (7.1)
Guam4 67 67 (100.0) 3 (4.5)
Marshall Islands4 108 108 (100.0) 0 (0.0)
N. Mariana Islands4 26 26 (100.0) 0 (0.0)
Puerto Rico4 49 49 (100.0) 3 (6.1)
Republic of Palau4 8 8 (100.0) 0 (0.0)









Table 29. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: 
Reporting Areas, 2011
1 Homeless within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Percent of those with known status. 
3 Excludes New York City.
4 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
See Surveillance Slide #27
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United States 9,946 9,883 (99.4) 224 (2.3)
Alabama 150 150 (100.0) 1 (0.7)
Alaska 61 61 (100.0) 0 (0.0)
Arizona 242 242 (100.0) 8 (3.3)
Arkansas 81 81 (100.0) 3 (3.7)
California 2,193 2,167 (98.8) 43 (2.0)
Colorado 62 62 (100.0) 0 (0.0)
Connecticut 80 76 (95.0) 5 (6.6)
Delaware 21 21 (100.0) 1 (4.8)
District of Columbia 55 55 (100.0) 2 (3.6)
Florida 711 711 (100.0) 5 (0.7)
Georgia 321 320 (99.7) 4 (1.3)
Hawaii 122 122 (100.0) 3 (2.5)
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 340 (99.4) 12 (3.5)
Indiana 93 91 (97.8) 3 (3.3)
Iowa 39 39 (100.0) 0 (0.0)
Kansas 35 35 (100.0) 0 (0.0)
Kentucky 70 70 (100.0) 2 (2.9)
Louisiana 159 159 (100.0) 2 (1.3)
Maine 9 9 (100.0) 0 (0.0)
Maryland 218 218 (100.0) 6 (2.8)
Massachusetts 188 188 (100.0) 4 (2.1)
Michigan 163 161 (98.8) 5 (3.1)
Minnesota 127 127 (100.0) 2 (1.6)
Mississippi 89 89 (100.0) 2 (2.2)
Missouri 91 86 (94.5) 3 (3.5)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 21 21 (100.0) 2 (9.5)
Nevada 85 85 (100.0) 1 (1.2)
New Hampshire 11 11 (100.0) 1 (9.1)
New Jersey 317 316 (99.7) 6 (1.9)
New Mexico 48 48 (100.0) 2 (4.2)
New York State3 206 205 (99.5) 5 (2.4)
New York City 675 663 (98.2) 37 (5.6)
North Carolina 228 228 (100.0) 3 (1.3)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 134 (97.1) 3 (2.2)
Oklahoma 82 82 (100.0) 3 (3.7)
Oregon 73 73 (100.0) 1 (1.4)
Pennsylvania 249 248 (99.6) 6 (2.4)
Rhode Island 25 25 (100.0) 0 (0.0)
South Carolina 133 133 (100.0) 3 (2.3)
South Dakota 14 14 (100.0) 3 (21.4)
Tennessee 148 148 (100.0) 3 (2.0)
Texas 1,227 1,227 (100.0) 23 (1.9)
Utah 32 32 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 213 213 (100.0) 0 (0.0)
Washington 188 187 (99.5) 5 (2.7)
West Virginia 12 12 (100.0) 1 (8.3)
Wisconsin 63 62 (98.4) 0 (0.0)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa4 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia4 99 99 (100.0) 4 (4.0)
Guam4 67 67 (100.0) 1 (1.5)
Marshall Islands4 108 107 (99.1) 0 (0.0)
N. Mariana Islands4 26 24 (92.3) 0 (0.0)
Puerto Rico4 49 49 (100.0) 4 (8.2)
Republic of Palau4 8 8 (100.0) 0 (0.0)




Cases with Information on
Residence in Long-term Care Facilities
Cases Reported As Residents of
Long-term Care Facilities2
No. No.(%) (%)
Table 30. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,1 
Age >15: Reporting Areas, 2011
1 Resident of long-term care facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Percent of those with known status.
3 Excludes New York City.
4 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
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United States 9,946 9,692 (97.4) 146 (1.5)
Alabama 150 149 (99.3) 6 (4.0)
Alaska 61 58 (95.1) 3 (5.2)
Arizona 242 200 (82.6) 8 (4.0)
Arkansas 81 81 (100.0) 0 (0.0)
California 2,193 2,139 (97.5) 21 (1.0)
Colorado 62 62 (100.0) 0 (0.0)
Connecticut 80 72 (90.0) 1 (1.4)
Delaware 21 21 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 0 (0.0)
Florida 711 702 (98.7) 13 (1.9)
Georgia 321 317 (98.8) 5 (1.6)
Hawaii 122 81 (66.4) -- --
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 336 (98.2) 3 (0.9)
Indiana 93 93 (100.0) 5 (5.4)
Iowa 39 39 (100.0) 0 (0.0)
Kansas 35 35 (100.0) 1 (2.9)
Kentucky 70 70 (100.0) 2 (2.9)
Louisiana 159 158 (99.4) 5 (3.2)
Maine 9 9 (100.0) 0 (0.0)
Maryland 218 217 (99.5) 1 (0.5)
Massachusetts 188 186 (98.9) 2 (1.1)
Michigan 163 156 (95.7) 7 (4.5)
Minnesota 127 127 (100.0) 1 (0.8)
Mississippi 89 89 (100.0) 1 (1.1)
Missouri 91 86 (94.5) 0 (0.0)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 21 20 (95.2) 0 (0.0)
Nevada 85 85 (100.0) 0 (0.0)
New Hampshire 11 11 (100.0) 0 (0.0)
New Jersey 317 316 (99.7) 3 (0.9)
New Mexico 48 48 (100.0) 2 (4.2)
New York State2 206 196 (95.1) 1 (0.5)
New York City 675 662 (98.1) 9 (1.4)
North Carolina 228 228 (100.0) 1 (0.4)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 130 (94.2) 2 (1.5)
Oklahoma 82 75 (91.5) 5 (6.7)
Oregon 73 73 (100.0) 1 (1.4)
Pennsylvania 249 244 (98.0) 1 (0.4)
Rhode Island 25 25 (100.0) 1 (4.0)
South Carolina 133 128 (96.2) 2 (1.6)
South Dakota 14 14 (100.0) 0 (0.0)
Tennessee 148 148 (100.0) 4 (2.7)
Texas 1,227 1,213 (98.9) 26 (2.1)
Utah 32 32 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 213 213 (100.0) 1 (0.5)
Washington 188 185 (98.4) 2 (1.1)
West Virginia 12 12 (100.0) 0 (0.0)
Wisconsin 63 61 (96.8) 0 (0.0)
Wyoming 4 3 (75.0) 0 (0.0)
Amercian Samoa3 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia3 99 99 (100.0) 0 (0.0)
Guam3 67 65 (97.0) 0 (0.0)
Marshall Islands3 108 108 (100.0) 1 (0.9)
N. Mariana Islands3 26 26 (100.0) 0 (0.0)
Puerto Rico3 49 49 (100.0) 9 (18.4)
Republic of Palau3 8 8 (100.0) 0 (0.0)




Cases with Information on
Injecting Drug Use
Cases Reporting Injecting Drug Use
No. No.(%) (%)
Table 31. Tuberculosis Cases and Percentages by Injecting Drug Use,1 Age >15: 
Reporting Areas, 2011
1 Injecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Excludes New York City.
3 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
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United States 9,946 9,686 (97.4) 735 (7.6)
Alabama 150 149 (99.3) 23 (15.4)
Alaska 61 58 (95.1) 8 (13.8)
Arizona 242 200 (82.6) 25 (12.5)
Arkansas 81 81 (100.0) 2 (2.5)
California 2,193 2,138 (97.5) 118 (5.5)
Colorado 62 62 (100.0) 1 (1.6)
Connecticut 80 72 (90.0) 2 (2.8)
Delaware 21 21 (100.0) 1 (4.8)
District of Columbia 55 55 (100.0) 4 (7.3)
Florida 711 703 (98.9) 74 (10.5)
Georgia 321 318 (99.1) 27 (8.5)
Hawaii 122 80 (65.6) -- --
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 337 (98.5) 32 (9.5)
Indiana 93 93 (100.0) 11 (11.8)
Iowa 39 39 (100.0) 1 (2.6)
Kansas 35 35 (100.0) 3 (8.6)
Kentucky 70 70 (100.0) 5 (7.1)
Louisiana 159 158 (99.4) 26 (16.5)
Maine 9 9 (100.0) 0 (0.0)
Maryland 218 217 (99.5) 5 (2.3)
Massachusetts 188 185 (98.4) 5 (2.7)
Michigan 163 154 (94.5) 24 (15.6)
Minnesota 127 127 (100.0) 3 (2.4)
Mississippi 89 89 (100.0) 10 (11.2)
Missouri 91 86 (94.5) 10 (11.6)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 21 20 (95.2) 0 (0.0)
Nevada 85 85 (100.0) 6 (7.1)
New Hampshire 11 11 (100.0) 0 (0.0)
New Jersey 317 316 (99.7) 14 (4.4)
New Mexico 48 48 (100.0) 7 (14.6)
New York State2 206 197 (95.6) 7 (3.6)
New York City 675 657 (97.3) 38 (5.8)
North Carolina 228 228 (100.0) 18 (7.9)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 130 (94.2) 13 (10.0)
Oklahoma 82 74 (90.2) 17 (23.0)
Oregon 73 73 (100.0) 5 (6.8)
Pennsylvania 249 244 (98.0) 8 (3.3)
Rhode Island 25 25 (100.0) 3 (12.0)
South Carolina 133 128 (96.2) 15 (11.7)
South Dakota 14 14 (100.0) 1 (7.1)
Tennessee 148 148 (100.0) 12 (8.1)
Texas 1,227 1,213 (98.9) 129 (10.6)
Utah 32 32 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 213 213 (100.0) 13 (6.1)
Washington 188 184 (97.9) 3 (1.6)
West Virginia 12 12 (100.0) 0 (0.0)
Wisconsin 63 62 (98.4) 3 (4.8)
Wyoming 4 4 (100.0) 1 (25.0)
American Samoa3 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia3 99 99 (100.0) 7 (7.1)
Guam3 67 65 (97.0) 0 (0.0)
Marshall Islands3 108 108 (100.0) 1 (0.9)
N. Mariana Islands3 26 26 (100.0) 0 (0.0)
Puerto Rico3 49 49 (100.0) 12 (24.5)
Republic of Palau3 8 8 (100.0) 0 (0.0)




Cases with Information on
Noninjecting Drug Use
Cases Reporting Noninjecting Drug Use
No. No.(%) (%)
Table 32. Tuberculosis Cases and Percentages by Noninjecting Drug Use,1 Age >15: 
Reporting Areas, 2011
1 Noninjecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Excludes New York City.
3 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
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United States 9,946 9,732 (97.8) 1,208 (12.4)
Alabama 150 148 (98.7) 36 (24.3)
Alaska 61 59 (96.7) 28 (47.5)
Arizona 242 199 (82.2) 34 (17.1)
Arkansas 81 81 (100.0) 3 (3.7)
California 2,193 2,141 (97.6) 209 (9.8)
Colorado 62 62 (100.0) 3 (4.8)
Connecticut 80 75 (93.8) 6 (8.0)
Delaware 21 21 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 9 (16.4)
Florida 711 703 (98.9) 119 (16.9)
Georgia 321 318 (99.1) 43 (13.5)
Hawaii 122 110 (90.2) 15 (13.6)
Idaho 11 11 (100.0) 0 (0.0)
Illinois 342 337 (98.5) 48 (14.2)
Indiana 93 93 (100.0) 16 (17.2)
Iowa 39 39 (100.0) 8 (20.5)
Kansas 35 35 (100.0) 4 (11.4)
Kentucky 70 70 (100.0) 9 (12.9)
Louisiana 159 158 (99.4) 36 (22.8)
Maine 9 9 (100.0) 1 (11.1)
Maryland 218 218 (100.0) 12 (5.5)
Massachusetts 188 185 (98.4) 15 (8.1)
Michigan 163 154 (94.5) 25 (16.2)
Minnesota 127 127 (100.0) 5 (3.9)
Mississippi 89 89 (100.0) 13 (14.6)
Missouri 91 86 (94.5) 13 (15.1)
Montana 8 8 (100.0) 1 (12.5)
Nebraska 21 19 (90.5) 1 (5.3)
Nevada 85 85 (100.0) 7 (8.2)
New Hampshire 11 11 (100.0) 1 (9.1)
New Jersey 317 316 (99.7) 25 (7.9)
New Mexico 48 48 (100.0) 13 (27.1)
New York State2 206 199 (96.6) 20 (10.1)
New York City 675 663 (98.2) 12 (1.8)
North Carolina 228 228 (100.0) 32 (14.0)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 138 129 (93.5) 15 (11.6)
Oklahoma 82 78 (95.1) 16 (20.5)
Oregon 73 73 (100.0) 4 (5.5)
Pennsylvania 249 244 (98.0) 21 (8.6)
Rhode Island 25 25 (100.0) 1 (4.0)
South Carolina 133 130 (97.7) 28 (21.5)
South Dakota 14 13 (92.9) 1 (7.7)
Tennessee 148 147 (99.3) 21 (14.3)
Texas 1,227 1,214 (98.9) 241 (19.9)
Utah 32 32 (100.0) 3 (9.4)
Vermont 7 6 (85.7) 0 (0.0)
Virginia 213 213 (100.0) 16 (7.5)
Washington 188 184 (97.9) 13 (7.1)
West Virginia 12 12 (100.0) 1 (8.3)
Wisconsin 63 62 (98.4) 4 (6.5)
Wyoming 4 4 (100.0) 1 (25.0)
American Samoa3 3 3 (100.0) 2 (66.7)
Fed. States of Micronesia3 99 98 (99.0) 1 (1.0)
Guam3 67 65 (97.0) 3 (4.6)
Marshall Islands3 108 105 (97.2) 20 (19.0)
N. Mariana Islands3 26 26 (100.0) 0 (0.0)
Puerto Rico3 49 49 (100.0) 4 (8.2)
Republic of Palau3 8 8 (100.0) 0 (0.0)









Table 33. Tuberculosis Cases and Percentages by Excess Alcohol Use,1 Age >15: 
Reporting Areas, 2011
1 Excess alcohol use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2 Excludes New York City.
3 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
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United States 9,946 9,587 96.4 (30.4) (3.7) (0.1) (1.6) (16.1) (13.9) (34.2)
Alabama 150 150 100 (23.3) (1.3) (0.7) (3.3) (13.3) (26.7) (31.3)
Alaska 61 55 90.2 (58.2) (1.8) (0.0) (0.0) (9.1) (5.5) (25.5)
Arizona 242 205 84.7 (35.6) (4.9) (0.0) (9.3) (14.1) (13.2) (22.9)
Arkansas 81 81 100 (21.0) (4.9) (1.2) (0.0) (21.0) (13.6) (38.3)
California 2,193 2,158 98.4 (26.7) (3.7) (0.1) (2.5) (20.5) (13.9) (32.5)
Colorado 62 62 100 (14.5) (8.1) (0.0) (0.0) (9.7) (29.0) (38.7)
Connecticut 80 72 90 (25.0) (6.9) (0.0) (1.4) (9.7) (15.3) (41.7)
Delaware 21 21 100 (9.5) (14.3) (0.0) (0.0) (14.3) (0.0) (61.9)
District of Columbia 55 55 100 (81.8) (0.0) (0.0) (0.0) (5.5) (0.0) (12.7)
Florida 711 696 97.9 (64.7) (2.6) (0.0) (1.7) (3.4) (0.7) (26.9)
Georgia 321 312 97.2 (35.6) (3.2) (0.6) (0.0) (11.5) (8.7) (40.4)
Hawaii 122 111 91 (18.9) (1.8) (0.0) (0.9) (23.4) (18.0) (36.9)
Idaho 11 11 100 (18.2) (0.0) (0.0) (0.0) (27.3) (9.1) (45.5)
Illinois 342 336 98.2 (18.8) (2.7) (0.3) (0.9) (22.6) (15.8) (39.0)
Indiana 93 92 98.9 (20.7) (4.3) (0.0) (1.1) (22.8) (21.7) (29.3)
Iowa 39 38 97.4 (13.2) (2.6) (0.0) (2.6) (21.1) (26.3) (34.2)
Kansas 35 35 100 (28.6) (2.9) (0.0) (0.0) (20.0) (22.9) (25.7)
Kentucky 70 70 100 (14.3) (1.4) (0.0) (5.7) (18.6) (22.9) (37.1)
Louisiana 159 157 98.7 (34.4) (3.2) (0.6) (2.5) (17.2) (7.6) (34.4)
Maine 9 9 100 (11.1) (0.0) (0.0) (0.0) (55.6) (11.1) (22.2)
Maryland 218 216 99.1 (18.5) (6.9) (0.5) (1.4) (13.9) (10.6) (48.1)
Massachusetts 188 188 100 (29.3) (4.3) (0.0) (1.1) (21.8) (12.8) (30.9)
Michigan 163 152 93.3 (65.1) (4.6) (0.0) (1.3) (0.0) (0.0) (28.9)
Minnesota 127 127 100 (16.5) (7.9) (0.0) (0.0) (16.5) (31.5) (27.6)
Mississippi 89 89 100 (46.1) (3.4) (0.0) (0.0) (16.9) (7.9) (25.8)
Missouri 91 0 0 -- -- -- -- -- -- --
Montana 8 8 100 (0.0) (12.5) (0.0) (0.0) (25.0) (12.5) (50.0)
Nebraska 21 21 100 (19.0) (0.0) (0.0) (0.0) (19.0) (9.5) (52.4)
Nevada 85 84 98.8 (6.0) (4.8) (0.0) (0.0) (10.7) (40.5) (38.1)
New Hampshire 11 11 100 (27.3) (0.0) (0.0) (0.0) (36.4) (0.0) (36.4)
New Jersey 317 317 100 (20.5) (5.0) (0.0) (0.9) (16.4) (14.8) (42.3)
New Mexico 48 48 100 (41.7) (0.0) (0.0) (2.1) (22.9) (6.3) (27.1)
New York State2 206 197 95.6 (24.4) (6.6) (0.5) (0.5) (18.8) (10.7) (38.6)
New York City 675 616 91.3 (46.3) (3.2) (0.0) (1.5) (15.1) (1.9) (32.0)
North Carolina 228 228 100 (31.6) (3.5) (0.4) (1.3) (20.2) (8.3) (34.6)
North Dakota 6 4 66.7 -- -- -- -- -- -- --
Ohio 138 134 97.1 (23.1) (1.5) (0.0) (1.5) (26.1) (17.9) (29.9)
Oklahoma 82 67 81.7 (23.9) (0.0) (0.0) (1.5) (23.9) (6.0) (44.8)
Oregon 73 73 100 (20.5) (4.1) (0.0) (0.0) (19.2) (28.8) (27.4)
Pennsylvania 249 249 100 (23.7) (5.2) (0.0) (0.0) (20.1) (14.9) (36.1)
Rhode Island 25 25 100 (12.0) (8.0) (0.0) (0.0) (8.0) (36.0) (36.0)
South Carolina 133 132 99.2 (34.1) (2.3) (0.0) (1.5) (22.0) (9.1) (31.1)
South Dakota 14 14 100 (0.0) (7.1) (0.0) (0.0) (7.1) (78.6) (7.1)
Tennessee 148 148 100 (29.7) (3.4) (0.0) (4.1) (14.9) (15.5) (32.4)
Texas 1,227 1,199 97.7 (29.1) (3.2) (0.2) (0.7) (13.5) (17.0) (36.4)
Utah 32 32 100 (15.6) (3.1) (0.0) (0.0) (18.8) (21.9) (40.6)
Vermont 7 7 100 (0.0) (0.0) (0.0) (0.0) (0.0) (85.7) (14.3)
Virginia 213 213 100 (0.0) (3.3) (0.0) (0.0) (9.9) (33.3) (53.5)
Washington 188 185 98.4 (10.3) (4.3) (0.0) (0.5) (17.3) (36.8) (30.8)
West Virginia 12 12 100 (8.3) (0.0) (0.0) (0.0) (33.3) (50.0) (8.3)
Wisconsin 63 61 96.8 (21.3) (1.6) (0.0) (1.6) (16.4) (24.6) (34.4)
Wyoming 4 4 100 (25.0) (0.0) (0.0) (0.0) (0.0) (25.0) (50.0)
American Samoa3 3 3 100 (0.0) (0.0) (0.0) (0.0) (33.3) (0.0) (66.7)
Fed. States of Micronesia3 99 98 99 (55.1) (0.0) (3.1) (1.0) (3.1) (16.3) (21.4)
Guam3 67 67 100 (26.9) (3.0) (0.0) (0.0) (22.4) (6.0) (41.8)
Marshall Islands3 108 108 100 (48.1) (1.9) (0.0) (0.0) (3.7) (18.5) (27.8)
N. Mariana Islands3 26 26 100 (30.8) (0.0) (0.0) (30.8) (3.8) (0.0) (34.6)
Puerto Rico3 49 49 100 (44.9) (4.1) (0.0) (0.0) (8.2) (16.3) (26.5)
Republic of Palau3 8 8 100 (12.5) (0.0) (0.0) (25.0) (37.5) (0.0) (25.0)
U.S. Virgin Islands3 ... ... ... ... ... ... ... ... ... ...
Table 34. Tuberculosis Cases and Percentages by Primary Occupation, Age >15: 
Reporting Areas, 2011
1 Occupation within past 12 months of TB diagnosis. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
2 Excludes New York City.
3 Not included in U.S. totals. 







Percentage of Cases by Occupation1
No. (%)










United States 10,528 10,279 10,183 (99.1) (0.7) (2.7) (86.2)
Alabama 161 156 156 (100.0) (0.6) (7.1) (82.7)
Alaska 67 65 64 (98.5) (0.0) (1.6) (79.7)
Arizona 255 246 238 (96.7) (0.0) (2.9) (92.0)
Arkansas 85 82 82 (100.0) (0.0) (7.3) (86.6)
California 2,323 2,272 2,254 (99.2) (0.6) (1.6) (88.1)
Colorado 70 68 68 (100.0) (0.0) (0.0) (83.8)
Connecticut 83 81 76 (93.8) (0.0) (1.3) (25.0)
Delaware 21 21 21 (100.0) (0.0) (4.8) (81.0)
District of Columbia 56 56 55 (98.2) (0.0) (0.0) (92.7)
Florida 754 737 735 (99.7) (0.8) (3.3) (86.3)
Georgia 347 332 331 (99.7) (2.1) (0.0) (94.6)
Hawaii 123 122 122 (100.0) (0.8) (1.6) (89.3)
Idaho 12 12 11 (91.7) (0.0) (0.0) (100.0)
Illinois 359 351 347 (98.9) (1.2) (3.7) (87.6)
Indiana 100 98 98 (100.0) (2.0) (2.0) (86.7)
Iowa 40 40 40 (100.0) (0.0) (0.0) (90.0)
Kansas 36 34 34 (100.0) (0.0) (0.0) (97.1)
Kentucky 71 69 69 (100.0) (0.0) (0.0) (82.6)
Louisiana 167 164 161 (98.2) (0.6) (5.6) (90.7)
Maine 9 8 8 (100.0) (0.0) (0.0) (100.0)
Maryland 233 228 227 (99.6) (2.2) (4.8) (83.3)
Massachusetts 196 191 191 (100.0) (0.5) (2.6) (76.4)
Michigan 170 168 166 (98.8) (0.0) (5.4) (79.5)
Minnesota 137 133 133 (100.0) (0.8) (6.0) (86.5)
Mississippi 91 89 88 (98.9) (2.3) (8.0) (80.7)
Missouri 98 95 92 (96.8) (0.0) (5.4) (75.0)
Montana 8 8 8 (100.0) (0.0) (0.0) (100.0)
Nebraska 23 23 23 (100.0) (0.0) (17.4) (69.6)
Nevada 95 93 92 (98.9) (0.0) (1.1) (95.7)
New Hampshire 11 11 11 (100.0) (0.0) (0.0) (81.8)
New Jersey 331 322 318 (98.8) (0.9) (1.6) (87.4)
New  Mexico 49 46 46 (100.0) (0.0) (0.0) (91.3)
New York State4 221 218 218 (100.0) (0.0) (2.3) (86.7)
New York City 689 674 654 (97.0) (0.3) (2.6) (84.6)
North Carolina 244 235 235 (100.0) (0.9) (0.9) (81.3)
North Dakota 7 7 7 (100.0) (0.0) (0.0) (100.0)
Ohio 145 143 141 (98.6) (0.0) (2.8) (84.4)
Oklahoma 94 89 88 (98.9) (15.9) (12.5) (60.2)
Oregon 74 74 74 (100.0) (0.0) (4.1) (91.9)
Pennsylvania 260 252 251 (99.6) (0.0) (2.4) (62.9)
Rhode Island 27 27 27 (100.0) (0.0) (3.7) (88.9)
South Carolina 140 134 134 (100.0) (0.0) (4.5) (86.6)
South Dakota 15 15 15 (100.0) (0.0) (6.7) (86.7)
Tennessee 156 149 149 (100.0) (0.0) (2.7) (91.9)
Texas 1,325 1,300 1,287 (99.0) (0.5) (2.5) (90.9)
Utah 34 34 34 (100.0) (2.9) (5.9) (82.4)
Vermont 8 8 8 (100.0) (0.0) (0.0) (62.5)
Virginia 221 218 216 (99.1) (0.0) (0.5) (95.4)
Washington 200 196 196 (100.0) (0.0) (2.0) (88.3)
West Virginia 13 12 12 (100.0) (0.0) (0.0) (91.7)
Wisconsin 70 69 68 (98.6) (1.5) (10.3) (79.4)
Wyoming 4 4 4 (100.0) (0.0) (0.0) (100.0)
American Samoa5 3 3 3 (100.0) (0.0) (0.0) (66.7)
Fed. States of Micronesia5 140 140 140 (100.0) (0.0) (0.7) (97.1)
Guam5 78 78 76 (97.4) (0.0) (2.6) (89.5)
Marshall Islands5 149 149 149 (100.0) (0.0) (0.0) (81.9)
N. Mariana Islands5 27 27 27 (100.0) (0.0) (0.0) (74.1)
Puerto Rico5 50 47 39 (83.0) (0.0) (0.0) (97.4)
Republic of Palau5 8 8 8 (100.0) (0.0) (0.0) (100.0)
U.S. Virgin Islands5 ... ... ... ... ... ... ...
Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen: 
Reporting Areas, 2011
1 Includes persons who were alive at diagnosis and started on one or more drug.
2 Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages 
shown only for reporting areas with information reported for >75% of cases.
3 I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol.
4 Excludes New York City.
5 Not included in U.S. totals.
Note: Excluding cases with no information on drug regimen, 226 (2.17%) persons were not started on any drugs, 13 (0.12%) were 




Cases with Information on
Initial Drug Regimen1








United States 8,070 7,727 (95.7) 736 (9.5) 124 (1.6)
Alabama 119 108 (90.8) 5 (4.6) 2 (1.9)
Alaska 60 59 (98.3) 14 (23.7) 4 (6.8)
Arizona 193 190 (98.4) 15 (7.9) 1 (0.5)
Arkansas 60 59 (98.3) 4 (6.8) 1 (1.7)
California 1,840 1,773 (96.4) 192 (10.8) 34 (1.9)
Colorado 52 52 (100.0) 7 (13.5) 1 (1.9)
Connecticut 69 66 (95.7) 6 (9.1) 0 (0.0)
Delaware 19 19 (100.0) 2 (10.5) 0 (0.0)
District of Columbia 46 46 (100.0) 3 (6.5) 0 (0.0)
Florida 604 567 (93.9) 42 (7.4) 6 (1.1)
Georgia 240 237 (98.8) 23 (9.7) 1 (0.4)
Hawaii 76 75 (98.7) 7 (9.3) 1 (1.3)
Idaho 10 9 (90.0) 2 (22.2) 0 (0.0)
Illinois 274 248 (90.5) 22 (8.9) 3 (1.2)
Indiana 74 73 (98.6) 8 (11.0) 2 (2.7)
Iowa 31 8 (25.8) -- -- -- --
Kansas 36 35 (97.2) 4 (11.4) 0 (0.0)
Kentucky 53 53 (100.0) 5 (9.4) 2 (3.8)
Louisiana 137 128 (93.4) 10 (7.8) 0 (0.0)
Maine 8 8 (100.0) 0 (0.0) 0 (0.0)
Maryland 166 165 (99.4) 13 (7.9) 2 (1.2)
Massachusetts 144 137 (95.1) 14 (10.2) 0 (0.0)
Michigan 123 122 (99.2) 9 (7.4) 1 (0.8)
Minnesota 101 101 (100.0) 12 (11.9) 3 (3.0)
Mississippi 66 66 (100.0) 6 (9.1) 0 (0.0)
Missouri 75 34 (45.3) -- -- -- --
Montana 5 5 (100.0) 0 (0.0) 0 (0.0)
Nebraska 18 18 (100.0) 0 (0.0) 0 (0.0)
Nevada 65 60 (92.3) 8 (13.3) 0 (0.0)
New Hampshire 10 10 (100.0) 1 (10.0) 0 (0.0)
New Jersey 267 262 (98.1) 34 (13.0) 8 (3.1)
New Mexico 43 43 (100.0) 0 (0.0) 0 (0.0)
New York State3 172 169 (98.3) 18 (10.7) 6 (3.6)
New York City 495 481 (97.2) 56 (11.6) 14 (2.9)
North Carolina 183 174 (95.1) 14 (8.0) 2 (1.1)
North Dakota 4 0 (0.0) -- -- -- --
Ohio 112 110 (98.2) 7 (6.4) 2 (1.8)
Oklahoma 68 67 (98.5) 2 (3.0) 1 (1.5)
Oregon 59 59 (100.0) 5 (8.5) 1 (1.7)
Pennsylvania 199 177 (88.9) 22 (12.4) 4 (2.3)
Rhode Island 20 20 (100.0) 1 (5.0) 0 (0.0)
South Carolina 107 101 (94.4) 4 (4.0) 0 (0.0)
South Dakota 7 7 (100.0) 1 (14.3) 0 (0.0)
Tennessee 109 106 (97.2) 7 (6.6) 0 (0.0)
Texas 1,009 982 (97.3) 88 (9.0) 16 (1.6)
Utah 24 24 (100.0) 3 (12.5) 1 (4.2)
Vermont 6 6 (100.0) 0 (0.0) 0 (0.0)
Virginia 175 174 (99.4) 15 (8.6) 2 (1.1)
Washington 160 158 (98.8) 14 (8.9) 1 (0.6)
West Virginia 13 12 (92.3) 1 (8.3) 0 (0.0)
Wisconsin 60 60 (100.0) 6 (10.0) 2 (3.3)
Wyoming 4 4 (100.0) 0 (0.0) 0 (0.0)
American Samoa4 3 3 (100.0) 1 (33.3) 0 (0.0)
Fed. States of Micronesia4 52 47 (90.4) 1 (2.1) 1 (2.1)
Guam4 43 39 (90.7) 4 (10.3) 0 (0.0)
Marshall Islands4 59 54 (91.5) 2 (3.7) 1 (1.9)
N. Mariana Islands4 16 15 (93.8) 2 (13.3) 0 (0.0)
Puerto Rico4 46 34 (73.9) -- -- -- --
Republic of Palau4 7 6 (85.7) 0 (0.0) 0 (0.0)
U.S. Virgin Islands4 ... ... ... ... ... ... ...
1 Patients tested to at least isoniazid and rifampin
2 Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District 
of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
3 Excludes New York City.
4 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility 











Isoniazid1 Isoniazid and Rifampin1
No. No.(%) (%)
66
United States 10,528 8,683 (82.5) 672 (7.7)
Alabama 161 153 (95.0) 7 (4.6)
Alaska 67 58 (86.6) 1 (1.7)
Arizona 255 211 (82.7) 10 (4.7)
Arkansas 85 73 (85.9) 4 (5.5)
California 2,323 1,820 (78.3) 100 (5.5)
Colorado 70 64 (91.4) 3 (4.7)
Connecticut 83 59 (71.1) 7 (11.9)
Delaware 21 21 (100.0) 0 (0.0)
District of Columbia 56 54 (96.4) 9 (16.7)
Florida 754 623 (82.6) 113 (18.1)
Georgia 347 310 (89.3) 31 (10.0)
Hawaii 123 108 (87.8) 1 (0.9)
Idaho 12 8 (66.7) 0 (0.0)
Illinois 359 311 (86.6) 22 (7.1)
Indiana 100 74 (74.0) 6 (8.1)
Iowa 40 32 (80.0) 1 (3.1)
Kansas 36 35 (97.2) 1 (2.9)
Kentucky 71 64 (90.1) 6 (9.4)
Louisiana 167 145 (86.8) 12 (8.3)
Maine 9 8 (88.9) 0 (0.0)
Maryland 233 205 (88.0) 13 (6.3)
Massachusetts 196 117 (59.7) 10 (8.5)
Michigan 170 135 (79.4) 5 (3.7)
Minnesota 137 121 (88.3) 3 (2.5)
Mississippi 91 87 (95.6) 9 (10.3)
Missouri 98 79 (80.6) 6 (7.6)
Montana 8 8 (100.0) 0 (0.0)
Nebraska 23 19 (82.6) 2 (10.5)
Nevada 95 89 (93.7) 2 (2.2)
New Hampshire 11 8 (72.7) 1 (12.5)
New Jersey 331 247 (74.6) 26 (10.5)
New Mexico 49 45 (91.8) 3 (6.7)
New York State3 221 174 (78.7) 11 (6.3)
New York City 689 546 (79.2) 58 (10.6)
North Carolina 244 238 (97.5) 12 (5.0)
North Dakota 7 6 (85.7) 0 (0.0)
Ohio 145 124 (85.5) 6 (4.8)
Oklahoma 94 59 (62.8) 1 (1.7)
Oregon 74 70 (94.6) 4 (5.7)
Pennsylvania 260 201 (77.3) 21 (10.4)
Rhode Island 27 26 (96.3) 2 (7.7)
South Carolina 140 124 (88.6) 12 (9.7)
South Dakota 15 12 (80.0) 0 (0.0)
Tennessee 156 149 (95.5) 20 (13.4)
Texas 1,325 1,081 (81.6) 95 (8.8)
Utah 34 33 (97.1) 1 (3.0)
Vermont 8 0 (0.0) 0 .
Virginia 221 203 (91.9) 9 (4.4)
Washington 200 171 (85.5) 6 (3.5)
West Virginia 13 10 (76.9) 0 (0.0)
Wisconsin 70 61 (87.1) 0 (0.0)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa4 3 3 (100.0) 0 (0.0)
Fed. States of Micronesia4 140 117 (83.6) 0 (0.0)
Guam4 78 48 (61.5) 0 (0.0)
Marshall Islands4 149 88 (59.1) 1 (1.1)
N. Mariana Islands4 27 19 (70.4) 0 (0.0)
Puerto Rico4 50 40 (80.0) 9 (22.5)
Republic of Palau4 8 8 (100.0) 1 (12.5)
U.S. Virgin Islands4 ... ... ... ... ...
Table 37. Tuberculosis Cases and Percentages by HIV Status: Reporting Areas, 2011
1 Includes only those cases in persons with negative, positive, or indeterminate HIV test results.
2 Counts and percentages shown only for reporting areas with information reported for >75% of cases. All 2011 Vermont cases are miss-
ing HIV status because these HIV data were not available at time of publication.
3 Excludes New York City.
4 Not included in U.S. totals. 





Cases with Information on HIV Status1 Cases in Persons with HIV-Positive Results2
No. (%) No. (%)
67
United States 11,528 11,282 11,028 (97.7) (70.7) (22.9) (6.4)
Alabama 168 164 164 (100.0) (96.3) (3.7) (0.0)
Alaska 37 36 36 (100.0) (52.8) (8.3) (38.9)
Arizona 232 227 209 (92.1) (77.5) (22.5) (0.0)
Arkansas 82 76 75 (98.7) (80.0) (20.0) (0.0)
California 2,467 2,425 2,388 (98.5) (50.6) (34.9) (14.4)
Colorado 85 84 83 (98.8) (89.2) (10.8) (0.0)
Connecticut 95 92 92 (100.0) (15.2) (30.4) (54.3)
Delaware 19 19 19 (100.0) (100.0) (0.0) (0.0)
District of Columbia 41 39 39 (100.0) (92.3) (7.7) (0.0)
Florida 822 795 790 (99.4) (69.7) (30.3) (0.0)
Georgia 412 407 381 (93.6) (74.3) (25.7) (0.0)
Hawaii 117 116 116 (100.0) (73.3) (26.7) (0.0)
Idaho 18 18 18 (100.0) (50.0) (50.0) (0.0)
Illinois 418 408 405 (99.3) (85.2) (14.8) (0.0)
Indiana 119 117 117 (100.0) (95.7) (4.3) (0.0)
Iowa 42 41 41 (100.0) (19.5) (80.5) (0.0)
Kansas 64 61 61 (100.0) (95.1) (4.9) (0.0)
Kentucky 75 74 73 (98.6) (86.3) (13.7) (0.0)
Louisiana 192 184 184 (100.0) (87.5) (12.5) (0.0)
Maine 9 9 9 (100.0) (0.0) (100.0) (0.0)
Maryland 218 212 207 (97.6) (93.2) (6.8) (0.0)
Massachusetts 242 239 232 (97.1) (73.7) (18.1) (8.2)
Michigan 144 135 132 (97.8) (81.8) (18.2) (0.0)
Minnesota 161 161 161 (100.0) (55.3) (44.7) (0.0)
Mississippi 121 117 117 (100.0) (97.4) (2.6) (0.0)
Missouri 79 78 0 (0.0) -- -- --
Montana 8 8 8 (100.0) (75.0) (25.0) (0.0)
Nebraska 32 31 30 (96.8) (56.7) (43.3) (0.0)
Nevada 106 103 99 (96.1) (97.0) (3.0) (0.0)
New Hampshire 16 16 16 (100.0) (12.5) (87.5) (0.0)
New Jersey 405 401 401 (100.0) (81.0) (19.0) (0.0)
New Mexico 48 41 41 (100.0) (73.2) (26.8) (0.0)
New York State3 246 240 239 (99.6) (72.8) (27.2) (0.0)
New York City 759 743 709 (95.4) (44.6) (19.2) (36.2)
North Carolina 250 244 244 (100.0) (95.1) (4.9) (0.0)
North Dakota 5 5 0 (0.0) -- -- --
Ohio 180 177 169 (95.5) (79.3) (20.7) (0.0)
Oklahoma 102 98 98 (100.0) (99.0) (1.0) (0.0)
Oregon 89 88 88 (100.0) (48.9) (29.5) (21.6)
Pennsylvania 236 230 230 (100.0) (81.3) (18.7) (0.0)
Rhode Island 24 24 24 (100.0) (95.8) (4.2) (0.0)
South Carolina 164 158 158 (100.0) (88.6) (11.4) (0.0)
South Dakota 18 17 17 (100.0) (64.7) (35.3) (0.0)
Tennessee 202 199 199 (100.0) (89.9) (10.1) (0.0)
Texas 1,501 1,473 1,459 (99.0) (76.9) (23.1) (0.0)
Utah 37 36 36 (100.0) (100.0) (0.0) (0.0)
Vermont 6 6 6 (100.0) (83.3) (16.7) (0.0)
Virginia 271 269 269 (100.0) (85.5) (14.5) (0.0)
Washington 256 254 254 (100.0) (89.4) (10.6) (0.0)
West Virginia 19 19 19 (100.0) (73.7) (26.3) (0.0)
Wisconsin 67 66 65 (98.5) (72.3) (27.7) (0.0)
Wyoming 2 2 1 (50.0) -- -- --
American Samoa4 4 4 3 (75.0) (100.0) (0.0) (0.0)
Fed. States of Micronesia4 190 190 136 (71.6) -- -- --
Guam4 102 100 94 (94.0) (94.7) (5.3) (0.0)
Marshall Islands4 125 125 56 (44.8) -- -- --
N. Mariana Islands4 32 32 30 (93.8) (100.0) (0.0) (0.0)
Puerto Rico4 63 58 58 (100.0) (89.7) (8.6) (1.7)
Republic of Palau4 18 18 7 (38.9) -- -- --
U.S. Virgin Islands4 ... ... ... ... ... ... ...
1 Most recent year for which data are available.
2 Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact inves-
tigation and dispensing of medication) provided by non–health department providers; Both Health Department and Private/Other: Both 
sectors involved in the care of the patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
3 Excludes New York City.
4 Not included in U.S. totals. 
Note: Ellipses indicate data not available.
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Cases with Information on
Type of Health Care Provider
68
United States 11,528 11,153 11,031 (98.9) (59.5) (30.3)
Alabama 168 164 164 (100.0) (39.0) (61.0)
Alaska 37 36 36 (100.0) (91.7) (8.3)
Arizona 232 213 203 (95.3) (73.9) (17.7)
Arkansas 82 76 76 (100.0) (30.3) (13.2)
California 2,467 2,391 2,320 (97.0) (51.9) (31.4)
Colorado 85 84 84 (100.0) (82.1) (14.3)
Connecticut 95 91 91 (100.0) (42.9) (29.7)
Delaware 19 19 19 (100.0) (47.4) (52.6)
District of Columbia 41 39 39 (100.0) (94.9) (0.0)
Florida 822 790 789 (99.9) (40.2) (54.8)
Georgia 412 400 396 (99.0) (79.3) (17.9)
Hawaii 117 115 114 (99.1) (32.5) (50.9)
Idaho 18 18 18 (100.0) (27.8) (50.0)
Illinois 418 407 402 (98.8) (46.0) (38.3)
Indiana 119 116 116 (100.0) (87.1) (10.3)
Iowa 42 41 41 (100.0) (70.7) (9.8)
Kansas 64 61 61 (100.0) (93.4) (6.6)
Kentucky 75 73 70 (95.9) (61.4) (31.4)
Louisiana 192 184 184 (100.0) (72.8) (15.2)
Maine 9 9 9 (100.0) (100.0) (0.0)
Maryland 218 212 209 (98.6) (78.0) (18.2)
Massachusetts 242 227 225 (99.1) (44.4) (32.9)
Michigan 144 133 130 (97.7) (50.8) (49.2)
Minnesota 161 161 161 (100.0) (88.8) (11.2)
Mississippi 121 117 117 (100.0) (59.8) (40.2)
Missouri 79 77 76 (98.7) (36.8) (50.0)
Montana 8 8 8 (100.0) (75.0) (25.0)
Nebraska 32 31 30 (96.8) (73.3) (16.7)
Nevada 106 103 103 (100.0) (76.7) (22.3)
New Hampshire 16 16 16 (100.0) (87.5) (12.5)
New Jersey 405 400 399 (99.8) (58.9) (19.5)
New Mexico 48 41 41 (100.0) (87.8) (12.2)
New York State4 246 239 239 (100.0) (18.4) (77.0)
New York City 759 723 721 (99.7) (6.7) (69.1)
North Carolina 250 242 242 (100.0) (97.1) (2.9)
North Dakota 5 5 5 (100.0) (0.0) (80.0)
Ohio 180 176 174 (98.9) (72.4) (10.3)
Oklahoma 102 85 84 (98.8) (91.7) (6.0)
Oregon 89 88 88 (100.0) (83.0) (14.8)
Pennsylvania 236 229 229 (100.0) (69.4) (21.0)
Rhode Island 24 24 24 (100.0) (25.0) (75.0)
South Carolina 164 158 158 (100.0) (93.0) (5.1)
South Dakota 18 17 17 (100.0) (41.2) (58.8)
Tennessee 202 199 199 (100.0) (96.5) (3.5)
Texas 1,501 1,467 1,459 (99.5) (76.7) (22.1)
Utah 37 36 36 (100.0) (100.0) (0.0)
Vermont 6 6 6 (100.0) (50.0) (50.0)
Virginia 271 268 268 (100.0) (92.5) (5.2)
Washington 256 251 251 (100.0) (70.1) (15.5)
West Virginia 19 19 18 (94.7) (72.2) (16.7)
Wisconsin 67 66 64 (97.0) (54.7) (43.8)
Wyoming 2 2 2 (100.0) (50.0) (50.0)
American Samoa5 4 4 4 (100.0) (0.0) (100.0)
Fed. States of Micronesia5 190 190 189 (99.5) (77.2) (20.1)
Guam5 102 100 95 (95.0) (96.8) (2.1)
Marshall Islands5 125 125 122 (97.6) (93.4) (6.6)
N. Mariana Islands5 32 32 29 (90.6) (100.0) (0.0)
Puerto Rico5 63 58 42 (72.4) -- --
Republic of Palau5 18 18 2 (11.1) -- --
U.S. Virgin Islands5 ... ... ... ... ... ...
Table 39. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): 
Reporting Areas, 20091
1 Most recent year for which data are available.
2 Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3 Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for 
reporting areas with information reported for >75% of cases.
4 Excludes New York City.
5 Not included in U.S. totals. 




Percentage of Cases by
Directly Observed Therapy3
No. (%) DOT Only






Cases with Information on
Directly Observed Therapy
69
Table 40. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy 
(COT): Reporting Areas, 20091
1 Most recent year for which data are available.
2 Initial isolate susceptible to rifampin (n=7,258) or susceptibility unknown (n=187); culture negative (n=2,008); culture status unknown (n=401).
3 Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during therapy. Percentage for U.S. 
based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for reporting areas with information reported 
for >90% of cases.
4 Excludes initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture, 
and those who moved out of country during treatment. 
5 Initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.
6 Excludes New York City.
7 Not included in U.S. totals. 





No. COT(%) No. COT(%)
Therapy <1 Year Indicated2,3,4
COT <1 Year(%)
Therapy >1 Year Indicated3,5
No. COT(%)
United States 11,528 9854 (87.7) (95.3) 629 (63.0) 10487 (93.3)
Alabama 168 146 (93.2) (98.6) 8 (75.0) 154 (97.4)
Alaska 37 32 (84.4) (87.5) 2 (100.0) 34 (88.2)
Arizona 232 178 (82.6) (87.1) 29 (37.9) 207 (80.2)
Arkansas 82 59 (86.4) (93.2) 7 (28.6) 66 (86.4)
California 2,467 2145 (83.2) (91.9) 66 (78.8) 2212 (91.5)
Colorado 85 69 (94.2) (100.0) 10 (60.0) 79 (94.9)
Connecticut 95 82 (86.6) (98.8) 3 (33.3) 85 (96.5)
Delaware 19 18 (77.8) (88.9) 0 ... 18 (88.9)
District of Columbia 41 32 (81.3) (96.9) 4 (75.0) 36 (94.4)
Florida 822 695 (93.2) (98.3) 39 (56.4) 734 (96.0)
Georgia 412 348 (83.6) (92.8) 26 (57.7) 374 (90.4)
Hawaii 117 96 (83.3) (99.0) 7 (57.1) 103 (96.1)
Idaho 18 17 (94.1) (94.1) 1 (0.0) 18 (88.9)
Illinois 418 364 (87.4) (97.0) 25 (64.0) 389 (94.9)
Indiana 119 106 (90.6) (97.2) 9 (77.8) 115 (95.7)
Iowa 42 39 (87.2) (97.4) 1 (0.0) 40 (95.0)
Kansas 64 55 (100.0) (100.0) 3 (100.0) 58 (100.0)
Kentucky 75 62 (91.9) (96.8) 1 (100.0) 63 (96.8)
Louisiana 192 170 (86.5) (95.3) 3 (66.7) 173 (94.8)
Maine 9 7 (100.0) (100.0) 1 (0.0) 8 (87.5)
Maryland 218 191 (88.5) (96.3) 13 (84.6) 204 (95.6)
Massachusetts 242 207 (83.1) (96.6) 14 (71.4) 221 (95.0)
Michigan 144 114 (89.5) (94.7) 12 (58.3) 126 (91.3)
Minnesota 161 146 (91.8) (97.3) 13 (61.5) 159 (94.3)
Mississippi 121 106 (88.7) (96.2) 5 (100.0) 111 (96.4)
Missouri 79 74 (81.1) (91.9) 3 (66.7) 77 (90.9)
Montana 8 7 (100.0) (100.0) 0 ... 7 (100.0)
Nebraska 32 29 (86.2) (89.7) 1 (100.0) 30 (90.0)
Nevada 106 94 (87.2) (97.9) 6 (50.0) 100 (95.0)
New Hampshire 16 15 (93.3) (100.0) 0 ... 15 (100.0)
New Jersey 405 349 (92.6) (97.4) 30 (60.0) 379 (94.5)
New Mexico 48 32 (90.6) (100.0) 3 (66.7) 35 (97.1)
New York State6 246 204 (82.4) (91.2) 14 (85.7) 221 (89.6)
New York City 759 665 (92.2) (97.1) 27 (81.5) 692 (96.5)
North Carolina 250 221 (93.2) (99.5) 6 (66.7) 227 (98.7)
North Dakota 5 5 (60.0) (100.0) 0 ... 5 (100.0)
Ohio 180 147 (91.2) (95.2) 9 (88.9) 156 (94.9)
Oklahoma 102 83 (89.2) (96.4) 1 (0.0) 84 (95.2)
Oregon 89 79 (97.5) (100.0) 6 (83.3) 85 (98.8)
Pennsylvania 236 202 (83.7) (95.5) 11 (81.8) 213 (94.8)
Rhode Island 24 23 (87.0) (95.7) 1 (0.0) 24 (91.7)
South Carolina 164 137 (92.0) (97.1) 9 (88.9) 146 (96.6)
South Dakota 18 17 (88.2) (94.1) 0 ... 17 (94.1)
Tennessee 202 176 (93.8) (98.3) 11 (81.8) 187 (97.3)
Texas 1,501 1228 (87.6) (95.4) 156 (51.9) 1384 (90.5)
Utah 37 28 (100.0) (100.0) 5 (100.0) 33 (100.0)
Vermont 6 5 (80.0) (100.0) 1 (0.0) 6 (83.3)
Virginia 271 244 (87.7) (96.7) 11 (63.6) 255 (95.3)
Washington 256 232 (91.4) (97.0) 12 (33.3) 244 (93.9)
West Virginia 19 16 (68.8) (81.3) 1 (0.0) 17 (76.5)
Wisconsin 67 56 (82.1) (96.4) 3 (66.7) 59 (94.9)
Wyoming 2 2 (50.0) (100.0) 0 ... 2 (100.0)
American Samoa7 4 3 (100.0) (100.0) 0 ... 3 (100.0)
Fed. States of Micronesia7 190 175 (82.9) (91.4) 10 (80.0) 186 (90.3)
Guam7 102 93 (96.8) (96.8) 4 (50.0) 97 (94.8)
Marshall Islands7 125 108 (88.9) (91.7) 4 (75.0) 112 (91.1)
N. Mariana Islands7 32 28 (96.4) (100.0) 1 (0.0) 29 (96.6)
Puerto Rico7 63 51 (86.3) (86.3) 1 (100.0) 52 (86.5)
Republic of Palau7 18 15 (26.7) (26.7) 1 (0.0) 16 (25.0)














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































United States 12349 (83.2) 12032 (84.1) 11759 (84.8) 11388 (85.2) 9854 (87.7)
Alabama 194 (89.7) 166 (86.7) 149 (91.9) 150 (90.0) 146 (93.2)
Alaska 57 (93.0) 63 (88.9) 43 (88.4) 45 (88.9) 32 (84.4)
Arizona 245 (83.7) 272 (79.8) 242 (71.1) 195 (72.8) 178 (82.6)
Arkansas 103 ... 89 (89.9) 96 (92.7) 74 (79.7) 59 (86.4)
California 2541 (81.3) 2398 (81.4) 2424 (79.6) 2386 (83.9) 2145 (83.2)
Colorado 85 (96.5) 108 (88.9) 91 (97.8) 94 (92.6) 69 (94.2)
Connecticut 87 (83.9) 77 (88.3) 96 (82.3) 88 (90.9) 82 (86.6)
Delaware 24 (87.5) 24 (83.3) 18 (94.4) 22 (81.8) 18 (77.8)
District of Columbia 49 (87.8) 64 (70.3) 51 (70.6) 49 (79.6) 32 (81.3)
Florida 968 (88.6) 919 (89.4) 884 (90.2) 826 (89.6) 695 (93.2)
Georgia 449 (82.0) 445 (82.5) 422 (85.1) 413 (87.9) 348 (83.6)
Hawaii 95 (74.7) 101 (79.2) 109 (77.1) 115 (77.4) 96 (83.3)
Idaho 21 (76.2) 18 (77.8) 8 (75.0) 11 (90.9) 17 (94.1)
Illinois 524 (80.0) 500 (82.2) 455 (84.6) 408 (86.8) 364 (87.4)
Indiana 133 (91.0) 116 (90.5) 118 (89.0) 102 (91.2) 106 (90.6)
Iowa 52 (84.6) 37 (86.5) 36 (88.9) 47 (89.4) 39 (87.2)
Kansas 57 (86.0) 73 (93.2) 53 (83.0) 54 (92.6) 55 (100.0)
Kentucky 104 (87.5) 75 (84.0) 108 (89.8) 88 (80.7) 62 (91.9)
Louisiana 218 ... 178 (77.0) 196 (79.6) 210 (79.5) 170 (86.5)
Maine 16 (75.0) 13 (100.0) 18 (88.9) 8 (87.5) 7 (100.0)
Maryland 249 (89.2) 226 (90.7) 246 (89.4) 248 (89.1) 191 (88.5)
Massachusetts 235 (78.7) 239 (85.8) 205 (81.0) 235 (80.9) 207 (83.1)
Michigan 201 (80.1) 200 (79.5) 186 (81.2) 146 (82.9) 114 (89.5)
Minnesota 183 (92.9) 200 (90.0) 225 (88.9) 199 (90.5) 146 (91.8)
Mississippi 84 (84.5) 97 (85.6) 118 (95.8) 96 (92.7) 106 (88.7)
Missouri 91 (85.7) 92 (78.3) 106 (76.4) 100 (86.0) 74 (81.1)
Montana 8 (87.5) 10 (90.0) 11 (100.0) 5 (100.0) 7 (100.0)
Nebraska 29 (75.9) 23 (100.0) 24 (95.8) 30 (80.0) 29 (86.2)
Nevada 106 ... 82 (90.2) 82 (86.6) 89 (83.1) 94 (87.2)
New Hampshire 4 (75.0) 15 (93.3) 10 (90.0) 17 (82.4) 15 (93.3)
New Jersey 423 (86.5) 463 (84.9) 411 (85.2) 379 (87.6) 349 (92.6)
New Mexico 26 (80.8) 37 (81.1) 43 (90.7) 48 (91.7) 32 (90.6)
New York State4 266 (87.6) 271 (85.6) 228 (87.3) 275 (85.8) 204 (82.4)
New York City 844 (82.0) 823 (84.4) 792 (90.7) 798 (88.7) 665 (92.2)
North Carolina 290 (85.9) 339 (87.3) 312 (91.7) 304 (90.8) 221 (93.2)
North Dakota 6 (50.0) 10 (60.0) 4 (100.0) 3 (33.3) 5 (60.0)
Ohio 231 (87.0) 205 (82.9) 221 (87.3) 189 (85.7) 147 (91.2)
Oklahoma 118 (85.6) 129 (81.4) 131 (81.7) 86 (76.7) 83 (89.2)
Oregon 95 (93.7) 71 (91.5) 88 (90.9) 70 (97.1) 79 (97.5)
Pennsylvania 270 ... 290 (83.4) 249 (84.3) 333 (81.1) 202 (83.7)
Rhode Island 41 (82.9) 24 (79.2) 40 (90.0) 34 (85.3) 23 (87.0)
South Carolina 231 (87.4) 194 (86.1) 188 (89.4) 160 (85.0) 137 (92.0)
South Dakota 13 (53.8) 12 (50.0) 11 (100.0) 15 (93.3) 17 (88.2)
Tennessee 267 (88.8) 239 (88.3) 202 (86.6) 247 (88.7) 176 (93.8)
Texas 1342 (82.3) 1363 (83.1) 1340 (81.9) 1319 (79.5) 1228 (87.6)
Utah 26 (96.2) 32 (84.4) 35 (94.3) 23 (95.7) 28 (100.0)
Vermont 7 (100.0) 6 (83.3) 3 (33.3) 5 (60.0) 5 (80.0)
Virginia 321 (83.2) 292 (85.3) 292 (88.4) 269 (83.6) 244 (87.7)
Washington 227 (83.3) 227 (81.9) 264 (88.6) 197 (90.4) 232 (91.4)
West Virginia 24 (58.3) 18 (77.8) 16 (100.0) 22 (95.5) 16 (68.8)
Wisconsin 69 (84.1) 63 (88.9) 57 (77.2) 57 (73.7) 56 (82.1)
Wyoming 0 ... 4 (100.0) 2 (50.0) 5 (80.0) 2 (50.0)
American Samoa5 5 ... 2 (100.0) 3 ... 3 (100.0) 3 (100.0)
Fed. States of Micronesia5 71 ... 76 ... 126 ... 157 ... 175 (82.9)
Guam5 58 (79.3) 52 (86.5) 90 (91.1) 84 (92.9) 93 (96.8)
Marshall Islands5 63 ... 33 ... 124 ... 115 (80.0) 108 (88.9)
N. Mariana Islands5 54 ... 44 ... 38 (84.2) 34 (70.6) 28 (96.4)
Puerto Rico5 86 (87.2) 89 (96.6) 81 (97.5) 69 (95.7) 51 (86.3)
Republic of Palau5 10 (100.0) 9 (66.7) 12 ... 14 ... 15 ...
U.S. Virgin Islands5 0 ... 0 ... 0 ... 4 (50.0) 0 ...
Reporting Area
2005 2006 2007 2008 2009
Year
No.2 No.2 No.2No.2(%)3 (%)3 (%)3 (%)3 (%)3
Table 43. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom 
Therapy Was Indicated for One Year or Less: Reporting Areas, 2005–20091
1 Most recent year for which data are available.
2 Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die 
during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or 
positive blood culture, and those who moved out of country during treatment.
3 Percentage of total cases in persons who completed therapy within one year for whom therapy less than 1 year was indicated.
4 Excludes New York City.
5 Not included in U.S. totals. 
Note: Ellipses indicate data not available.




Cities and Metropolitan Statistical Areas, 2011
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Albuquerque, NM 12 10
Anaheim, CA 24 30
Arlington, TX 21 19
Atlanta, GA 15 9
Austin, TX 45 60
Baltimore, MD 39 41
Birmingham, AL 25 17
Boston, MA 44 58
Buffalo, NY 13 9
Charlotte, NC 35 38
Chicago, IL 166 161
Cincinnati, OH 8 22
Cleveland, OH 27 26
Colorado Springs, CO 7 8
Columbus, OH 38 54
Corpus Christi, TX 10 12
Dallas, TX 130 131
Denver, CO 23 25
Detroit, MI 48 49
El Paso, TX 28 40
Fort Worth, TX 35 70
Fresno, CA 25 34
Honolulu, HI 51 52
Houston, TX 225 234
Indianapolis, IN 30 35
Jacksonville, FL 66 67
Kansas City, MO 16 14
Las Vegas, NV 76 85
Long Beach, CA 29 42
Los Angeles, CA 246 238
Louisville, KY 22 35
Memphis, TN 45 46
Mesa, AZ 13 10
Miami, FL 111 98
Milwaukee, WI 19 19
Minneapolis, MN 38 39
Nashville, TN 29 30
Newark, NJ 20 25
New Orleans, LA 24 44
New York, NY 689 711
Norfolk, VA 4 3
Oakland, CA 45 58
Omaha, NE 11 15
Philadelphia, PA 101 93
Phoenix, AZ 56 81
Pittsburgh, PA 7 5
Portland, OR 30 41
Sacramento, CA 56 46
St. Louis, MO 31 28
St. Paul, MN 26 31
San Antonio, TX 94 83
San Diego, CA 147 125
San Francisco, CA 108 98
San Jose, CA 116 127
Santa Ana, CA 40 42
Seattle, WA 53 51
Tampa, FL 17 24
Toledo, OH 1 2
Tucson, AZ 23 17
Virginia Beach, VA 4 14
Washington, DC 56 42
Wichita, KS 7 12
TOTAL - 62 CITIES 3,600 3,785
San Juan, PR 17 31
Table 44. Tuberculosis Cases in Selected Cities1: 2011 and 2010
Cases2
2011 2010City
1 Historical list of cities.
2 Excludes cases known to not be within city limits. Residence within city limits was determined by the health department.
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Table 45. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2011 and 2010
Metropolitan 
Statistical Area
Cases Case Rates Population 
Estimates 
20112011 20112010 2010
Akron, OH 2 3 0.3 0.4 701,456
Albany-Schenectady-Troy, NY 13 20 1.5 2.3 871,478
Albuquerque, NM 14 17 1.6 1.9 898,642
Allentown-Bethlehem-Easton, PA-NJ 11 11 1.3 1.3 824,916
Atlanta-Sandy Springs-Marietta, GA 211 252 3.9 4.8 5,359,205
Augusta-Richmond County, GA-SC 26 35 4.6 6.3 561,858
Austin-Round Rock, TX 71 82 4.0 4.7 1,783,519
Bakersfield, CA 40 36 4.7 4.3 851,710
Baltimore-Towson, MD 91 89 3.3 3.3 2,729,110
Baton Rouge, LA 20 22 2.5 2.7 808,242
Birmingham-Hoover, AL 36 39 3.2 3.5 1,132,264
Boise City-Nampa, ID 5 12 0.8 1.9 627,664
Boston-Cambridge-Quincy, MA-NH 158 181 3.4 4.0 4,591,112
Bridgeport-Stamford-Norwalk, CT 33 33 3.6 3.6 925,899
Buffalo-Niagara Falls, NY 15 11 1.3 1.0 1,134,039
Cape Coral-Fort Myers, FL 26 26 4.1 4.2 631,330
Charleston-North Charleston, SC 21 34 3.1 5.1 682,121
Charlotte-Gastonia-Concord, NC-SC 53 52 3.0 2.9 1,795,472
Chattanooga, TN-GA 10 12 1.9 2.3 533,372
Chicago-Naperville-Joliet, IL 336 343 3.5 3.6 9,504,753
Cincinnati-Middleton, OH-KY-IN 19 37 0.9 1.7 2,138,038
Cleveland-Elyria-Mentor, OH 43 42 2.1 2.0 2,068,283
Colorado Springs, CO 7 8 1.1 1.2 660,319
Columbia, SC 16 10 2.1 1.3 777,116
Columbus, OH 56 68 3.0 3.7 1,858,464
Dallas-Fort Worth-Arlington, TX 342 373 5.2 5.8 6,526,548
Dayton, OH 9 10 1.1 1.2 845,388
Denver-Aurora, CO 48 49 1.8 1.9 2,599,504
Des Moines-West Des Moines, IA 12 14 2.1 2.4 580,255
Detroit-Warren-Livonia, MI 55 60 1.3 1.4 4,285,832
Durham-Chapel Hill, NC 13 18 2.5 3.6 512,979
El Paso, TX 37 48 4.5 6.0 820,790
Fresno, CA 46 54 4.9 5.8 942,904
Grand Rapids-Wyoming, MI 21 17 2.7 2.2 779,604
Greensboro-High Point, NC 26 34 3.6 4.7 730,966
Greenville, SC 15 16 2.3 2.5 647,401
Harrisburg-Carlisle, PA 7 11 1.3 2.0 552,911
Hartford-West Hartford-East Hartford, CT 21 30 1.7 2.5 1,213,255
Honolulu, HI 103 81 10.7 8.5 963,607
Houston-Sugar Land-Baytown, TX 397 402 6.5 6.7 6,086,538
Indianapolis-Carmel, IN 44 45 2.5 2.6 1,778,568
Jackson, MS 41 39 7.5 7.2 545,394
Jacksonville, FL 77 80 5.7 5.9 1,360,251
Kansas City, MO-KS 35 35 1.7 1.7 2,052,676
Knoxville, TN 2 11 0.3 1.6 704,500
Lakeland, FL 16 16 2.6 2.7 609,492
Lancaster, PA 5 12 1.0 2.3 523,594
Las Vegas-Paradise, NV 57 97 2.9 5.0 1,969,975
Little Rock-North Little Rock-Conway, AR 19 16 2.7 2.3 709,901
Los Angeles-Long Beach-Santa Ana, CA 923 946 7.1 7.4 12,944,801
Louisville-Jefferson County, KY-IN 27 41 2.1 3.2 1,294,849
Madison, WI 12 11 2.1 1.9 576,467
McAllen-Edinburg-Mission, TX 80 69 10.0 8.8 797,810
Memphis, TN-MS-AR 53 62 4.0 4.7 1,325,605
Miami-Fort Lauderdale-Pompano Beach, FL 292 292 5.1 5.2 5,670,125
Milwaukee-Waukesha-West Allis, WI 30 23 1.9 1.5 1,562,216
Minneapolis-St. Paul-Bloomington, MN-WI 103 120 3.1 3.7 3,318,486
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Modesto, CA 9 16 1.7 3.1 518,522
Nashville-Davidson-Murfreesboro-Franklin, TN 55 56 3.4 3.5 1,617,142
New Haven-Milford, CT 19 15 2.2 1.7 861,113
New Orleans-Metairie-Kenner, LA 61 82 5.1 7.0 1,191,089
New York-Northern New Jersey-Long Island, NY-NJ-PA 1092 1191 5.7 6.3 19,015,900
Ogden-Clearfield, UT 4 6 0.7 1.1 555,916
Oklahoma City, OK 34 31 2.7 2.5 1,278,053
Omaha-Council Bluffs, NE-IA 12 16 1.4 1.8 877,110
Orlando-Kissimmee, FL 80 82 3.7 3.8 2,171,360
Oxnard-Thousand Oaks-Ventura, CA 35 33 4.2 4.0 831,771
Palm Bay-Melbourne-Titusville, FL 9 10 1.7 1.8 543,566
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 196 202 3.3 3.4 5,992,414
Phoenix-Mesa-Scottsdale, AZ 171 203 4.0 4.8 4,263,236
Pittsburgh, PA 30 16 1.3 0.7 2,359,746
Portland-South Portland-Biddeford, ME 3 6 0.6 1.2 515,807
Portland-Vancouver-Beaverton, OR-WA 60 80 2.7 3.6 2,262,605
Poughkeepsie-Newburgh-Middletown, NY 12 14 1.8 2.1 672,871
Providence-New Bedford-Fall River, RI-MA 34 37 2.1 2.3 1,600,224
Provo-Orem, UT 4 . 0.7 . 540,834
Raleigh-Cary, NC 31 44 2.7 3.9 1,163,515
Richmond, VA 30 43 2.4 3.4 1,269,380
Riverside-San Bernardino-Ontario, CA 121 134 2.8 3.2 4,304,997
Rochester, NY 26 19 2.5 1.8 1,055,278
Sacramento-Arden Arcade-Roseville, CA 85 75 3.9 3.5 2,176,235
St. Louis, MO-IL 49 56 1.7 2.0 2,817,355
Salt Lake City, UT 17 13 1.5 1.2 1,145,905
San Antonio, TX 104 96 4.7 4.5 2,194,927
San Diego-Carlsbad-San Marcos, CA 263 222 8.4 7.1 3,140,069
San Francisco-Oakland-Fremont, CA 372 388 8.5 8.9 4,391,037
San Jose-Sunnyvale-Santa Clara, CA 184 194 9.9 10.5 1,865,450
Sarasota-Bradenton-Venice, FL 24 29 3.4 4.1 709,355
Scranton-Wilkes-Barre, PA 9 5 1.6 0.9 563,223
Seattle-Tacoma-Bellevue, WA 155 156 4.4 4.5 3,500,026
Springfield, MA 16 16 2.3 2.3 693,204
Stockton, CA 44 46 6.3 6.7 696,214
Syracuse, NY 8 13 1.2 2.0 662,553
Tampa-St. Petersburg-Clearwater, FL 82 125 2.9 4.5 2,824,724
Toledo, OH 3 3 0.5 0.5 650,266
Tucson, AZ 28 19 2.8 1.9 989,569
Tulsa, OK 24 15 2.5 1.6 946,962
Virginia Beach-Norfolk-Newport News, VA-NC 20 34 1.2 2.0 1,679,894
Washington-Arlington-Alexandria, DC-VA-MD-WV 333 314 5.8 5.6 5,703,948
Wichita, KS 8 12 1.3 1.9 625,526
Worchester, MA 14 18 1.7 2.3 801,227
Youngstown-Warren-Boardman, OH-PA 3 6 0.5 1.1 562,739
Total - 102 Areas 8274 8799 4.0 4.3 205,086,431
San Juan-Caguas-Guaynabo, PR 13 4 0.5 0.2 2,468,598
Table 45. (Cont’d) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2011 and 2010
Metropolitan 
Statistical Area
Cases Case Rates Population 
Estimates 
20112011 20112010 2010
Note: 2011 and 2010 population case counts and rates updated using U.S. Census Annual Estimates of the Resident Population for 
Counties: April 1, 2000 to July 1, 2009 (http://www.census.gov/popest/data/counties/totals/2009/CO-EST2009-01.html) and (http://www.
census.gov/popest/data/counties/totals/2011/files/CO-EST2011-Alldata.csv) (accessed August 8, 2012).
See Technical Notes for definition of MSA.
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Table 46. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2011
Akron, OH 2 0 0 0 0 2 0 0
Albany-Schenectady-Troy, NY 13 0 1 1 5 1 5 0
Albuquerque, NM 14 0 0 1 2 6 5 0
Allentown-Bethlehem-Easton, PA-NJ 11 1 0 1 5 1 3 0
Atlanta-Sandy Springs-Marietta, GA 211 6 10 26 78 65 26 0
Augusta-Richmond County, GA-SC 26 0 0 1 15 10 0 0
Austin-Round Rock, TX 71 3 3 6 25 26 8 0
Bakersfield, CA 40 5 1 2 16 12 4 0
Baltimore-Towson, MD 91 2 2 5 45 22 15 0
Baton Rouge, LA 20 2 0 3 5 7 3 0
Birmingham-Hoover, AL 36 3 3 2 14 10 4 0
Boise City-Nampa, ID 5 0 1 1 2 1 0 0
Boston-Cambridge-Quincy, MA-NH 158 6 0 19 59 39 35 0
Bridgeport-Stamford-Norwalk, CT 33 2 0 4 14 7 6 0
Buffalo-Niagara Falls, NY 15 0 0 4 2 5 4 0
Cape Coral-Fort Myers, FL 26 1 0 3 6 12 4 0
Charleston-North Charleston, SC 21 1 0 2 6 5 7 0
Charlotte-Gastonia-Concord, NC-SC 53 2 0 3 21 20 7 0
Chattanooga, TN-GA 10 1 0 2 3 2 2 0
Chicago-Naperville-Joliet, IL 336 5 11 25 101 109 85 0
Cincinnati-Middleton, OH-KY-IN 19 0 0 2 10 4 3 0
Cleveland-Elyria-Mentor, OH 43 2 0 1 11 11 18 0
Colorado Springs, CO 7 1 0 1 2 2 1 0
Columbia, SC 16 0 0 2 7 4 3 0
Columbus, OH 56 1 3 11 22 9 10 0
Dallas-Fort Worth-Arlington, TX 342 10 10 34 134 108 46 0
Dayton, OH 9 0 0 0 5 2 2 0
Denver-Aurora, CO 48 2 3 5 17 14 7 0
Des Moines-West Des Moines, IA 12 0 0 1 6 3 2 0
Detroit-Warren-Livonia, MI 55 0 1 4 11 16 23 0
Durham-Chapel Hill, NC 13 0 1 1 5 2 4 0
El Paso, TX 37 2 0 3 14 6 12 0
Fresno, CA 46 3 2 1 7 20 13 0
Grand Rapids-Wyoming, MI 21 0 0 6 8 6 1 0
Greensboro-High Point, NC 26 1 1 6 6 5 7 0
Greenville, SC 15 1 1 3 1 4 5 0
Harrisburg-Carlisle, PA 7 1 0 1 1 3 1 0
Hartford-West Hartford-East Hartford, CT 21 0 1 2 7 9 2 0
Honolulu, HI 103 1 0 10 20 38 34 0
Houston-Sugar Land-Baytown, TX 397 18 6 47 131 129 66 0
Indianapolis-Carmel, IN 44 1 1 6 12 12 12 0
Jackson, MS 41 1 0 4 12 21 3 0
Jacksonville, FL 77 1 3 10 17 34 12 0
Kansas City, MO-KS 35 1 3 7 6 11 7 0
Knoxville, TN 2 0 0 1 1 0 0 0
Lakeland, FL 16 0 0 0 2 8 6 0
Lancaster, PA 5 0 0 0 2 2 1 0
Las Vegas-Paradise, NV 57 6 2 3 15 18 13 0
Little Rock-North Little Rock-Conway, AR 19 0 0 2 5 5 7 0
Los Angeles-Long Beach-Santa Ana, CA 923 32 16 72 242 305 256 0
Louisville-Jefferson County, KY-IN 27 1 0 1 6 15 4 0
Madison, WI 12 0 0 3 5 2 2 0
McAllen-Edinburg-Mission, TX 80 7 2 8 28 22 13 0
Memphis, TN-MS-AR 53 2 3 11 14 16 7 0
Miami-Fort Lauderdale-Pompano Beach, FL 292 10 5 24 98 104 51 0
Milwaukee-Waukesha-West Allis, WI 30 4 1 2 5 12 6 0




Cases Under 5 15 –24
Unknown 
or 
Missing5–14 25–44 45–64 >65
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Table 46. (Cont’d) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2011
Metropolitan 






Note: See Technical Notes for definition of MSA.
5–14 25–44 45–64 >65
Modesto, CA 9 0 0 1 1 4 3 0
Nashville-Davidson-Murfreesboro-Franklin, TN 55 1 0 6 29 15 4 0
New Haven-Milford, CT 19 0 0 4 8 6 1 0
New Orleans-Metairie-Kenner, LA 61 2 2 5 20 25 7 0
New York-Northern New Jersey-Long Island, NY-NJ-PA 1092 21 14 123 415 299 220 0
Ogden-Clearfield, UT 4 0 0 0 2 0 2 0
Oklahoma City, OK 34 3 0 2 15 9 5 0
Omaha-Council Bluffs, NE-IA 12 1 1 2 3 4 1 0
Orlando-Kissimmee, FL 80 1 3 5 24 29 18 0
Oxnard-Thousand Oaks-Ventura, CA 35 2 1 1 12 13 6 0
Palm Bay-Melbourne-Titusville, FL 9 0 1 0 2 4 2 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 196 4 1 20 75 61 35 0
Phoenix-Mesa-Scottsdale, AZ 171 3 2 23 74 34 35 0
Pittsburgh, PA 30 1 1 2 11 6 9 0
Portland-South Portland-Biddeford, ME 3 0 0 1 1 0 1 0
Portland-Vancouver-Beaverton, OR-WA 60 0 2 8 23 11 16 0
Poughkeepsie-Newburgh-Middletown, NY 12 0 0 0 5 3 4 0
Providence-New Bedford-Fall River, RI-MA 34 3 0 3 15 8 5 0
Provo-Orem, UT 4 0 0 2 1 1 0 0
Raleigh-Cary, NC 31 3 0 4 16 4 4 0
Richmond, VA 30 0 1 2 13 7 7 0
Riverside-San Bernardino-Ontario, CA 121 3 0 7 34 49 28 0
Rochester, NY 26 1 1 2 8 11 3 0
Sacramento-Arden Arcade-Roseville, CA 85 1 2 7 26 28 21 0
St. Louis, MO-IL 49 2 0 4 21 15 6 1
Salt Lake City, UT 17 1 1 2 7 4 2 0
San Antonio, TX 104 10 3 7 33 29 22 0
San Diego-Carlsbad-San Marcos, CA 263 7 8 29 68 81 70 0
San Francisco-Oakland-Fremont, CA 372 12 12 26 97 118 107 0
San Jose-Sunnyvale-Santa Clara, CA 184 4 2 12 52 61 53 0
Sarasota-Bradenton-Venice, FL 24 0 0 1 12 5 6 0
Scranton-Wilkes-Barre, PA 9 0 0 2 2 5 0 0
Seattle-Tacoma-Bellevue, WA 155 4 7 20 46 38 40 0
Springfield, MA 16 1 0 6 3 2 4 0
Stockton, CA 44 3 1 0 14 14 12 0
Syracuse, NY 8 1 0 2 4 1 0 0
Tampa-St. Petersburg-Clearwater, FL 82 3 7 8 20 30 14 0
Toledo, OH 3 0 0 0 0 1 2 0
Tucson, AZ 28 2 3 0 6 9 8 0
Tulsa, OK 24 5 2 0 5 9 3 0
Virginia Beach-Norfolk-Newport News, VA-NC 20 0 4 1 3 6 6 0
Washington-Arlington-Alexandria, DC-VA-MD-WV 333 10 5 39 144 87 48 0
Wichita, KS 8 0 0 1 2 3 2 0
Worchester, MA 14 0 0 2 3 5 4 0
Youngstown-Warren-Boardman, OH-PA 3 0 0 0 0 0 3 0
Total - 102 Areas 8274 266 189 818 2736 2520 1744 1
San Juan-Caguas-Guaynabo, PR 13 1 0 1 6 3 2 0
82
Akron, OH 2 1 0 0 0 0 1 0 0
Albany-Schenectady-Troy, NY 13 1 0 7 2 0 3 0 0
Albuquerque, NM 14 9 0 0 3 0 2 0 0
Allentown-Bethlehem-Easton, PA-NJ 11 2 0 4 2 0 3 0 0
Atlanta-Sandy Springs-Marietta, GA 211 44 0 46 98 0 23 0 0
Augusta-Richmond County, GA-SC 26 3 0 3 18 0 2 0 0
Austin-Round Rock, TX 71 29 0 24 9 0 9 0 0
Bakersfield, CA 40 23 0 8 6 0 3 0 0
Baltimore-Towson, MD 91 13 0 28 33 0 17 0 0
Baton Rouge, LA 20 3 0 1 8 0 7 1 0
Birmingham-Hoover, AL 36 1 0 6 24 0 5 0 0
Boise City-Nampa, ID 5 0 0 2 2 0 0 1 0
Boston-Cambridge-Quincy, MA-NH 158 25 0 58 45 0 25 1 4
Bridgeport-Stamford-Norwalk, CT 33 8 0 11 9 0 5 0 0
Buffalo-Niagara Falls, NY 15 0 0 3 6 0 6 0 0
Cape Coral-Fort Myers, FL 26 8 0 6 5 0 7 0 0
Charleston-North Charleston, SC 21 2 0 1 13 0 5 0 0
Charlotte-Gastonia-Concord, NC-SC 53 14 0 9 19 0 10 1 0
Chattanooga, TN-GA 10 3 0 2 2 0 3 0 0
Chicago-Naperville-Joliet, IL 336 95 0 108 87 0 46 0 0
Cincinnati-Middleton, OH-KY-IN 19 4 0 7 3 0 5 0 0
Cleveland-Elyria-Mentor, OH 43 0 0 14 21 0 8 0 0
Colorado Springs, CO 7 2 0 2 2 1 0 0 0
Columbia, SC 16 6 0 2 5 0 3 0 0
Columbus, OH 56 2 0 11 25 0 18 0 0
Dallas-Fort Worth-Arlington, TX 342 109 0 73 105 1 54 0 0
Dayton, OH 9 0 0 1 1 0 7 0 0
Denver-Aurora, CO 48 14 0 15 11 0 8 0 0
Des Moines-West Des Moines, IA 12 1 0 5 5 0 1 0 0
Detroit-Warren-Livonia, MI 55 3 0 23 11 0 16 0 2
Durham-Chapel Hill, NC 13 5 0 2 4 0 2 0 0
El Paso, TX 37 35 0 2 0 0 0 0 0
Fresno, CA 46 29 0 15 1 0 1 0 0
Grand Rapids-Wyoming, MI 21 5 0 7 4 1 3 0 1
Greensboro-High Point, NC 26 3 0 8 10 0 5 0 0
Greenville, SC 15 2 0 6 2 0 5 0 0
Harrisburg-Carlisle, PA 7 0 0 2 1 0 4 0 0
Hartford-West Hartford-East Hartford, CT 21 2 0 8 4 0 7 0 0
Honolulu, HI 103 1 0 82 1 18 1 0 0
Houston-Sugar Land-Baytown, TX 397 172 0 83 90 0 52 0 0
Indianapolis-Carmel, IN 44 7 0 11 8 0 18 0 0
Jackson, MS 41 5 0 3 30 0 3 0 0
Jacksonville, FL 77 9 0 11 45 1 11 0 0
Kansas City, MO-KS 35 7 0 9 13 1 5 0 0
Knoxville, TN 2 1 0 1 0 0 0 0 0
Lakeland, FL 16 4 0 1 5 0 6 0 0
Lancaster, PA 5 1 0 1 1 0 2 0 0
Las Vegas-Paradise, NV 57 21 0 18 8 1 9 0 0
Little Rock-North Little Rock-Conway, AR 19 2 0 1 11 0 5 0 0
Los Angeles-Long Beach-Santa Ana, CA 923 381 1 421 48 3 65 0 4
Louisville-Jefferson County, KY-IN 27 3 0 3 9 0 12 0 0
Madison, WI 12 3 0 7 2 0 0 0 0
McAllen-Edinburg-Mission, TX 80 80 0 0 0 0 0 0 0
Memphis, TN-MS-AR 53 3 0 4 38 0 7 1 0
Miami-Fort Lauderdale-Pompano Beach, FL 292 104 1 20 123 5 39 0 0
Milwaukee-Waukesha-West Allis, WI 30 3 0 13 9 0 5 0 0
Minneapolis-St. Paul-Bloomington, MN-WI 103 8 0 34 57 0 4 0 0
Table 47. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan 


























Modesto, CA 9 5 0 3 0 0 0 0 1
Nashville-Davidson-Murfreesboro-Franklin, TN 55 14 0 11 14 0 16 0 0
New Haven-Milford, CT 19 4 0 8 3 0 4 0 0
New Orleans-Metairie-Kenner, LA 61 10 0 14 22 0 15 0 0
New York-Northern New Jersey-Long Island, NY-NJ-PA 1092 329 0 396 230 0 121 2 14
Ogden-Clearfield, UT 4 1 0 1 1 0 1 0 0
Oklahoma City, OK 34 11 3 10 1 0 6 0 3
Omaha-Council Bluffs, NE-IA 12 1 0 2 4 1 4 0 0
Orlando-Kissimmee, FL 80 17 0 18 28 0 17 0 0
Oxnard-Thousand Oaks-Ventura, CA 35 15 0 15 1 0 4 0 0
Palm Bay-Melbourne-Titusville, FL 9 1 0 0 3 0 5 0 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 196 34 0 75 59 0 26 2 0
Phoenix-Mesa-Scottsdale, AZ 171 94 3 38 12 0 24 0 0
Pittsburgh, PA 30 2 0 10 8 0 10 0 0
Portland-South Portland-Biddeford, ME 3 0 0 1 1 0 1 0 0
Portland-Vancouver-Beaverton, OR-WA 60 7 0 30 10 1 11 1 0
Poughkeepsie-Newburgh-Middletown, NY 12 4 0 4 2 0 2 0 0
Providence-New Bedford-Fall River, RI-MA 34 7 0 11 7 0 8 0 1
Provo-Orem, UT 4 2 0 0 0 2 0 0 0
Raleigh-Cary, NC 31 3 0 12 13 0 3 0 0
Richmond, VA 30 4 0 10 6 0 10 0 0
Riverside-San Bernardino-Ontario, CA 121 61 0 38 7 0 15 0 0
Rochester, NY 26 3 0 3 9 0 11 0 0
Sacramento-Arden Arcade-Roseville, CA 85 12 0 44 15 2 10 0 2
St. Louis, MO-IL 49 2 0 12 23 0 11 0 1
Salt Lake City, UT 17 4 0 9 2 0 2 0 0
San Antonio, TX 104 76 0 13 9 0 6 0 0
San Diego-Carlsbad-San Marcos, CA 263 127 1 94 13 3 25 0 0
San Francisco-Oakland-Fremont, CA 372 49 1 239 32 16 29 3 3
San Jose-Sunnyvale-Santa Clara, CA 184 21 0 142 7 1 11 1 1
Sarasota-Bradenton-Venice, FL 24 6 0 8 2 0 8 0 0
Scranton-Wilkes-Barre, PA 9 3 0 1 1 0 3 1 0
Seattle-Tacoma-Bellevue, WA 155 8 1 77 41 3 25 0 0
Springfield, MA 16 2 0 12 0 0 2 0 0
Stockton, CA 44 17 0 25 0 0 2 0 0
Syracuse, NY 8 0 0 4 3 0 1 0 0
Tampa-St. Petersburg-Clearwater, FL 82 13 0 16 28 0 25 0 0
Toledo, OH 3 0 0 1 0 0 2 0 0
Tucson, AZ 28 11 2 2 7 0 6 0 0
Tulsa, OK 24 1 3 4 5 0 9 0 2
Virginia Beach-Norfolk-Newport News, VA-NC 20 0 0 3 10 0 7 0 0
Washington-Arlington-Alexandria, DC-VA-MD-WV 333 76 0 119 114 0 22 2 0
Wichita, KS 8 1 0 3 4 0 0 0 0
Worchester, MA 14 0 0 7 3 0 3 0 1
Youngstown-Warren-Boardman, OH-PA 3 0 0 0 0 0 3 0 0
Total - 102 Areas 8274 2379 16 2798 1864 61 1099 17 40
San Juan-Caguas-Guaynabo, PR 13 13 0 0 0 0 0 0 0
Table 47. (Cont’d) Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan 
Statistical Areas with >500,000 Population, 2011
1 Persons of Hispanic or Latino origin may be of any race or multiple race.
2 Indicates two or more races reported for a person.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Is-
lander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not include persons 
of Hispanic ethnicity.


























Akron, OH 2 1 (50.0) 1 (50.0) 0 (0.0)
Albany-Schenectady-Troy, NY 13 3 (23.1) 10 (76.9) 0 (0.0)
Albuquerque, NM 14 8 (57.1) 6 (42.9) 0 (0.0)
Allentown-Bethlehem-Easton, PA-NJ 11 4 (36.4) 7 (63.6) 0 (0.0)
Atlanta-Sandy Springs-Marietta, GA 211 93 (44.1) 118 (55.9) 0 (0.0)
Augusta-Richmond County, GA-SC 26 20 (76.9) 6 (23.1) 0 (0.0)
Austin-Round Rock, TX 71 28 (39.4) 43 (60.6) 0 (0.0)
Bakersfield, CA 40 16 (40.0) 24 (60.0) 0 (0.0)
Baltimore-Towson, MD 91 32 (35.2) 59 (64.8) 0 (0.0)
Baton Rouge, LA 20 17 (85.0) 3 (15.0) 0 (0.0)
Birmingham-Hoover, AL 36 24 (66.7) 12 (33.3) 0 (0.0)
Boise City-Nampa, ID 5 1 (20.0) 4 (80.0) 0 (0.0)
Boston-Cambridge-Quincy, MA-NH 158 28 (17.7) 130 (82.3) 0 (0.0)
Bridgeport-Stamford-Norwalk, CT 33 6 (18.2) 27 (81.8) 0 (0.0)
Buffalo-Niagara Falls, NY 15 8 (53.3) 7 (46.7) 0 (0.0)
Cape Coral-Fort Myers, FL 26 14 (53.8) 12 (46.2) 0 (0.0)
Charleston-North Charleston, SC 21 17 (81.0) 4 (19.0) 0 (0.0)
Charlotte-Gastonia-Concord, NC-SC 53 24 (45.3) 29 (54.7) 0 (0.0)
Chattanooga, TN-GA 10 5 (50.0) 5 (50.0) 0 (0.0)
Chicago-Naperville-Joliet, IL 336 118 (35.1) 218 (64.9) 0 (0.0)
Cincinnati-Middleton, OH-KY-IN 19 5 (26.3) 14 (73.7) 0 (0.0)
Cleveland-Elyria-Mentor, OH 43 25 (58.1) 18 (41.9) 0 (0.0)
Colorado Springs, CO 7 1 (14.3) 6 (85.7) 0 (0.0)
Columbia, SC 16 7 (43.8) 9 (56.3) 0 (0.0)
Columbus, OH 56 19 (33.9) 37 (66.1) 0 (0.0)
Dallas-Fort Worth-Arlington, TX 342 167 (48.8) 175 (51.2) 0 (0.0)
Dayton, OH 9 4 (44.4) 5 (55.6) 0 (0.0)
Denver-Aurora, CO 48 13 (27.1) 35 (72.9) 0 (0.0)
Des Moines-West Des Moines, IA 12 2 (16.7) 10 (83.3) 0 (0.0)
Detroit-Warren-Livonia, MI 55 16 (29.1) 38 (69.1) 1 (1.8)
Durham-Chapel Hill, NC 13 5 (38.5) 8 (61.5) 0 (0.0)
El Paso, TX 37 10 (27.0) 27 (73.0) 0 (0.0)
Fresno, CA 46 11 (23.9) 34 (73.9) 1 (2.2)
Grand Rapids-Wyoming, MI 21 4 (19.0) 17 (81.0) 0 (0.0)
Greensboro-High Point, NC 26 9 (34.6) 17 (65.4) 0 (0.0)
Greenville, SC 15 9 (60.0) 6 (40.0) 0 (0.0)
Harrisburg-Carlisle, PA 7 4 (57.1) 3 (42.9) 0 (0.0)
Hartford-West Hartford-East Hartford, CT 21 9 (42.9) 12 (57.1) 0 (0.0)
Honolulu, HI 103 26 (25.2) 77 (74.8) 0 (0.0)
Houston-Sugar Land-Baytown, TX 397 181 (45.6) 216 (54.4) 0 (0.0)
Indianapolis-Carmel, IN 44 23 (52.3) 21 (47.7) 0 (0.0)
Jackson, MS 41 32 (78.0) 9 (22.0) 0 (0.0)
Jacksonville, FL 77 55 (71.4) 22 (28.6) 0 (0.0)
Kansas City, MO-KS 35 18 (51.4) 17 (48.6) 0 (0.0)
Knoxville, TN 2 0 (0.0) 2 (100.0) 0 (0.0)
Lakeland, FL 16 8 (50.0) 8 (50.0) 0 (0.0)
Lancaster, PA 5 3 (60.0) 2 (40.0) 0 (0.0)
Las Vegas-Paradise, NV 57 21 (36.8) 36 (63.2) 0 (0.0)
Little Rock-North Little Rock-Conway, AR 19 14 (73.7) 5 (26.3) 0 (0.0)
Los Angeles-Long Beach-Santa Ana, CA 923 176 (19.1) 737 (79.8) 10 (1.1)
Louisville-Jefferson County, KY-IN 27 21 (77.8) 6 (22.2) 0 (0.0)
Madison, WI 12 0 (0.0) 12 (100.0) 0 (0.0)
McAllen-Edinburg-Mission, TX 80 28 (35.0) 52 (65.0) 0 (0.0)
Memphis, TN-MS-AR 53 42 (79.2) 11 (20.8) 0 (0.0)
Miami-Fort Lauderdale-Pompano Beach, FL 292 89 (30.5) 203 (69.5) 0 (0.0)
Milwaukee-Waukesha-West Allis, WI 30 13 (43.3) 17 (56.7) 0 (0.0)
Minneapolis-St. Paul-Bloomington, MN-WI 103 10 (9.7) 93 (90.3) 0 (0.0)
Table 48. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born 
Persons1: Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan 
Statistical Area







Modesto, CA 9 0 (0.0) 9 (100.0) 0 (0.0)
Nashville-Davidson-Murfreesboro-Franklin, TN 55 23 (41.8) 32 (58.2) 0 (0.0)
New Haven-Milford, CT 19 2 (10.5) 17 (89.5) 0 (0.0)
New Orleans-Metairie-Kenner, LA 61 38 (62.3) 23 (37.7) 0 (0.0)
New York-Northern New Jersey-Long Island, NY-NJ-PA 1092 237 (21.7) 854 (78.2) 1 (0.1)
Ogden-Clearfield, UT 4 1 (25.0) 3 (75.0) 0 (0.0)
Oklahoma City, OK 34 21 (61.8) 13 (38.2) 0 (0.0)
Omaha-Council Bluffs, NE-IA 12 6 (50.0) 6 (50.0) 0 (0.0)
Orlando-Kissimmee, FL 80 35 (43.8) 45 (56.3) 0 (0.0)
Oxnard-Thousand Oaks-Ventura, CA 35 8 (22.9) 26 (74.3) 1 (2.9)
Palm Bay-Melbourne-Titusville, FL 9 7 (77.8) 2 (22.2) 0 (0.0)
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 196 61 (31.1) 135 (68.9) 0 (0.0)
Phoenix-Mesa-Scottsdale, AZ 171 43 (25.1) 128 (74.9) 0 (0.0)
Pittsburgh, PA 30 15 (50.0) 15 (50.0) 0 (0.0)
Portland-South Portland-Biddeford, ME 3 0 (0.0) 3 (100.0) 0 (0.0)
Portland-Vancouver-Beaverton, OR-WA 60 13 (21.7) 47 (78.3) 0 (0.0)
Poughkeepsie-Newburgh-Middletown, NY 12 4 (33.3) 8 (66.7) 0 (0.0)
Providence-New Bedford-Fall River, RI-MA 34 8 (23.5) 26 (76.5) 0 (0.0)
Provo-Orem, UT 4 1 (25.0) 3 (75.0) 0 (0.0)
Raleigh-Cary, NC 31 12 (38.7) 19 (61.3) 0 (0.0)
Richmond, VA 30 14 (46.7) 16 (53.3) 0 (0.0)
Riverside-San Bernardino-Ontario, CA 121 35 (28.9) 85 (70.2) 1 (0.8)
Rochester, NY 26 16 (61.5) 10 (38.5) 0 (0.0)
Sacramento-Arden Arcade-Roseville, CA 85 28 (32.9) 55 (64.7) 2 (2.4)
St. Louis, MO-IL 49 28 (57.1) 21 (42.9) 0 (0.0)
Salt Lake City, UT 17 2 (11.8) 15 (88.2) 0 (0.0)
San Antonio, TX 104 59 (56.7) 45 (43.3) 0 (0.0)
San Diego-Carlsbad-San Marcos, CA 263 79 (30.0) 184 (70.0) 0 (0.0)
San Francisco-Oakland-Fremont, CA 372 67 (18.0) 305 (82.0) 0 (0.0)
San Jose-Sunnyvale-Santa Clara, CA 184 18 (9.8) 161 (87.5) 5 (2.7)
Sarasota-Bradenton-Venice, FL 24 9 (37.5) 15 (62.5) 0 (0.0)
Scranton-Wilkes-Barre, PA 9 5 (55.6) 4 (44.4) 0 (0.0)
Seattle-Tacoma-Bellevue, WA 155 31 (20.0) 124 (80.0) 0 (0.0)
Springfield, MA 16 3 (18.8) 13 (81.3) 0 (0.0)
Stockton, CA 44 12 (27.3) 32 (72.7) 0 (0.0)
Syracuse, NY 8 1 (12.5) 7 (87.5) 0 (0.0)
Tampa-St. Petersburg-Clearwater, FL 82 50 (61.0) 32 (39.0) 0 (0.0)
Toledo, OH 3 1 (33.3) 2 (66.7) 0 (0.0)
Tucson, AZ 28 12 (42.9) 16 (57.1) 0 (0.0)
Tulsa, OK 24 20 (83.3) 4 (16.7) 0 (0.0)
Virginia Beach-Norfolk-Newport News, VA-NC 20 15 (75.0) 5 (25.0) 0 (0.0)
Washington-Arlington-Alexandria, DC-VA-MD-WV 333 79 (23.7) 254 (76.3) 0 (0.0)
Wichita, KS 8 1 (12.5) 7 (87.5) 0 (0.0)
Worchester, MA 14 2 (14.3) 12 (85.7) 0 (0.0)
Youngstown-Warren-Boardman, OH-PA 3 2 (66.7) 1 (33.3) 0 (0.0)
Total - 102 Areas 8274 2671 (32.3) 5581 (67.5) 22 (0.3)
San Juan-Caguas-Guaynabo, PR 13 7 (53.8) 6 (46.2) 0 (0.0)
Table 48. (Cont’d) Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born 
Persons1: Metropolitan Statistical Areas with >500,000 Population, 2011
1 Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands. 
Note: See Technical Notes for definition of MSA.
Metropolitan 
Statistical Area







Akron, OH 2 2 (100.0) 0 (0.0)
Albany-Schenectady-Troy, NY 13 13 (100.0) 0 (0.0)
Albuquerque, NM 14 14 (100.0) 2 (14.3)
Allentown-Bethlehem-Easton, PA-NJ 11 11 (100.0) 0 (0.0)
Atlanta-Sandy Springs-Marietta, GA 211 209 (99.1) 20 (9.5)
Augusta-Richmond County, GA-SC 26 26 (100.0) 1 (3.8)
Austin-Round Rock, TX 71 71 (100.0) 3 (4.2)
Bakersfield, CA 40 39 (97.5) 1 (2.5)
Baltimore-Towson, MD 91 90 (98.9) 3 (3.3)
Baton Rouge, LA 20 20 (100.0) 0 (0.0)
Birmingham-Hoover, AL 36 36 (100.0) 3 (8.3)
Boise City-Nampa, ID 5 5 (100.0) 0 (0.0)
Boston-Cambridge-Quincy, MA-NH 158 157 (99.4) 7 (4.4)
Bridgeport-Stamford-Norwalk, CT 33 33 (100.0) 0 (0.0)
Buffalo-Niagara Falls, NY 15 14 (93.3) 1 (6.7)
Cape Coral-Fort Myers, FL 26 26 (100.0) 3 (11.5)
Charleston-North Charleston, SC 21 21 (100.0) 2 (9.5)
Charlotte-Gastonia-Concord, NC-SC 53 53 (100.0) 4 (7.5)
Chattanooga, TN-GA 10 10 (100.0) 0 (0.0)
Chicago-Naperville-Joliet, IL 336 333 (99.1) 33 (9.8)
Cincinnati-Middleton, OH-KY-IN 19 16 (84.2) 0 (0.0)
Cleveland-Elyria-Mentor, OH 43 43 (100.0) 1 (2.3)
Colorado Springs, CO 7 7 (100.0) 0 (0.0)
Columbia, SC 16 16 (100.0) 0 (0.0)
Columbus, OH 56 56 (100.0) 0 (0.0)
Dallas-Fort Worth-Arlington, TX 342 342 (100.0) 34 (9.9)
Dayton, OH 9 9 (100.0) 1 (11.1)
Denver-Aurora, CO 48 48 (100.0) 3 (6.3)
Des Moines-West Des Moines, IA 12 12 (100.0) 2 (16.7)
Detroit-Warren-Livonia, MI 55 54 (98.2) 0 (0.0)
Durham-Chapel Hill, NC 13 13 (100.0) 1 (7.7)
El Paso, TX 37 37 (100.0) 2 (5.4)
Fresno, CA 46 46 (100.0) 3 (6.5)
Grand Rapids-Wyoming, MI 21 20 (95.2) 0 (0.0)
Greensboro-High Point, NC 26 26 (100.0) 0 (0.0)
Greenville, SC 15 15 (100.0) 1 (6.7)
Harrisburg-Carlisle, PA 7 7 (100.0) 0 (0.0)
Hartford-West Hartford-East Hartford, CT 21 19 (90.5) 0 (0.0)
Honolulu, HI 103 92 (89.3) 10 (9.7)
Houston-Sugar Land-Baytown, TX 397 397 (100.0) 10 (2.5)
Indianapolis-Carmel, IN 44 44 (100.0) 5 (11.4)
Jackson, MS 41 41 (100.0) 7 (17.1)
Jacksonville, FL 77 77 (100.0) 17 (22.1)
Kansas City, MO-KS 35 35 (100.0) 4 (11.4)
Knoxville, TN 2 2 (100.0) 1 (50.0)
Lakeland, FL 16 16 (100.0) 1 (6.3)
Lancaster, PA 5 5 (100.0) 0 (0.0)
Las Vegas-Paradise, NV 57 57 (100.0) 2 (3.5)
Little Rock-North Little Rock-Conway, AR 19 19 (100.0) 3 (15.8)
Los Angeles-Long Beach-Santa Ana, CA 923 916 (99.2) 58 (6.3)
Louisville-Jefferson County, KY-IN 27 27 (100.0) 6 (22.2)
Madison, WI 12 12 (100.0) 0 (0.0)
McAllen-Edinburg-Mission, TX 80 80 (100.0) 0 (0.0)
Memphis, TN-MS-AR 53 53 (100.0) 3 (5.7)
Miami-Fort Lauderdale-Pompano Beach, FL 292 292 (100.0) 20 (6.8)
Milwaukee-Waukesha-West Allis, WI 30 30 (100.0) 0 (0.0)
Minneapolis-St. Paul-Bloomington, MN-WI 103 103 (100.0) 2 (1.9)
Table 49. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: 
Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan 
Statistical Area





Cases Reported as Being 
Homeless2
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Modesto, CA 9 9 (100.0) 0 (0.0)
Nashville-Davidson-Murfreesboro-Franklin, TN 55 55 (100.0) 4 (7.3)
New Haven-Milford, CT 19 19 (100.0) 0 (0.0)
New Orleans-Metairie-Kenner, LA 61 61 (100.0) 4 (6.6)
New York-Northern New Jersey-Long Island, NY-NJ-PA 1092 1077 (98.6) 22 (2.0)
Ogden-Clearfield, UT 4 4 (100.0) 0 (0.0)
Oklahoma City, OK 34 33 (97.1) 4 (11.8)
Omaha-Council Bluffs, NE-IA 12 12 (100.0) 1 (8.3)
Orlando-Kissimmee, FL 80 79 (98.8) 5 (6.3)
Oxnard-Thousand Oaks-Ventura, CA 35 35 (100.0) 2 (5.7)
Palm Bay-Melbourne-Titusville, FL 9 9 (100.0) 1 (11.1)
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 196 196 (100.0) 7 (3.6)
Phoenix-Mesa-Scottsdale, AZ 171 138 (80.7) 11 (6.4)
Pittsburgh, PA 30 30 (100.0) 0 (0.0)
Portland-South Portland-Biddeford, ME 3 3 (100.0) 1 (33.3)
Portland-Vancouver-Beaverton, OR-WA 60 60 (100.0) 4 (6.7)
Poughkeepsie-Newburgh-Middletown, NY 12 12 (100.0) 0 (0.0)
Providence-New Bedford-Fall River, RI-MA 34 34 (100.0) 2 (5.9)
Provo-Orem, UT 4 4 (100.0) 1 (25.0)
Raleigh-Cary, NC 31 30 (96.8) 2 (6.5)
Richmond, VA 30 30 (100.0) 0 (0.0)
Riverside-San Bernardino-Ontario, CA 121 121 (100.0) 1 (0.8)
Rochester, NY 26 25 (96.2) 0 (0.0)
Sacramento-Arden Arcade-Roseville, CA 85 75 (88.2) 6 (7.1)
St. Louis, MO-IL 49 45 (91.8) 0 (0.0)
Salt Lake City, UT 17 17 (100.0) 1 (5.9)
San Antonio, TX 104 104 (100.0) 3 (2.9)
San Diego-Carlsbad-San Marcos, CA 263 263 (100.0) 15 (5.7)
San Francisco-Oakland-Fremont, CA 372 371 (99.7) 20 (5.4)
San Jose-Sunnyvale-Santa Clara, CA 184 181 (98.4) 4 (2.2)
Sarasota-Bradenton-Venice, FL 24 24 (100.0) 0 (0.0)
Scranton-Wilkes-Barre, PA 9 9 (100.0) 0 (0.0)
Seattle-Tacoma-Bellevue, WA 155 155 (100.0) 5 (3.2)
Springfield, MA 16 16 (100.0) 1 (6.3)
Stockton, CA 44 43 (97.7) 7 (15.9)
Syracuse, NY 8 8 (100.0) 0 (0.0)
Tampa-St. Petersburg-Clearwater, FL 82 81 (98.8) 11 (13.4)
Toledo, OH 3 2 (66.7) 0 (0.0)
Tucson, AZ 28 28 (100.0) 1 (3.6)
Tulsa, OK 24 23 (95.8) 3 (12.5)
Virginia Beach-Norfolk-Newport News, VA-NC 20 20 (100.0) 0 (0.0)
Washington-Arlington-Alexandria, DC-VA-MD-WV 333 333 (100.0) 11 (3.3)
Wichita, KS 8 8 (100.0) 0 (0.0)
Worchester, MA 14 14 (100.0) 1 (7.1)
Youngstown-Warren-Boardman, OH-PA 3 3 (100.0) 0 (0.0)
Total - 102 Areas 8274 8166 (98.7) 441 (5.3)
San Juan-Caguas-Guaynabo, PR 13 13 (100.0) 0 (0.0)
Table 49. (Cont’d) Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: 
Metropolitan Statistical Areas with >500,000 Population, 2011
1 Homeless within past 12 months of TB diagnosis. 
2 Percent of those with known status. 
Note: See Technical Notes for definition of MSA.
Metropolitan 
Statistical Area No. No.(%) (%)
Total
Cases
Cases with Information on 
Homeless Status
Cases Reported as Being 
Homeless2
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Tuberculosis in the U.S.-affiliated Pacific Island Jurisdictions (USAPI), 2011
The US-affiliated Pacific Islands consist of six jurisdictions that cover an area within the Pacific 
Ocean that is larger than the continental United States. Three are U.S. flag territories: American 
Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), and Guam. The other three 
— Federated States of Micronesia (FSM), Republic of the Marshall Islands (RMI), and Republic of 
Palau – are independent countries but are also freely associated with the United States. These inde-
pendent countries have Compacts of Free Association with the United States; under these compacts, 
the countries are fully sovereign in domestic and foreign affairs, but give responsibility for their 
health, education, defense, and other essential operations to the United States. Through these agree-
ments, citizens residing in these three countries are able to immigrate to the United States without 
the usual overseas screening for health conditions that is required of those permanently resettling 
from other foreign countries.
As a result of their affiliations with the United States, the USAPIs are among the recipients of U.S. 
federal government funding, including CDC cooperative agreement funding for domestic TB control 
program activities.
How do the USAPI TB programs differ from the 50 U.S. state programs? 
Geographically, the USAPI constitutes a total land area equivalent to two-thirds of Rhode •	
Island (1,545 square miles). While there are 10 population centers, many Pacific Islanders 
live on surrounding islands, creating challenges for diagnosis and treatment of TB. Across 
these jurisdictions, basic infrastructure needs are not uniformly available; several of these 
jurisdictions are in close proximity to countries with higher rates of endemic TB.
There is a consistent shortage of health care providers in all job classes, and continuing •	
education opportunities are limited, often requiring staff to travel off-island for significant 
amounts of time. These challenges impact the delivery of health care.
The region grapples with health problems common to developed countries (diabetes, obesity, •	
cancer) as well as those common to developing countries; infant mortality rates in this region 
exceed the national average, in some areas as much as 5 times greater.
While case counts in this region are similar to low-incidence states, the burden of disease •	
is much greater when compared to U.S. areas with similar case counts.  The burden of 
disease in the region far exceeds that of any metropolitan statistical area with a population 
of 500,000 or greater.  The USAPI regional TB case rate (87.7/100,000) is almost10 times 
greater than that of the State of Hawaii (8.9/100,000) and 26 times greater than the U.S. 
national rate (3.4/100,000).
92
USAPI Regional Total 405 87.7 461,939
American Samoa 3 5.4 55,198
Northern Mariana Islands 27 51.8 52,167
Federated States of Micronesia 140 131 106,836
Guam 78 48.9 159,600
Marshall Islands 149 221.8 67,182
Palau 8 38.2 20,956
Hawaii1 123 8.9 1,374,810
United States1 10,528 3.4 311,591,917
Table 1.  Tuberculosis Cases and Case Rates for USAPIs, Hawaii, and the United States, 2010
Cases Rate PopulationJurisdiction
1Not included in USAPI regional total.
USAPI TB Surveillance Data Highlights, 2011 (N=405)
94 (23%) age less than 15 years•	
99 (24%) age 25–44 years•	
221 (55%) male•	
84 (21%) not born in the USAPI jurisdictions or the United States•	
50 (60%) of these emigrating from the Republic of the Philippines o 
272 (67%) diagnosed with pulmonary disease only•	
180 (44%) positive culture for •	 Mycobacterium tuberculosis
2 (<1%) with MDR TB; no cases of XDR TB•	
137 (34%) were unemployed•	
The data reported here reflect cases reported to the CDC National TB Surveillance System using 
the Report of Verified Case of Tuberculosis (RVCT). Denominators for computing 2011 rates for 
the United States and Hawaii were obtained from Annual Estimates of the Population for the United 
States and States, and for Puerto Rico; for all other areas, from IDB Summary Demographic Data 
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Slide Narratives for US Affiliated Pacific Islands:
Slide 1 - USAPI. Map of U.S.-Affiliated Pacific Islands by TB Case Rates, 2011. This map of the 
Pacific region shows the case rates by jurisdiction.
Slide 2 - TB Case rates, U.S.-Affiliated Pacific Islands, 2011. This bar chart shows TB rates for 
the U.S. Pacific Islands for reported cases in 2011. These case rates from 5.4 per 100,000 in Ameri-
can Samoa to 221.8 per 100,000 in the Republic of the Marshall Islands. The overall case rate for 
the United States (3.4 per 100,000) and for Hawaii (8.9 per 100,000) are also shown. 
Slide 2 - USAPI. Reported TB Cases by Age Group, U.S.-Affiliated Pacific Islands, 2011. This 
pie chart shows the age distribution of persons reported with TB in the U.S. Pacific Islands in 2011. 
Twenty three percent were children under 15 years of age and 16% were among 15 to 24 year-olds, 
whereas 25% were among 25 to 44 years of age, 29% were among 45 to 64 year-olds, and 7% were 
among those at least 65 years old.
Slide 3 - USAPI. TB Case Rates by Age Group and Sex, U.S.-Affiliated Pacific Islands, 2011. 
This slide graphs the rates in 2011 of persons reported with TB in the U.S. Pacific Islands in 2011 
by age group and sex. Children under 15 years old had a rate of approximately 48 per 100,000 for 
females and approximately 45 per 100,000 for males. In those between the ages of 25-44 years old 
females accounted for 47 per 100,000 and males were approximately 52 per 100,000.
Slide 4 - USAPI. Anti-TB Drug Susceptibility, U.S.- Affiliated Pacific Islands, 2011.  This pie 
chart shows the level of drug susceptibility for culture positive cases for in the U.S. Pacific Islands 
in 2011.  Data were available for 92.2% of culture-positive cases for which drug susceptibility test-
ing was available for 2011. Any isoniazid resistance that was not multi-drug resistance was 4.2%. 
Resistance to at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), was 
1.2%. Other resistance (Not MDR or INH resistant) or missing testing to at least one first-line drug 
was 2.4%.
100

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Tuberculosis in the United States
National Tuberculosis Surveillance System Highlights from 2011
Slide 1 (title slide). Tuberculosis in the United States—National Tuberculosis Surveillance System, Highlights 
from 2011.  This slide set was prepared by the Division of Tuberculosis Elimination, Centers for Disease Control 
and Prevention (CDC), Department of Health and Human Services (DHHS).  It provides trends for the recent past 
and highlights data collected through the National Tuberculosis Surveillance System for 2011.  Since 1953, through 
the cooperation of state and local health departments, CDC has collected information on newly reported cases of 
tuberculosis (TB) disease in the United States.  The data presented here were collected via the revised TB case 
report introduced in 2009.  Currently, each individual TB case report (Report of Verified Case of Tuberculosis or 
RVCT) is submitted electronically to CDC.  The data for this slide set are based on updates received by CDC as of 
June 25, 2012.  All case counts and rates for years 1993–2011 have been updated.
Slide 2. Reported TB Cases, United States, 1982–2011.  The resurgence of TB in the mid-1980s was marked by 
several years of increasing case counts until its peak in 1992.  Case counts began decreasing again in 1993, and 
2011 marked the nineteenth year of decline in the total number of TB cases reported in the United States since the 
peak of the resurgence.  From 1992 until 2002, the total number of TB cases decreased 5%–7% annually.  From 
2002 to 2003, however, the total number of TB cases decreased by only 1.4%.  An unprecedented decrease oc-
curred in 2009, when the total number of TB cases decreased by more than 10% from 2008 to 2009. In 2011, a total 
of 10,528 cases were reported from the 50 states and the District of Columbia (DC).  This represents a decline of 
5.8% from 2011 and approximately 60.5% from 1992.  
Slide 3. TB Morbidity, United States, 2005-2011.   This slide provides the total number of reported U.S. TB cases 
and the associated rates for each of the past 6 years.  Rate is defined as cases per 100,000 population.  The number 
of TB cases decreased from 13,727 in 2006 to 10,528 in 2011, and the TB rate decreased from 4.6 in 2006 to 3.4 in 
2011. 
Slide 4. TB Case Rates, United States, 2011.  This map shows TB rates for 2011.  Thirty-seven states reported 
a rate less than 3.4TB cases per 100,000, the 2011 national average. Thirteen states and DC reported a rate above 
3.4 TB cases per 100,000; these accounted for 67% of the national total in 2011 and have experienced substantial 
overall decreases in cases and rates from 1992 through 2011.
Slide 5. TB Case Rates by Age Group, United States, 1993–2011.  This slide shows the last 19 years’ declin-
ing trend in TB rates by age group.  Starting in 2011, case rates in all age groups have declined by more than 
50%:persons 65 years and older (from 17.7 per 100,000 in 1993 to 5.4in 2011); adults aged 45 to 64 years (from 
12.4 to 4.0); adults aged 25 to 44 years (from 11.5 to 4.1); those 15 to 24 years of age (from 5.0 to 2.4); and in 
children under 15 years of age (from 2.9 to 0.9)
Slide 6. Reported TB Cases by Age Group, United States, 2011.  This pie chart shows the age distribution of 
persons reported with TB in 2011.  Five percent were children under 15 years of age, 10% were age 15 to 24, 32% 
were age 25 to 44, 31% were age 45 to 64, and 21% were at least 65 years old.
Slide 7. TB Case Rates by Age Group and Sex, United States, 2011.  This slide graphs the TB rates in 2011 by 
age group and sex.  It shows that rates tended to increase with age, ranging from a low of less than 1 per 100,000 
in children aged 5 - 14 to a high of 7.4 per 100,000 in men 65 years and older. As age increased, the case rate in 
men increased faster than women; the rates in men 45 years and older were approximately more than twice those in 
same-age women.
Slide 8. TB Case Rates by Race/Ethnicity, United States, 2003–2011.  This slide shows the declining trend in 
TB rates by race/ethnicity during the last 9 years.  Asians had the highest TB rates, which declined from 29.9 per 
100,000 in 2003 to 20.9 in 2011, and had a percent decline over the time period of 30%.  Rates also declined in 
the following racial/ethnic groups: among non-Hispanic blacks or African-Americans, from 11.7 in 2003 to 6.3 in 
2011 (-46%); among Hispanics, from 10.3 to 5.8 (-44%); among American Indians and Alaska Natives, from 8.2 to 
5.6 (-32%); and among non-Hispanic whites, from 1.4 to 0.8 (-43%).  Ratesdecreased among Native Hawaiian or 
Other Pacific Islanders after two years of increase since 2008, from 16.2 in 2003 to 15.9 in 2011 (-2%).
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Several important factors likely contribute to the disproportionate burden of TB in minorities.  In persons 
who were born in countries where TB is common, TB disease may result from infection acquired in the country of 
origin.  Unequal distribution of TB risk factors, such as HIV infection, may also contribute to increased exposure to 
TB or to an increased risk of developing TB once infected with M. tuberculosis. 
Slide 9. TB Case Rates by Age Group and Race/Ethnicity, United States, 2011.  This slide presents TB rates 
in 2011 by age group and race/ethnicity.  After infancy (age under 5), risk typically increased with age across all 
racial and ethnic groups. Rates were consistently higher in minority racial and ethnic groups than in non-Hispanic 
whites.  Rates were the highest in Asians and Native Hawaiians and Other Pacific Islanders, particularly in adult 
age groups.  The impact of foreign birth is a consideration in interpreting rate variations by race/ethnicity.  For ex-
ample, 96% of cases in the Asian group occurred in foreign-born persons, compared with 74% of cases in Hispan-
ics and 36% of cases in non-Hispanic blacks or African-Americans.  Persons reporting two or more races totaled 
less than 1% of all cases.  
Slide 10. Reported TB Cases by Race/Ethnicity, United States, 2011.  In 2011, 84% of all reported TB cases 
occurred in racial and ethnic minorities (29% in Hispanics, 30% in Asians, 23% in non-Hispanic blacks or African-
Americans, 1% in American Indians or Alaska Natives, and  1% in Native Hawaiians or Other Pacific Islanders), 
whereas 16% of cases occurred in non-Hispanic whites.  Persons reporting two or more races totaled less than 1% 
of all cases.  This is the first year that Asians have constituted the single largest percentage of TB cases among all 
racial/ethnic groups; Hispanics had previously held the largest TB percentage for seven years. Non-Hispanic blacks 
or African Americans have remained the third largest racial/ethnic group for four years now.
Slide 11. Number of TB Cases in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.  This graph 
plots the number of U.S.-born vs. foreign-born persons reported with TB each year, from 1993 through 2011.  It 
illustrates the increase in the percentage of cases occurring in foreign-born persons during this period, from 29% in 
1993 to 62% in 2011.  Overall, the number of cases in foreign-born persons remained virtually level, with approxi-
mately 7,000–8,000 cases each year before 2009, until 2009 when the number dropped to 6,854. That decreasing 
trend continued in 2011 with the number of foreign-born cases dropping to 6,510. The number in U.S.-born persons 
decreased from more than 17,000 in 1993 to 3,981 in 2011.
Slide 12. Trends in TB Cases in Foreign-born Persons, United States, 1991–2011.  This slide shows trends in 
the past 20 years of TB cases in foreign-born persons in the United States from 1991 through 2011. The percentage 
of TB cases accounted for by foreign-born persons increased from 28% in 1990 to 62% in 2011.
Slide 13. Reported TB Cases by Origin and Race/Ethnicity, United States, 2011.  Among U.S.-born persons 
with TB in 2011, 39% were non-Hispanic black or African-American, 33% were non-Hispanic white, 19% were 
Hispanic or Latino, 3% were Asian, 3% were American Indian or Alaska Native, and 2% were Native Hawaiian or 
Other Pacific Islander.  Among the foreign-born, 46% were Asian, 34% were Hispanic or Latino, 13% were non-
Hispanic black or African-American, and 5% were non-Hispanic white.  Cases among American Indians or Alaska 
Natives and among Native Hawaiians or Other Pacific Islanders constituted less than 1%, respectively, of the cases 
among the foreign-born and are not shown.  Persons reporting two or more races totaled less than 1% of all cases. 
Slide 14. Percentage of TB Cases Among Foreign-born Persons, United States, 2001 and 2011.  The percent-
age range of the total number of TB cases that occurred in foreign-born persons in each state is highlighted for 
2001 and 2011 in these side-by-side maps.  The number of states with less than 25% of their TB cases among the 
foreign-born decreased from 13 states in 2001 to 6 states in 2011. The number of states with at least 25-49% of 
cases among the foreign-born decreased from 14 states in 2001 to 11 states in 2011. However, the number of states 
that had 50% or more of their cases among the foreign-born increased from 23 states in 2001 to 34 states in 2011.
Slide 15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.  TB rates in 
foreign-born persons remain higher than those in the U.S.-born population.  From 1993 through 2011, the rates in 
U.S.-born persons decreased from 7.4 per 100,000 to 1.5, whereas the rates in foreign-born persons decreased from 
34.0 per 100,000 to 17.2.
Slide 16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.  This is the same as 
Slide 15, but the rates are presented on a logarithmic scale to better illustrate the trend in TB rates among the U.S.-
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born and foreign-born. The lines show a greater rate of decline among the U.S.-born compared with the foreign-
born during this period.
Slide 17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2011.  This slide shows 
the overall distribution of the countries of birth of foreign-born persons reported with TB in 2011, with the top 
seven highlighted.  The list of countries has remained relatively constant since 1986, when information on coun-
try of birth was first reported by all areas submitting reports to CDC. In 2011 the seven top countries accounted 
for 61% of the total cases, with Mexico accounting for 22%; the Philippines, 11.6%; Vietnam, 8.4%; India, 7.7%; 
China, 5.8%; Haiti, 2.9%; and Guatemala, 2.5%.Persons from more than 135 other countries each accounted for 
2% or less of the total, but altogether accounted for 39% of foreign-born persons reported with TB.
Slide 18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2011.  The length 
of U.S. residence among foreign-born persons prior to their TB diagnosis in 2011 is shown in these stacked bars.  
Overall, 14% had been in the United States for less than 1 year, 17% between 1 and 4 years, and 59% for at least 
5 years.  The distribution is also shown for the top three countries of birth: Mexico, the Philippines, and Vietnam.  
Among persons born in Mexico, 9% had been in the United States for less than 1 year, 11% between 1 and 4 years, 
and 66% for at least 5 years. Among persons born in the Philippines, 15% had been in the United States for less 
than 1 year, 13% between 1 and 4 years, and 61% for at least 5 years.  Among persons born in Vietnam, 10% had 
been in the United States for less than 1 year, 12% between 1 and 4 years, and 62% for at least 5 years.
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2011.  Primary drug resistance is shown 
for the past 19 years.  The graph starts in 1993, the year in which the individual TB case reports submitted to the 
national surveillance system began collecting information on initial susceptibility test results for patients with 
culture-positive TB.  Data were available for more than 85% of culture-positive cases for each year.  Primary resis-
tance was calculated by using data from persons with no reported prior TB episode. Resistance to at least isoniazid 
remained between 7.0% and 8.6% between 1993 and 2010, however in 2011, this increased to 9.2%.  Resistance to 
at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), decreased from 2.5% in 1993 to 1.1% 
in 1997, and remained at approximately 1.0 % until 2009 and 2010 when it increased to 1.1% and 1.2%, respec-
tively. In 2011, it increased again to 1.3%.
Slide 20. Primary MDR TB, United States, 1993–2011.  This graph focuses on trends in primary MDR TB 
(based on initial isolates from persons with no prior history of TB) in the United States from 1993 through 2011.  
The number of primary MDR TB cases, represented by bars, steadily declined from 407 in 1993 to 115 in 2001.  
Since then, the total number of primary MDR TB cases has fluctuated from 86 to 132 cases, with 98 cases reported 
for 2011.  Primary MDR TB, shown by the line, decreased from 2.5% in 1993 to approximately 1.1% in 1997, and 
has fluctuated around 1.0% since then. In 2011, the percentage increased to 1.3%. 
Slide 21. Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.  
This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons.  Based on initial isolates from 
persons with no prior history of TB, the percentage of isoniazid resistance was approximately two times higher 
among foreign-born persons than among U.S.-born persons.  In foreign-born persons, the percentage declined from 
12.4% in 1993 to 10.7% in 2011.  In U.S.-born persons, the percentagedecreased from 6.8% in 1993 to 4.2% in 
2007, but has increased since then to 6.5% in 2011. 
Slide 22. Primary MDR TB in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.  This graph 
highlights primary MDR TB in U.S.-born versus foreign-born persons.  The percentage with primary MDR TB 
has declined among both groups since 1993, although the decline in the U.S.-born has been greater.  As a result, 
the proportion of primary MDR TB cases in the US that are attributed to foreign-born persons increased from ap-
proximately 25% in 1993 to 83% in 2011 (not shown on slide).  Among the U.S.-born, the percentage with primary 
MDR TB remained between 0.4% and 0.7% from 1999 through 2010 and was 0.6% in 2011.  The percentage 
among foreign-born persons has fluctuated year by year, while averaging approximately 1.5% from 1999 through 
2010. In 2011, the percentage of primary MDR TB among foreign-born persons was 1.7%
Slide 23. Extensively Drug Resistant (XDR) TB, as Defined on Initial Drug Susceptibility Testing (DST), 
United States, 1993–2011.  This graph shows the annual number of counted XDR TB cases as defined on initial 
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DST from 1993-2011, reported as of June 25,2012 ; XDR TB is defined as resistance to isoniazid and rifampin, 
plus resistance to any fluoroquinolone and at least one of three injectable second-line anti-TB drugs. Six cases 
of XDR TB were reported in 2011. The most reported in a single year was 10 in 1993, while there were no cases 
reported in 2003 and 2009. There is no apparent trend in the number of cases over time. 
Slide 24. Reporting of HIV Test Results in Persons with TB by Age Group, United States, 1993–2011.  This 
slide shows the completeness of reporting of HIV test results in persons with TB by age group from 1993 through 
2011.  The percentage of TB patients for whom test results were reported increased from 30% among all ages in 
1993 to 82% in 2011.  Among adults aged 25–44 years, the percentage increased from 46% in 1993 to 90% in 
2011.   California began reporting HIV test results to CDC in 2011; this accounts for the substantial percentage 
increase for that year.
Slide 25. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993–2011.  This slide pro-
vides minimum estimates of HIV coinfection among persons reported with TB from 1993 through 2011.  Since the 
addition of the request for HIV status to the individual TB case report in 1993, incomplete reporting has provided a 
challenge to calculating reliable estimates.  Results from the cross-matching of TB and AIDS registries have been 
used to supplement reported HIV test results.  For all ages, the estimated percentage of HIV coinfection in persons 
reported with TB decreased from 15% to 6% overall and from 29% to 10% in persons aged 25 to 44 years during 
this period. 
Slide 26. TB Cases by Residence in Correctional Facilities, Age ≥15, United States, 1993-2011. This graph 
highlights the number of cases that were a resident of any type of correctional facility at the time of TB diagno-
sis. Cases must have been 15 years of age or greater. The number of cases residing in a correctional facility has 
decreased from 1,117 cases in 1994 to 424 cases in 2011. Between the years 2000 and 2010, the number of cases 
residing in a correctional facility has fluctuated between 587 (in 2000) to as low as 460 (in 2002). The first year 
to drop below this range was 2011, to 424 cases. Of total cases, the percentage of cases residing in a correctional 
facility has ranged from 5.1% in 1994 to 3.3% in 2002. The 1990s saw a decreasing trend in percentage until 2002. 
Since 2002, the trend has showed an increase; in 2010 the percentage of total cases was 4.7%. In 2011, this percent-
age decreased to 4.3%, only the second decrease since 2002. 
Slide 27. TB Cases by Homeless Status, Age ≥15, United States, 1993-2011. This graph shows the number of 
TB cases reported to be homeless within twelve months prior to their TB diagnosis from 1993 through 2011. Cases 
must have been above 14 years of age. The number of homeless cases has decreased from a high of 1379 cases in 
1994 to 565 in 2011 and parallels the overall decline in cases during this time. This category has seen a continuous 
decrease in cases since 1994; the years 2003, 2006, and 2010 have been exceptions with a small increase in cases. 
Of total cases, 6.8% were homeless in 1994 and percentages have ranged between 7.5% in 1993 and 5.4% in 2009. 
Since 2009 there has been a small increase in 2010 (5.7%) and in 2011 (5.8%).
Slide 28. Mode of Treatment Administration in Persons Reported with TB, United States, 1993–2009.  In 
1993, the reporting areas began providing information about mode of treatment administration on the individual TB 
case report form.  Treatment administered as only directly observed therapy (DOT) increased from 21.7% in 1993 
to 59.5% in 2009, the latest year with available data.  The proportion of patients who received at least some portion 
of their treatment as DOT (based on combining the percentage of patients who received only DOT and the percent-
age for whom some portion was self-administered) remained the same in 2009 as it was in 2008.  In 2009, 89.8% of 
patients received at least some portion of their treatment as DOT.
Slide 29. Completion of TB Therapy, United States, 1993–2009.  The reporting areas began providing infor-
mation on completion of therapy in 1993 through the individual TB case report form.  The calculations exclude 
persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with 
miliary disease or positive blood culture.  Overall completion of therapy had remained at approximately 92-93% 
from 1998 through 2008, but increased to 95% in 2009.. Completion in 1 year or less increased from 64% in 1993 
to 88% in 2009, the latest year with available data.  The current DHHS Healthy People 2020 objective is comple-
tion of therapy in 1 year or less in 93% of patients.  CDC is working with state and local health departments to 
determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.
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Tuberculosis Case Definition for Public Health Surveillance1
(Revised May 13, 2009) 
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, usually characterized patho-
logically by the formation of granulomas. The most common site of infection is the lung, but other 
organs may be involved. 
Clinical case definition
A case that meets all of the following criteria: 
A positive tuberculin skin test result or positive interferon gamma release assay for •	 M. tuber-
culosis
Other signs and symptoms compatible with tuberculosis (TB) (e.g., abnormal chest radio-•	
graph, abnormal chest computerized tomography scan or other chest imaging study, or clini-
cal evidence of current disease)
Treatment with two or more anti-TB medications•	
A completed diagnostic evaluation•	
Laboratory criteria for diagnosis 
Isolation of •	 M. tuberculosis complex from a clinical specimen,* 
or
Demonstration of •	 M. tuberculosis complex from a clinical specimen by nucleic acid amplifi-
cation test,† 
or
Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or can-•	
not be obtained or is falsely negative or contaminated.
Case classification
Confirmed: a case that meets the clinical case definition or is laboratory confirmed
Comment
A case should not be counted twice within any consecutive 12-month period. However, a case oc-
curring in a patient who had previously had verified TB disease should be reported and counted 
again if more than 12 months have elapsed since the patient completed therapy. A case should also 
be reported and counted again if the patient was lost to supervision for greater than 12 months and 
TB disease can be verified again. Mycobacterial diseases other than those caused by M. tuberculosis 
complex should not be counted in tuberculosis morbidity statistics unless there is concurrent tuber-
culosis.
                                                                                                                  
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic acid high-pressure liquid 
chromatography performed on a culture from a clinical specimen) are acceptable under this criterion.
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria species for clinical purposes. 
A culture isolate of M. tuberculosis complex is required for complete drug susceptibility testing and also genotyping. 
However, for surveillance purposes, CDC will accept results obtained from NAA tests approved by the Food and Drug 
Administration (FDA) and used according to the approved product labeling on the package insert, or a test produced 
and validated in accordance with applicable FDA and Clinical Laboratory Improvement Amendments (CLIA) regula-




Recommendations for Counting Reported Tuberculosis Cases
(Revised May 13, 2009)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in July 
1997, numerous changes have occurred, and many issues have been raised within the field of tu-
berculosis (TB) surveillance.  This current version updates and supersedes the previous version.
A distinction should be made between reporting TB cases to a health department and counting 
TB cases for determining incidence of disease.  Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers.  From these reports, the state or local TB control officer must deter-
mine which cases meet the current surveillance definition for TB disease and whether the case 
is countable.  These countable TB cases are then reported to the Centers for Disease Control and 
Prevention (CDC).  
Beginning in 2009, state and local TB control officers may also report to CDC those TB cases 
that are verified but not countable for morbidity statistics, as a measure of programmatic and case 
management burden. The noncountable report can include persons with TB disease recurring 
within a consecutive 12-month period after the patient completed TB therapy. 
I. Reporting TB Cases. CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments 
based on the current “Tuberculosis Case Definition for Public Health Surveillance” (Ap-
pendix A). This notification is essential in order for TB programs to
Ensure case supervision•	
Ensure completion of appropriate therapy•	
Ensure completion of contact investigations•	
Evaluate program effectiveness•	
Assess trends and characteristics of TB morbidity•	
II. TB Surveillance. For purposes of surveillance, a case of TB is defined on the basis of 
laboratory or clinical evidence of active disease due to M. tuberculosis complex.*
________________________________
* Because most laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis from very closely related species, 
these laboratories report culture results as being positive or negative for “Mycobacterium tuberculosis complex.” Although in almost 
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M. tuberculosis, other species are possible. Other spe-
cies in the Mycobacterium tuberculosis complex include M. bovis, M. africanum, M. microti, M. canetii, M. caprae, M. pinnipedii, and 
M. mungi; the inclusion of these species in M. tuberculosis complex should not impact public health laboratories or programs, because 
only a few laboratories identify to the species level.  These seven species are almost identical in DNA homology studies. In terms of 
their ability to cause clinical disease or be transmissible from person to person, M. bovis, M. africanum, M. microti, M. canetii, M. pin-
nipedii, and M. mungi behave like M. tuberculosis; therefore, disease caused by any of the organisms should be reported as TB, using 
the Report of Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of M. bovis, which may be isolated from 
persons who have received the vaccine for protection against TB or as cancer immunotherapy; disease caused by the BCG strain of M. 
bovis should not be reported as TB.
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a. Laboratory Case Definition
Isolation of •	 M. tuberculosis complex from a clinical specimen.  The use of rapid identi-
fication techniques for M. tuberculosis performed on a culture from a clinical specimen, 
such as DNA probes and high-pressure liquid chromatography (HPLC), is acceptable 
under this criterion.
OR
Demonstration of •	 M. tuberculosis from a clinical specimen by nucleic acid amplifica-
tion (NAA) test. NAA tests must be accompanied by cultures of mycobacterial species. 
However, for surveillance purposes, CDC will accept results obtained from NAA tests 
approved by the Food and Drug Administration (FDA) and used according to the ap-
proved product labeling on the package insert, or a test produced and validated in accor-
dance with applicable FDA and Clinical Laboratory Improvement Amendments (CLIA) 
regulations.     
OR   
Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not •	
been or cannot be obtained or is falsely negative or contaminated; historically this crite-
rion has been most commonly used to diagnose TB in the postmortem setting.  
b.   Clinical Case Definition. In the absence of laboratory confirmation of M. tuberculosis com-
plex after a diagnostic process has been completed, persons must have all of the following 
criteria for clinical TB:
Evidence of TB infection based on a positive tuberculin skin test result or positive inter-•	
feron gamma release assay for M. tuberculosis 
Current treatment with two or more anti-TB medications•	
AND
One of the following:•	
(1) Signs and symptoms compatible with current TB disease, such as an abnormal chest 
radiograph or abnormal chest computerized tomography scan or other chest imag-
ing study, 
OR
(2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight loss, 
hemoptysis)
NOTE: The software for TB surveillance developed by CDC includes a calculated variable called “Vercrit,” 
for which one of the values is “Provider Diagnosis.”  “Provider Diagnosis” is selected when the user chooses 
to override a “Suspect” default value in the case verification screen as “Verified by Provider Diagnosis.”  Thus, 
“Provider Diagnosis” is not a component of the case definition for TB in the current “Tuberculosis Case Defini-
tion for Public Health Surveillance” (Appendix A).  CDC’s national morbidity reports have traditionally included 
all TB cases that are considered verified by the reporting areas, without a requirement that cases meet the pub-
lished case definition.
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III. Counting TB Cases. Cases that meet the current CDC surveillance case definition for 
verified TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States.  The 
remaining 8 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. 
Virgin Islands) report cases to CDC but are not included in the annual incidence for the 
United States. The laboratory and clinical case definitions are the two diagnostic catego-
ries used in the CDC “Tuberculosis Case Definition for Public Health Surveillance.”
Most verified TB cases are accepted for counting based on laboratory confirmation 
of M. tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB.  If 
disease recurs in a person within any 12-consecutive-month period after the patient 
completed therapy, count only one episode as a case. However, if TB disease recurs 
in a person, and if more than 12 months have elapsed since the person completed 
TB therapy or was lost to supervision, the TB case is considered a separate episode 
and should be counted as a new case.  
Mycobacterial diseases other than those caused by M. tuberculosis complex should 
not be counted in TB morbidity statistics unless there is concurrent TB. 
a. Verified TB Cases
COUNT
Count only verified TB cases that meet the laboratory or clinical case definitions 
(see Section II).  The diagnosis of TB must be verified by the TB control officer 
or designee.  The current CDC surveillance case definition for TB describes and 
defines the criteria to be used in the case definition for TB disease. 
DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for confirma-
tion of disease.  Do not count as a case the patient for which two or more anti-TB 
medications have been prescribed for preventive therapy for exposure to multidrug- 
resistant (MDR) TB, or while the diagnosis is still pending
b. Nontuberculous Mycobacterial Diseases (NTM)
COUNT
An episode of TB disease diagnosed concurrently with another nontuberculous my-
cobacterial disease should be counted as a TB case.
DO NOT COUNT
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.
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c. TB Cases Reported at Death
COUNT
TB cases first reported to the health department at the time of a person’s death are 
counted as incident cases, provided the person had current disease at the time of 
death. The TB control officer should verify the diagnosis of TB.
DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy.
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign Visi-
tors3
COUNT
Immigrants and refugees who are examined after arriving in the United States and 
diagnosed with clinically active TB requiring anti-TB medications should be re-
ported and counted by the locality of their current residence at the time of diagnosis 
regardless of citizenship status.
Border crossers* who are diagnosed with TB and plan to receive anti-TB therapy 
from a locality in the United States for 90 days or more should be reported and 
counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic person-
nel) who are diagnosed with TB, are receiving anti-TB therapy, and have been, 
or plan to remain in, the United States for 90 days or more should be reported and 
counted by the locality of current residence.
*Border crosser — defined, by the U.S. Citizenship and Immigration Services 
(USCIS)2 as “an alien resident of the United States reentering the country after an 
absence of less than six months in Canada or Mexico, or a nonresident alien en-
tering the United States across the Canadian border for stays of no more than six 
months, or across the Mexican border for stays of no more than 72 hours.” Border 
crossers may go back and forth across the border many times in a short period.
DO NOT COUNT
Any person who was diagnosed and started on anti-TB drugs in another country 
should not be counted as a new case but should be reported as a verified noncount-
able TB case.  
Border crossers* and foreign visitors who are diagnosed with TB and receive anti-
TB therapy from a locality in the United States for less than 90 days but plan to 
return to their native country to continue therapy should not be reported or counted 
by the locality where they receive anti-TB therapy.
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e. Out-of-State or Out-of-Area Residents 
COUNT 
A person’s TB case should be counted by the locality in which he or she resides at 
the time of diagnosis.  TB in a person who has no address should be counted by the 
locality that diagnosed and is treating the TB.  The TB control officer should notify 
the appropriate out-of-state or out-of-area TB control officer of the person’s home 
locality to (1) determine whether the case has already been counted to avoid “dou-
ble counting,” and (2) agree on which TB control office should count the case if it 
has not yet been counted. 
DO NOT COUNT 
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident 
and whose TB has already been counted by the out-of-area TB control office.
f. Migrants and Other Transients 
COUNT
Persons without any fixed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and 
counted where diagnosed.
DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that 
they have already been counted by another locality.  
g. Federal Facilities (e.g., Military and Veterans Administration Facilities)  
COUNT
Cases in military personnel, dependents, or veterans should be reported and counted 
by the locality where the persons are residing in the United States at the time of 
diagnosis and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a mili-
tary base outside the United States but are referred elsewhere for treatment (e.g., a 
military base located within the United States), the TB case should be reported and 
counted where treated and not where the diagnosis was made.
DO NOT COUNT
Do not count if the case was already counted by another locality in the United 
States.
h. Indian Health Service
COUNT
TB should be reported to the local health authority (e.g., state or county) and count-
ed where diagnosed and treatment initiated.  However, for a specific group such as 
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the Navajo Nation, which is geographically located in multiple states, health depart-
ments should discuss each case and determine which locality should count the case.
DO NOT COUNT
Do not count if the case was already counted by another locality. 
i. Correctional Facilities (e.g., Local, State, Federal, and Military)
COUNT
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities. TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated.
DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere 
by another locality or correctional facility, even if treatment continues at another 
locale or correctional facility. 
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States
DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted.  TB in 
these persons should be counted by the country in which they are residing, regard-
less of their plans to return to the United States for further work-up or treatment.
IV. Suggested Administrative Practices
To promote uniformity in TB case counting, the following administrative procedures 
are recommended:
(a) All TB cases verified by the 52 reporting areas with count authority (50 states, District 
of Columbia, and New York City) during the calendar year (by December 31) will be 
included in the annual U.S. incidence count for that year. All tuberculosis cases verified 
during the calendar year by a reporting area with count authority from one of the remain-
ing 8 reporting areas (American Samoa, Federated States of Micronesia, Guam, Marshall 
Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Is-
lands) are also counted but are not included in the annual incidence for the United States. 
Cases for which bacteriologic results are pending or for which confirmation of disease is 
questionable for any other reason should not be counted until their status is clearly deter-
mined; they should be counted at the time they meet the criteria for counting. This means 
that a case reported in one calendar year could be included in the morbidity count for the 
following year. The reporting area with count authority should ensure that there is agree-
ment between final local and state TB figures reported to CDC. Currently, some reporting 
areas may not use this suggested protocol. Some of these areas may wait until the begin-
ning of the following year when they have received and processed all of the TB cases 
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for inclusion in the annual case count for the previous year.  If reporting areas decide to 
revise their protocols, they should be aware that their TB trends may change.
(b) TB is occasionally reported to health departments over the telephone, by letter or fax, or 
on forms other than the Report of Verified Case of Tuberculosis (RVCT). Such informa-
tion should be accepted as an official morbidity report if sufficient details are provided; 
otherwise, the notification should be used as an indicator of a possible TB case (suspect) 
which should be investigated promptly for confirmation.
V. TB Surveillance Definitions
Case - an episode of TB disease in a person meeting the laboratory or clinical 
criteria for TB as defined in the document “Tuberculosis Case Definition for Public 
Health Surveillance” (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., 
a known contact to an active TB case or a person with signs or symptoms consistent 
with TB) who is currently under evaluation for TB disease.
Verification of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB 
control official who is familiar with TB surveillance definitions; if all the criteria for 
a TB case are met, the TB case is then verified and eligible for counting. 
Counting of a TB case - the process whereby a reporting area with count author-
ity evaluates verified TB cases against count criteria (e.g., assesses for case dupli-
cation). These cases are then counted for morbidity in that locality (e.g., state or 
county) and reported to CDC for national morbidity counting. Noncountable, veri-
fied cases may also be sent to CDC.
Mycobacterium tuberculosis complex (M. tuberculosis complex) - Because most 
laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis 
from very closely related species, these laboratories report culture results as being 
positive or negative for “Mycobacterium tuberculosis complex.” Although in almost 
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M. 
tuberculosis, other species are possible. For example, one study in San Diego found 
that 6% of human tuberculosis was caused by Mycobacterium bovis; cultures from 
these cases would be reported by most laboratories as being positive for M. tuber-
culosis complex. Other species in the Mycobacterium tuberculosis complex include 
M. africanum, M. microti, M. canetii, M. caprae, and M. pinnipedii. Although M. 
microti, M. canetii, M. caprae, and M. pinnipedii are newly described species, their 
inclusion in M. tuberculosis complex should not impact public health laboratories or 
programs because only a few laboratories identify to the species level. These seven 
species are almost identical in DNA homology studies. In terms of their ability to 
cause clinical disease or be transmissible from person to person, M. bovis, M. afri-
canum, M. microti, M. canetti, M. caprae, and M. pinnipedii behave like M. tuber-
culosis; therefore, disease caused by any of the organisms should be reported as TB, 
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using the Report of Verified Case of Tuberculosis (RVCT). The only exception is 
the BCG strain of M. bovis, which may be isolated from persons who have received 
the vaccine for protection against TB or as cancer immunotherapy; disease caused 
by the BCG strain of M. bovis should not be reported as TB.
 
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium 
tuberculosis complex that can cause human infection or disease.  Common nontu-
berculous mycobacteria include M. avium complex or MAC (M. avium, M. intracel-
lulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M. fortuitum, and 
M. simiae.  Other terms have been used to represent NTM, including MOTT (myco-
bacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verified TB cases to 
CDC.  Currently there are 60 reporting areas: the 50 states, District of Columbia, 
New York City, American Samoa, Federated States of Micronesia, Guam, Marshall 
Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin 
Islands.  The annual incidence of tuberculosis for the United States is based on 52 
reporting areas (the 50 states, District of Columbia, and New York City).
Alien - defined by the U.S. Citizenship and Immigration Services (USCIS)2 as “any 
person not a citizen or national of the United States.”
Border crosser - defined, by the U.S. Citizenship and Immigration Services 
(USCIS)2 as “an alien resident of the United States reentering the country after an 
absence of less than six months in Canada or Mexico, or a nonresident alien en-
tering the United States across the Canadian border for stays of no more than six 
months, or across the Mexican border for stays of no more than 72 hours.”  Border 
crossers may go back and forth across the border many times in a short period.
Class A TB with waiver3 
All applicants who have tuberculosis disease and have been granted a waiver. 
Class B1 TB, Pulmonary3 
 
 No treatment 
Applicants who have medical history, physical exam, HIV, or CXR findings •	
suggestive of pulmonary TB but have negative AFB sputum smears and 
cultures and are not diagnosed with TB or can wait to have TB treatment 
started after immigration. 
Completed treatment 
Applicants who were diagnosed with pulmonary TB and successfully •	
completed directly observed therapy prior to immigration. The cover sheet 
should indicate if the initial sputum smears and cultures were positive and if 
drug susceptibility testing results are available. 
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Class B1 TB, Extrapulmonary3 
Applicants with evidence of extrapulmonary TB. Document the anatomic site of 
infection. 
Class B2 TB, Latent TB Infection (LTBI) Evaluation3 
 
Applicants who have a tuberculin skin test ≥10 mm but otherwise have a negative 
evaluation for TB. The size of the TST reaction, the applicant’s status with respect 
to LTBI treatment, and the medication(s) used should be documented. For appli-
cants who had more than one TST, whether the applicant converted the TST should 
be documented (i.e., initial TST <10 mm but subsequent TST ≥10 mm). 
Class B3 TB, Contact Evaluation3 
 
Applicants who are a recent contact of a known tuberculosis case. The size of the 
applicant’s TST reaction should be documented. Information about the source case, 
name, alien number, relationship to contact, and type of tuberculosis should also be 
documented.
Immigrant - defined by the USCIS2  as “an alien admitted to the United States as 
a lawful permanent resident.  Immigrants are those persons lawfully accorded the 
privilege of residing permanently in the United States.  They may be issued immi-
grant visas by the Department of State overseas or adjusted to permanent resident 
status by the USCIS of the United States.”
Permanent Resident Alien - see Immigrant. 
Waivers3 - A provision allows applicants undergoing pulmonary or laryngeal 
tuber culosis treatment to petition for a Class A TB with waiver. Waivers should be 
pursued for any immigrant or refugee who has a complicated clinical course and 
would benefit from receiving treatment of their tuberculosis in the United States. 
Applicants diag nosed with tuberculosis disease who are both smear- and culture-
negative and will be traveling to the United States prior to start of treatment do not 
need to complete the waiver process.
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Appendix C
National Surveillance for Severe Adverse Events Associated with Treatment for 
Latent Tuberculosis Infection - Reporting Information
This information is included to alert our public health partners of the importance of reporting se-
vere (i.e., hospitalization or death) adverse events associated with treatment for latent TB infec-
tion (LTBI). Data on severe adverse events (SAEs) among persons receiving treatment for LTBI 
are needed to serve as a basis for periodic evaluation of guidelines for treatment of LTBI. 
 In April 2000, after the publication of updated Guidelines for Targeted Tuberculin Testing and 
Treatment of Latent Tuberculosis Infection1, DTBE began receiving reports of SAEs related to the 
use of a 2-month course of rifampin and pyrazinamide (RZ) for treatment of LTBI.  In response, 
DTBE requested and received reports and conducted on-site investigations of liver injury in persons 
on treatment for LTBI, and treatment guidelines were revised to recommend against the general use 
of rifampin and pyrazinamide to treat LTBI.2, 3 In January 2004, DTBE implemented the National 
Surveillance System for Severe Adverse Events Associated with Treatment for LTBI, which collects 
reports about SAEs associated with any treatment regimen for LTBI, to quantify the frequency of 
SAEs and to characterize the clinical features of affected patients.4 
Local medical providers should report possible LTBI-treatment associated SAEs to their respective 
local/state health departments. State health departments should report SAEs that occurred on or after 
January 1, 2004 to DTBE (e-mail: LTBIdrugevents@cdc.gov).
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